<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003430.pub2" GROUP_ID="COLOCA" ID="001900112621374649" MERGED_FROM="" MODIFIED="2017-01-04 13:19:39 +0000" MODIFIED_BY="Henning Keinke Andersen" REVIEW_NO="038" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2017-01-04 13:19:39 +0000" MODIFIED_BY="Henning Keinke Andersen">
<TITLE MODIFIED="2016-12-07 02:57:19 +0100" MODIFIED_BY="[Empty name]">Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas</TITLE>
<CONTACT MODIFIED="2017-01-04 13:19:39 +0000" MODIFIED_BY="Henning Keinke Andersen"><PERSON ID="z1211011453098787989601057082896" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Jingen</FIRST_NAME><LAST_NAME>Lu</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>Longhuadoctor_jin@163.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Anorectal Surgery</DEPARTMENT><ORGANISATION>Longhua Hospital, Shanghai Traditional Chinese Medicine University</ORGANISATION><ADDRESS_1>725 South Wanping Road, Xuhui District</ADDRESS_1><CITY>Shanghai</CITY><ZIP>200032</ZIP><REGION>Shanghai</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86-013774320630</PHONE_1><FAX_1>+86-21-64698179</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2017-01-04 13:19:39 +0000" MODIFIED_BY="Henning Keinke Andersen"><PERSON ID="z1211011443526877248655918785954" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Yibo</FIRST_NAME><LAST_NAME>Yao</LAST_NAME><POSITION>Dr</POSITION><EMAIL_1>Elevenzoe@163.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Anorectal Surgery</DEPARTMENT><ORGANISATION>Longhua Hospital, Shanghai Traditional Chinese Medicine University</ORGANISATION><ADDRESS_1>725 South Wanping Road, Xuhui District</ADDRESS_1><CITY>Shanghai</CITY><ZIP>200032</ZIP><REGION>Shanghai</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>86-013774320630</PHONE_1><FAX_1>86-21-64698179</FAX_1></ADDRESS></PERSON><PERSON ID="32212196170187591241091215150732" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Tao</FIRST_NAME><LAST_NAME>Suo</LAST_NAME><POSITION>Associate Chief Physician</POSITION><EMAIL_1>simonsuo@aliyun.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of General Surgery, Institute of General Surgery</DEPARTMENT><ORGANISATION>Zhongshan Hospital, Fudan University</ORGANISATION><ADDRESS_1>180 Fenglin Road, Xuhui District</ADDRESS_1><CITY>Shanghai</CITY><ZIP>200032</ZIP><REGION>Shanghai</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 21 64041990-2365</PHONE_1><FAX_1>+86 21 64038472</FAX_1></ADDRESS></PERSON><PERSON ID="FB6EA65182E26AA200C04FC108587891" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Roland</FIRST_NAME><LAST_NAME>Andersson</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>roland.andersson@med.lu.se</EMAIL_1><ADDRESS><DEPARTMENT>Department of Surgery, Clinical Sciences</DEPARTMENT><ORGANISATION>Faculty of Medicine, Lund University</ORGANISATION><ADDRESS_1>Lund University Hospital</ADDRESS_1><CITY>Lund</CITY><ZIP>SE-221 85</ZIP><COUNTRY CODE="SE">Sweden</COUNTRY><PHONE_1>+46 46 17 23 59</PHONE_1><FAX_1>+46 46 14 72 98</FAX_1></ADDRESS></PERSON><PERSON ID="z1211011458341322808218048717754" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Yongqing</FIRST_NAME><LAST_NAME>Cao</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>longhuadoctor_cao@163.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Anorectal Surgery</DEPARTMENT><ORGANISATION>Longhua Hospital, Shanghai Traditional Chinese Medicine University</ORGANISATION><ADDRESS_1>725 South Wanping Road, Xuhui District</ADDRESS_1><CITY>Shanghai</CITY><ZIP>200032</ZIP><REGION>Shanghai</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86-013801800862</PHONE_1><FAX_1>+86-21-64698179</FAX_1></ADDRESS></PERSON><PERSON ID="z1211011449061375387212637559037" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Chen</FIRST_NAME><LAST_NAME>Wang</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>longhuadoctor_wang@163.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Anorectal Surgery</DEPARTMENT><ORGANISATION>Longhua Hospital, Shanghai Traditional Chinese Medicine University</ORGANISATION><ADDRESS_1>725 South Wanping Road</ADDRESS_1><CITY>Shanghai</CITY><ZIP>200032</ZIP><REGION>Shanghai</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86-013391112552</PHONE_1><FAX_1>+86-21-64698179</FAX_1></ADDRESS></PERSON><PERSON ID="z1211011453098787989601057082896" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Jingen</FIRST_NAME><LAST_NAME>Lu</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>Longhuadoctor_jin@163.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Anorectal Surgery</DEPARTMENT><ORGANISATION>Longhua Hospital, Shanghai Traditional Chinese Medicine University</ORGANISATION><ADDRESS_1>725 South Wanping Road, Xuhui District</ADDRESS_1><CITY>Shanghai</CITY><ZIP>200032</ZIP><REGION>Shanghai</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86-013774320630</PHONE_1><FAX_1>+86-21-64698179</FAX_1></ADDRESS></PERSON><PERSON ID="z1212211349077446510049829559599" ROLE="AUTHOR"><FIRST_NAME>Evelyne</FIRST_NAME><LAST_NAME>Chui</LAST_NAME><POSITION>Statistician</POSITION><EMAIL_1>evelyne_chui@hotmail.com</EMAIL_1><ADDRESS><ORGANISATION>Systematic Review Solutions Ltd</ORGANISATION><ADDRESS_1>5-6 West Tashan Road</ADDRESS_1><CITY>Yan Tai</CITY><ZIP>264000</ZIP><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+44 (0)7905 213712</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2016-12-07 14:35:43 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="4" MONTH="4" YEAR="2016"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="4" MONTH="4" YEAR="2016"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="12" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2002"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2002"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-01-04 14:09:43 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-01-04 14:09:43 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="4" YEAR="2016"/>
<DESCRIPTION>
<P>New searches performed. Two new identified RCTs included in this update.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2017-01-02 08:38:24 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-01-02 08:38:24 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="24" MONTH="6" YEAR="2013"/>
<DESCRIPTION>
<P>New search run and one further report with 8-
year follow-
up data added. Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="13" MONTH="11" YEAR="2001"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2013-05-09 10:56:26 +0200" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2013-05-09 10:54:52 +0200" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>Mount Sinai Hospital</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University of Toronto, Department of Surgery</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2013-05-09 10:54:52 +0200" MODIFIED_BY="[Empty name]">
<NAME>Long-yi Group, Long-hua Hospital (Affiliated hospital of Shanghai Traditional Chinese Medicine University) LYTD-06</NAME>
<COUNTRY CODE="CN">China</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2013-05-09 10:54:37 +0200" MODIFIED_BY="[Empty name]">
<NAME>Research and Innovation group, Shanghai Traditional Chinese Medicine University</NAME>
<COUNTRY CODE="CN">China</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2013-05-09 10:56:26 +0200" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2013-05-09 10:55:47 +0200" MODIFIED_BY="[Empty name]">
<NAME>Hai-Pai Traditional Chinese Medicine Heritage Research Base - Gu's general surgery ZYSNXD-CC-APGC-JD002</NAME>
<COUNTRY CODE="CN">China</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2013-05-09 10:56:26 +0200" MODIFIED_BY="[Empty name]">
<NAME>National Natural Science Foundation of China. Scheme number:81273763</NAME>
<COUNTRY CODE="CN">China</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2017-01-04 10:30:04 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2017-01-02 14:18:29 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2016-12-07 12:01:06 +0100" MODIFIED_BY="[Empty name]">Does dietary fibre prevent the recurrence of colorectal adenomas and carcinomas?</TITLE>
<SUMMARY_BODY MODIFIED="2017-01-02 14:18:29 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>We asked</B>
</P>
<P>Does nutritional supplement of dietary fibre prevent recurrence of precancerous polyps and cancer in the bowel in participants with a history of polyps having been removed to achieve a polyp-free colon at baseline for the intervention.</P>
<P>
<B>Background </B>
</P>
<P>Colorectal (bowel) cancer is common worldwide but is especially prevalent in industrialised countries. Genes, diet and lifestyle all seem to be important in the development of bowel cancer. Several communities with low bowel cancer rates have diets that are rich in fibre. Increasing the levels of fibre in the diet in industrialised countries might therefore help to reduce the rate of bowel cancer.</P>
<P>
<B>Search Date</B>
</P>
<P>The evidence is current to 4 April 2016.</P>
<P>
<B>Study characteristics</B>
</P>
<P>Seven studies met the inclusion criteria. However, only five studies with 4798 participants provided data for this review. The mean ages of the participants ranged from 56 to 66 years. The participants all had a history of adenomas and would have had at least one procedure to remove them to achieve a polyp-free colon at baseline.The interventions in the included studies were wheat bran fibre, ispaghula husk, or a comprehensive dietary intervention with high fibre whole food sources used alone or in combination. These were compared to low-fibre (2 to 3 g per day), placebo, or a regular diet.</P>
<P>
<B>Key results</B>
</P>
<P>This review found that increasing fibre in a Western diet for two to eight years did not lower the risk of bowel cancer. Paradoxically, after four years participants receiving dietary fibre had higher rates of bowel cancer compared with the control group, with the absolute increase in risk being one percent.</P>
<P>
<B>Quality of evidence</B>
</P>
<P>The quality of evidence was low. The high risk of bias of included studies, small sample size, large number of missing data and the use of indirect measures gave us little confidence on the findings of this review.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2017-01-02 14:15:33 +0100" MODIFIED_BY="[Empty name]">
<P>This is an update of the Cochrane review published in 2002.</P>
<P>Colorectal cancer (CRC) is a major cause of morbidity and mortality in industrialised countries. Experimental evidence has supported the hypothesis that dietary fibre may protect against the development of CRC, although epidemiologic data have been inconclusive.<BR/>
</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2017-01-02 14:39:49 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effect of dietary fibre on the recurrence of colorectal adenomatous polyps in people with a known history of adenomatous polyps and on the incidence of CRC compared to placebo. Further, to identify the reported incidence of adverse effects, such as abdominal pain or diarrhoea, that resulted from the fibre intervention.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2017-01-02 14:16:11 +0100" MODIFIED_BY="[Empty name]">
<P>We identified randomised controlled trials (RCTs) from Cochrane Colorectal Cancer's Specialised Register, CENTRAL, MEDLINE and Embase (search date, 4 April 2016). We also searched ClinicalTrials.gov and WHO International Trials Registry Platform on October 2016.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2017-01-02 14:16:46 +0100" MODIFIED_BY="[Empty name]">
<P>We included RCTs or quasi-RCTs. The population were those having a history of adenomatous polyps, but no previous history of CRC, and repeated visualisation of the colon/rectum after at least two-years' follow-up. Dietary fibre was the intervention. The primary outcomes were the number of participants with: 1. at least one adenoma, 2. more than one adenoma, 3. at least one adenoma greater than or equal to 1 cm, or 4. a new diagnosis of CRC. The secondary outcome was the number of adverse events.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2017-01-02 14:17:09 +0100" MODIFIED_BY="[Empty name]">
<P>Two reviewers independently extracted data, assessed trial quality and resolved discrepancies by consensus. We used risk ratios (RR) and risk difference (RD) with 95% confidence intervals (CI) to measure the effect. If statistical significance was reached, we reported the number needed to treat for an additional beneficial outcome (NNTB) or harmful outcome (NNTH). We combined the study data using the fixed-effect model if it was clinically, methodologically, and statistically reasonable.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]">
<P>We included seven studies, of which five studies with 4798 participants provided data for analyses in this review. The mean ages of the participants ranged from 56 to 66 years. All participants had a history of adenomas, which had been removed to achieve a polyp-free colon at baseline. The interventions were wheat bran fibre, ispaghula husk, or a comprehensive dietary intervention with high fibre whole food sources alone or in combination. The comparators were low-fibre (2 to 3 g per day), placebo, or a regular diet. The combined data showed no statistically significant difference between the intervention and control groups for the number of participants with at least one adenoma (5 RCTs, n = 3641, RR 1.04, 95% CI 0.95 to 1.13, low-quality evidence), more than one adenoma (2 RCTs, n = 2542, RR 1.06, 95% CI 0.94 to 1.20, low-quality evidence), or at least one adenoma 1 cm or greater (4 RCTs, n = 3224, RR 0.99, 95% CI 0.82 to 1.20, low-quality evidence) at three to four years. The results on the number of participants diagnosed with colorectal cancer favoured the control group over the dietary fibre group (2 RCTS, n = 2794, RR 2.70, 95% CI 1.07 to 6.85, low-quality evidence). After 8 years of comprehensive dietary intervention, no statistically significant difference was found in the number of participants with at least one recurrent adenoma (1 RCT, n = 1905, RR 0.97, 95% CI 0.78 to 1.20), or with more than one adenoma (1 RCT, n = 1905, RR 0.89, 95% CI 0.64 to 1.24). More participants given ispaghula husk group had at least one recurrent adenoma than the control group (1 RCT, n = 376, RR 1.45, 95% CI 1.01 to 2.08). Other analyses by types of fibre intervention were not statistically significant. The overall dropout rate was over 16% in these trials with no reasons given for these losses. Sensitivity analysis incorporating these missing data shows that none of the results can be considered as robust; when the large numbers of participants lost to follow-up were assumed to have had an event or not, the results changed sufficiently to alter the conclusions that we would draw. Therefore, the reliability of the findings may have been compromised by these missing data (attrition bias) and should be interpreted with caution.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2017-01-02 14:17:50 +0100" MODIFIED_BY="[Empty name]">
<P>There is a lack of evidence from existing RCTs to suggest that increased dietary fibre intake will reduce the recurrence of adenomatous polyps in those with a history of adenomatous polyps within a two to eight year period. However, these results may be unreliable and should be interpreted cautiously, not only because of the high rate of loss to follow-up, but also because adenomatous polyp is a surrogate outcome for the unobserved true endpoint CRC. Longer-term trials with higher dietary fibre levels are needed to enable confident conclusion.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2017-01-04 10:30:04 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2017-01-04 10:30:04 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2017-01-04 10:28:23 +0100" MODIFIED_BY="[Empty name]">
<P>Colorectal cancer (CRC) is a leading cause of morbidity and mortality in industrialised nations, and is the third most common cancer worldwide with an estimated 1.24 million new cases of CRC diagnosed in 2008 (<LINK REF="REF-CRUK-2012" TYPE="REFERENCE">CRUK 2012</LINK>). Globally, the incidence of CRC varies 10-fold with the highest rates found in Australia and New Zealand, North America and Europe; the lowest rates are found in South-Central Asia and Africa (<LINK REF="REF-Jemal-2011" TYPE="REFERENCE">Jemal 2011</LINK>). Incidence rates from 27 European Union countries found that the highest incidences occur in Slovakia for men (91 cases per 100,000) and Denmark for women (50 cases per 100,000), while the lowest rates are in Greece for both sexes (24 cases per 100,000 for men and 17 per 100,000 for women) (<LINK REF="REF-GLOBOCAN-2008" TYPE="REFERENCE">GLOBOCAN 2008</LINK>). These geographical differences are thought to be due to dietary and environmental factors, with the disease occurring mainly in high-income countries with a Western culture (<LINK REF="REF-Boyle-2000" TYPE="REFERENCE">Boyle 2000</LINK>, <LINK REF="REF-Center-2009" TYPE="REFERENCE">Center 2009</LINK>), although these figures may be affected by ascertainment bias, due to underreporting in low- and middle-income countries. Age is an important risk factor with the risk of CRC increasing in people after the age of 40, and increasing markedly at 50 years, with more than 90% of CRC occurring in those aged 50 or older and the prevalence rising across all five-year age categories, reaching a peak at 70 to 74 years of age (<LINK REF="REF-Corley-2013" TYPE="REFERENCE">Corley 2013</LINK>; <LINK REF="REF-Giovannucci-2006" TYPE="REFERENCE">Giovannucci 2006;</LINK> <LINK REF="REF-Ries-2008" TYPE="REFERENCE">Ries 2008</LINK>).</P>
<P>Colorectal cancers mostly arise from dysplastic adenomatous polyps, and develop from the cumulative effect of sequential genetic alterations (multistep carcinogenesis), which can develop sporadically, or develop due to an inherited genetic cancer predisposition (<LINK REF="REF-Arnold-2005" TYPE="REFERENCE">Arnold 2005</LINK>; <LINK REF="REF-Shussman-2014" TYPE="REFERENCE">Shussman 2014</LINK>). It is estimated that 70% of CRCs develop sporadically, whilst 30% of CRCs are due to an inherited form of the disease (<LINK REF="REF-Jasperson-2010" TYPE="REFERENCE">Jasperson 2010</LINK>). Sporadic forms of CRC are thought to be related to lifestyle factors, and the geographical variation in CRC incidence and findings from migrant studies (<LINK REF="REF-McCredie-1999" TYPE="REFERENCE">McCredie 1999</LINK>; <LINK REF="REF-Winkels-2014" TYPE="REFERENCE">Winkels 2014</LINK>) suggest that diet (<LINK REF="REF-Gonzalez-2006" TYPE="REFERENCE">Gonzalez 2006;</LINK> <LINK REF="REF-Terry-2001" TYPE="REFERENCE">Terry 2001</LINK>; <LINK REF="REF-Winkels-2014" TYPE="REFERENCE">Winkels 2014</LINK>), and other lifestyle factors (<LINK REF="REF-Fu-2012" TYPE="REFERENCE">Fu 2012</LINK>; <LINK REF="REF-Potter-1993" TYPE="REFERENCE">Potter 1993</LINK>) play an important role in the aetiology of the disease. In 1971, based on the observation that CRC was rare in rural areas of many African countries, Burkitt hypothesized that the consumption of dietary fibre in those regions was protective (<LINK REF="REF-Burkitt-1971" TYPE="REFERENCE">Burkitt 1971</LINK>). Further, he postulated that the high intake of refined carbohydrates in Western countries increased the risk of developing CRC.<BR/>
</P>
</CONDITION>
<INTERVENTION MODIFIED="2017-01-04 10:30:04 +0100" MODIFIED_BY="[Empty name]">
<P>At present, there is no consensus on how dietary fibre should be defined. The original standard classification (<LINK REF="REF-Trowell-1976" TYPE="REFERENCE">Trowell 1976</LINK>) describes dietary fibre as being composed of remnants of plant cells that are resistant to hydrolysis by human alimentary enzymes. This includes all indigestible polysaccharides such as celluloses, hemicelluloses, oligosaccharides, pectins, gums and waxes as well as lignin, a chemical compound most commonly derived from wood that is also present in plants. Dietary fibre is further classified as soluble (i.e. pectin, agar) or insoluble (cellulose, heteroxylans and lignified cell walls (wheat bran)), with the soluble form being less protective against cancer (<LINK REF="REF-Bunzel-2005" TYPE="REFERENCE">Bunzel 2005</LINK>; <LINK REF="REF-Ferguson-1996" TYPE="REFERENCE">Ferguson 1996</LINK>; <LINK REF="REF-Murphy-2012" TYPE="REFERENCE">Murphy 2012</LINK>). Some have suggested that resistant starch, the portion of starch that remains undigested in the small intestine, actually functions as a dietary fibre (<LINK REF="REF-Prosky-2000" TYPE="REFERENCE">Prosky 2000</LINK>), though it is not part of the standard definition. More recently, the European Food and Safety Authority (EFSA) defined dietary fibre as non-digestible carbohydrates plus lignin, including non-starch polysaccharides: cellulose; hemicelluloses; pectins; hydrocolloids (i.e. gums, mucilages, glucans); resistant oligosaccharides, fructo-oligosaccharides, galacto-oligosaccharides, other resistant oligosaccharides; resistant starch, consisting of physically enclosed starch, some types of raw starch granules, retrograded amylose, chemically or physically modified starches, or both; and lignin associated with the dietary fibre polysaccharides (<LINK REF="REF-EFSA-2010" TYPE="REFERENCE">EFSA 2010</LINK>). Another limitation in examining the relationship between dietary fibre and the risk of CRC is that individuals with high fibre content in their diet are likely to have healthier diets and lifestyles in general, and this can result in residual confounding, especially as the effect of this factor is difficult to separate in epidemiological studies (<LINK REF="REF-Huxley-2013" TYPE="REFERENCE">Huxley 2013</LINK>).</P>
<P>Most, but not all, experimental studies in humans and animals support the protective effects of dietary fibre in the development of CRC (<LINK REF="REF-Alberts-1996a" TYPE="REFERENCE">Alberts 1996a</LINK>; <LINK REF="REF-Aune-2011a" TYPE="REFERENCE">Aune 2011a</LINK>; <LINK REF="REF-Egeberg-2010" TYPE="REFERENCE">Egeberg 2010</LINK>; <LINK REF="REF-Fung-2010" TYPE="REFERENCE">Fung 2010</LINK>; <LINK REF="REF-Kritchevsky-1999" TYPE="REFERENCE">Kritchevsky 1999</LINK>; <LINK REF="REF-Reddy-1999" TYPE="REFERENCE">Reddy 1999</LINK>). Protection is thought to be mediated through two main mechanisms referred to as direct and indirect (<LINK REF="REF-Ferguson-1996" TYPE="REFERENCE">Ferguson 1996</LINK>; <LINK REF="REF-Lupton-1999" TYPE="REFERENCE">Lupton 1999</LINK>; <LINK REF="REF-Sowa-2000" TYPE="REFERENCE">Sowa 2000</LINK>). The direct mechanism postulates that dietary fibre reduces exposure of the gastrointestinal mucosa to carcinogens or tumour promoters through absorption, increased nutrient dilution and shortening faecal transit time. The indirect mechanism addresses the protective role that bacteria in the colon may play through a number of enzymatic processes. For instance butyrate, a chemical formed in the colon by bacterial fermentation of dietary fibre, is thought to reduce the activity of tumour promoters. In addition to these proposed mechanisms, the source of dietary fibres has also been identified as an important contributing factor. Data from studies in humans and other animals has consistently shown wheat bran to be superior to pectin, oat or corn bran (<LINK REF="REF-Dhingra-2012" TYPE="REFERENCE">Dhingra 2012</LINK>).</P>
<P>Two previously published meta-analyses reported a similar protective effect of fibre and other dietary consumption on the incidence of CRC. In 1990, the first meta-analysis examined the effects of dietary fibre and vegetables on the incidence of CRC. A search of all epidemiologic studies published between 1970 and 1988 was carried out. The authors critically assessed 23 case-control studies, 15 correlation studies, two cohort studies and three time-trend studies. The combined odds ratio for data that were combined from 12 case-control studies was 0.57 (95% CI 0.50 to 0.64) (<LINK REF="REF-Trock-1990" TYPE="REFERENCE">Trock 1990</LINK>). Studies that demonstrated "equivocal support for protective effect" were excluded. In 1992, a second meta-analysis reviewed studies that were published between 1975 and 1988 and examined the effects of fibre, vitamin C, and beta-carotene on CRC risk (<LINK REF="REF-Heine_x002d_Broring-2015" TYPE="REFERENCE">Heine-Broring 2015</LINK>; <LINK REF="REF-Howe-1992" TYPE="REFERENCE">Howe 1992</LINK>; <LINK REF="REF-Jung-2013" TYPE="REFERENCE">Jung 2013</LINK>). Thirteen case control studies were identified, and data from a total of 5287 people with CRC and 10,470 controls were combined. Using logistic regression analysis, the risk ratio (RR) of CRC for the highest versus lowest quintile of fibre intake was 0.53 (95% CI 0.47 to 0.61). However, when the authors included only studies in which the participants used validated diet questionnaires and in which qualitative data on dietary habits and cooking methods were reported, consumption of dietary fibre was not shown to be protective (<LINK REF="REF-Friedenreich-1994" TYPE="REFERENCE">Friedenreich 1994</LINK>; <LINK REF="REF-Wrieden-2007" TYPE="REFERENCE">Wrieden 2007</LINK>). The findings from both meta-analyses are tempered by the presence of a number of methodological weaknesses as well as the problem of selection and recall bias commonly associated with case control studies. </P>
<P>In a population-based cohort study in which 61,463 Swedish women were followed for 9.6 years, a weak association was found between increased fruit consumption and a decreased risk of CRC, though there was no association between cereal fibre intake and CRC (<LINK REF="REF-Aoyama-2014" TYPE="REFERENCE">Aoyama 2014</LINK>; <LINK REF="REF-Aune-2011b" TYPE="REFERENCE">Aune 2011b</LINK>; <LINK REF="REF-Terry-2001" TYPE="REFERENCE">Terry 2001</LINK>). These results persisted after known confounders such as the use of multivitamins, exercise and decreased smoking and alcohol intake were adjusted for. The authors also noted a positive association between several healthy lifestyle changes and increased consumption of fibre, fruits and vegetables. Other large observational studies, however, have reported that dietary fibre and consumption of fruits and vegetables were not associated with a reduced risk of CRC (<LINK REF="REF-Fuchs-1999" TYPE="REFERENCE">Fuchs 1999</LINK>; <LINK REF="REF-Michels-2000" TYPE="REFERENCE">Michels 2000</LINK>). Two American cohort studies, the Nurses Health Study, that followed 88,757 women, and the Health Professionals' Follow-up Study, that followed 47,325 men for 16 and 10 years respectively, found that CRC risk was unaffected by the intake of dietary fibre, fruits and vegetables. Asano and colleagues (<LINK REF="REF-Asano-2002" TYPE="REFERENCE">Asano 2002</LINK>) carried out a Cochrane review (which is the original version of the current review) investigating the effect of dietary fibre on the incidence or recurrence of colorectal adenomas, the incidence of CRC, and incidence of adverse effects that resulted from the fibre intervention. This review included five studies with 4349 participants, and reported a range of interventions including wheat bran fibre, ispaghula husk, or a comprehensive dietary intervention with high fibre whole food sources alone or in combination. The findings of the review by <LINK REF="REF-Asano-2002" TYPE="REFERENCE">Asano 2002</LINK> is consistent with those of <LINK REF="REF-Fuchs-1999" TYPE="REFERENCE">Fuchs 1999</LINK> and <LINK REF="REF-Michels-2000" TYPE="REFERENCE">Michels 2000</LINK>.</P>
</INTERVENTION>
<THEORY MODIFIED="2016-12-07 02:57:36 +0100" MODIFIED_BY="[Empty name]">
<P>Mechanisms underlying how dietary fibre might reduce the risk of CRC are unclear. Proposed theories include that fibre may play a role in binding potential carcinogens in the colon and its ability to absorb larger quantities of water thereby increasing faecal bulk and shortening transit time. In addition, bacterial fermentation may lower the pH of the colon through the production of short-chain fatty acids (<LINK REF="REF-Harris-1993" TYPE="REFERENCE">Harris 1993</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2017-01-02 14:29:56 +0100" MODIFIED_BY="[Empty name]">
<P>To date, the results from observational studies assessing the effects of dietary fibre on the development of CRC have been inconclusive, despite some evidence with large sample size supporting a reduction in risk (<LINK REF="STD-Kunzmann-2015" TYPE="STUDY">Kunzmann 2015</LINK>; <LINK REF="REF-Song-2015" TYPE="REFERENCE">Song 2015</LINK>). In addition, the methodological limitations inherent in these observational studies make it difficult to interpret the findings. A systematic review of randomised controlled trials is therefore required in order to better evaluate data surrounding this important issue.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2017-01-02 14:38:13 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effect of dietary fibre on the recurrence of colorectal adenomatous polyps in people with a known history of adenomatous polyps and on the incidence of CRC compared to placebo. Further, to identify the reported incidence of adverse effects, such as abdominal pain or diarrhoea, that resulted from the fibre intervention.</P>
</OBJECTIVES>
<METHODS MODIFIED="2017-01-02 14:45:09 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2017-01-02 14:41:44 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2016-07-13 11:25:13 +0200" MODIFIED_BY="[Empty name]">
<P>We included randomised controlled trials (RCTs; parallel or cluster) and quasi-RCTs comparing dietary fibre supplementation to a control.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2017-01-02 14:41:33 +0100" MODIFIED_BY="[Empty name]">
<P>We included participants with a history of adenomatous polyps, but not CRC in this review. All participants had to have undergone at least one documented procedure that directly visualised the colon and rectum at baseline and was repeated at least two years from the baseline investigation. The polyps could be either new incidences or recurrent adenomatous polyps, however, once detected by the colonoscopy test, appropriate procedures had to have been performed (i.e. polypectomy) to ensure that the colon or rectum were free of polyps at baseline.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2017-01-02 14:41:38 +0100" MODIFIED_BY="[Empty name]">
<P>Studies included in this review had an intervention of dietary fibre. Dietary fibre is composed of the remnants of plant cells resistant to hydrolysis by human alimentary enzymes and included all indigestible polysaccharides (celluloses, hemicelluloses, oligosaccharides, pectins, gums, waxes) and lignin. We have also included resistant starches in the definition of dietary fibre for the purposes of this review.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2017-01-02 14:41:44 +0100" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2017-01-02 14:41:43 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Number of participants with at least one adenomatous polyp</LI>
<LI>Number of participants with more than one adenomatous polyp</LI>
<LI>Number of participants with at least one adenomatous polyp that is 1 cm or greater</LI>
<LI>Number of participants with a new diagnosis of CRC</LI>
</OL>
<P>The diagnosis of adenomatous polyps or CRC was confirmed pathologically.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2017-01-02 14:41:44 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Number of participants that reported at least one adverse event</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2017-01-02 14:42:20 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2017-01-02 14:42:20 +0100" MODIFIED_BY="[Empty name]">
<P>We identified RCTs from Cochrane Colorectal Cancer's Specialised Register (4 April 2016), the Cochrane Central Register of Controlled Trials (CENTRAL, 2016, Issue 4 in the Cochrane Library) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>), MEDLINE (Ovid), 1950 to 4 April 2016 (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>) and Embase (Ovid), 1974 to 4 April 2016 (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>). <BR/>No language or publication status restrictions were applied.<BR/>
</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2017-01-02 14:42:14 +0100" MODIFIED_BY="[Empty name]">
<P>We handsearched reference lists from published studies, journal articles and bibliographies of relevant systematic reviews. We also searched <A HREF="https://www.clinicaltrials.gov/">ClinicalTrials.gov</A> and <A HREF="http://www.who.int/ictrp/en/">WHO International Trials Registry Platform</A> to identify any ongoing trials. See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2017-01-02 14:45:09 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2017-01-02 14:42:41 +0100" MODIFIED_BY="[Empty name]">
<P>Two reviewers (YY and JL) independently performed two stages of screenings. First, titles and abstracts of all references identified through the searches were screened and clearly irrelevant reports were excluded. Second, full texts of potentially eligible studies and abstracts that were difficult to determine inclusion for were retrieved for further assessment and assessed according to the pre-defined inclusion criteria. We excluded reports that did not meet the inclusion criteria and listed reasons for their exclusion. We resolved any discrepancies by discussion. We included all eligible studies irrespective of whether measured outcomes were reported on.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2017-01-02 14:42:51 +0100" MODIFIED_BY="[Empty name]">
<P>In this update, two reviewers (CW and YQC) independently extracted data on methods, participants, interventions and outcomes using a standardised data extraction form, which we piloted prior to the data extraction. Data was then entered into Review Manager 5 (RevMan 5) software for analysis (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We resolved any disagreements by discussion and where uncertainty remained we consulted a third person (TS/RA).</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2017-01-02 14:43:12 +0100" MODIFIED_BY="[Empty name]">
<P>Two authors (EC and YY) assessed the quality of the trials using the Cochrane 'Risk of bias' tool described in the Cochrane Handbook for Systematic Reviews of Interventions (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>We independently evaluated the quality of the included trials and assessed the following risk of bias domains:</P>
<OL>
<LI>random sequence generation;</LI>
<LI>allocation concealment;</LI>
<LI>blinding of participants and personnel;</LI>
<LI>blinding of outcome assessment:</LI>
<LI>incomplete outcome data:</LI>
<LI>selective reporting bias; and</LI>
<LI>other potential sources of bias (such as recruitment rate, limited frequency of colonoscopy follow ups).</LI>
</OL>
<P>We judged each domain as high risk, low risk or unclear risk according to criteria used in the Cochrane 'Risk of bias' tool (see <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>) (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We sought clarification from the trialists if the published data provided inadequate information for the review. We tried to retrieve trial protocols of included studies to assess selective reporting bias. We presented the results of the risk of bias assessment in two figures (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2017-01-02 14:43:26 +0100" MODIFIED_BY="[Empty name]">
<P>As the outcomes were binary, we reported the risk ratio (RR) and risk difference (RD) with 95% confidence intervals (CI). If the RD was statistically significant, we calculated the number needed to treat for an additional beneficial outcome (NNTB) or the number needed to treat for an additional harmful outcome (NNTH). We assessed the studies clinically and methodologically to see if it was reasonable to consider combining data. If so, we used a fixed-effect model for the analysis.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2017-01-02 14:44:12 +0100" MODIFIED_BY="[Empty name]">
<P>The unit of analysis was the individual participant. There were no unit of analysis issues. However, if there had been cluster-randomised trials (such as randomisations by clinician or practice), in which the clustering effect had not been incorporated by study authors, we would have accounted for this by dividing binary data by a design effect using the mean number of participants per cluster (m) and the intra-class correlation coefficient (ICC) (Design effect = 1 + (m-1)*ICC) (<LINK REF="REF-Donner-2002" TYPE="REFERENCE">Donner 2002</LINK>).</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2017-01-02 14:44:18 +0100" MODIFIED_BY="[Empty name]">
<P>Where data were missing, we attempted to contact study authors for further information. The current update reported data from original trials regardless of whether the trialists had employed intention-to-treat (ITT) analysis. However, for those data derived from completers only, we conducted best/worst case scenario sensitivity analyses to assess the impact of missing data on the estimates of effect.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2017-01-02 14:44:34 +0100" MODIFIED_BY="[Empty name]">
<P>We evaluated the statistical heterogeneity in the data using the I<SUP>2 </SUP>statistic (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). If the I<SUP>2</SUP> statistic for heterogeneity was significant (i.e. 50% or greater), we scrutinised the studies to identify potential factors that could explain the heterogeneity (e.g. variations in mean age of participants between studies). We evaluated clinical heterogeneity in included studies by assessment of study population characteristics.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2017-01-02 14:44:42 +0100" MODIFIED_BY="[Empty name]">
<P>If there had been 10 or more studies, we would have used funnel plots to investigate reporting bias as described in the Cochrane Handbook for Systematic Reviews of Interventions (<LINK REF="REF-Sterne-2011" TYPE="REFERENCE">Sterne 2011</LINK>). However, as we identified only five relevant studies, and fewer than 10 studies has limited power to detect small-study effects (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>), we did not produce any funnel plots.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2017-01-02 14:45:09 +0100" MODIFIED_BY="[Empty name]">
<P>We performed the meta-analysis using the RevMan 5 software provided by Cochrane (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). Despite the differences between the trials, we used a fixed-effect model meta-analysis that uses the assumption that there was one true effect size underlying all the studies in the analysis, and that all differences in observed effects were due to sampling error (<LINK REF="REF-Borenstein-2010" TYPE="REFERENCE">Borenstein 2010</LINK>), as random-effects models produce poor estimates when there are small numbers of studies (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Summary of findings</HEADING>
<P>We evaluated the quality of evidence using the Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach for all primary outcomes for the comparison of dietary fibre (all study interventions) versus control (<LINK REF="REF-Sch_x00fc_nemann-2011" TYPE="REFERENCE">Schünemann 2011</LINK>) (see <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). The quality of evidence could be downgraded by one (serious concern) or two levels (very serious concern) for the following reasons: risk of bias, inconsistency (unexplained heterogeneity, inconsistency of results), indirectness (indirect population, intervention, control, outcomes), imprecision (wide confidence interval, single trials), or publication bias. The quality could also be upgraded by one level due to a large summary effect.</P>
</SUBSECTION>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2017-01-04 10:03:22 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2017-01-04 10:03:22 +0100" MODIFIED_BY="[Empty name]">
<P>Details of the included and excluded studies are listed in the tables of <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and of <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
<SEARCH_RESULTS MODIFIED="2017-01-02 14:45:37 +0100" MODIFIED_BY="[Empty name]">
<P>The 2012 search of the databases yielded 781 references (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>), and the subsequent update search performed in April 2016 yielded additional 247 references. The number was reduced to 804 records after duplicates were removed. Of these, we excluded 757 at title and abstract level. We identified one record to be an ongoing study and another record was a conference abstract, which we were unable to trace as a full publications. Forty-five full-text articles were short-listed for further scrutiny, out of which we excluded 20 studies (with 24 references). Finally, we included seven studies (encompassing 21 references), of which five studies (encompassing 17 references) contributed data to meta-analysis.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2017-01-04 10:03:22 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Study design and length</HEADING>
<P>All included studies were described as being randomised. The study length ranged from one year (<LINK REF="STD-Alberts-1996b" TYPE="STUDY">Alberts 1996b</LINK>) to four years (<LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>), with the latter being subject to a further follow-up at eight years.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Study participants</HEADING>
<P>Seven studies with 4960 participants met the inclusion criteria, however, only five studies with 4798 participants provided data for this review. The two largest studies were both conducted in USA (<LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>), and the other five included studies were conducted in USA (<LINK REF="STD-Alberts-1996b" TYPE="STUDY">Alberts 1996b</LINK>; <LINK REF="STD-Decosse-1989" TYPE="STUDY">Decosse 1989</LINK>), 10 European countries (<LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>), Australia (<LINK REF="STD-MacLennan-1995" TYPE="STUDY">MacLennan 1995</LINK>), and Canada (<LINK REF="STD-McKeown_x002d_Eyssen-1994" TYPE="STUDY">McKeown-Eyssen 1994</LINK>). The mean ages of the participants ranged from 56 to 66 years. The participants all had a known history of adenomas and would have had at least one procedure to remove them to achieve a polyp-free colon at baseline.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Types of Interventions</HEADING>
<P>Three of the studies included wheat bran fibre (WBF) supplementation as the sole intervention or a supplement to a low fat diet/calcium or ascorbic acid (4 g a day) and alpha-tocopherol (400 mg a day) intake. The doses ranged from 13.5 g a day WBF (<LINK REF="STD-Alberts-1996b" TYPE="STUDY">Alberts 1996b</LINK>; <LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>), 22.5 g a day WBF (<LINK REF="STD-Decosse-1989" TYPE="STUDY">Decosse 1989</LINK>), 25 g a day WBF (<LINK REF="STD-MacLennan-1995" TYPE="STUDY">MacLennan 1995</LINK>), and 20 g WBF per 100 g snack to supplement the diet to reach a goal of 50 g of dietary fibre a day (<LINK REF="STD-McKeown_x002d_Eyssen-1994" TYPE="STUDY">McKeown-Eyssen 1994</LINK>). One study included 3.5 g a day of ispaghula husk supplementation as a fibre intervention (<LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>). Another study used a comprehensive dietary intervention that obtained a high fibre diet through whole foods (<LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>). These are relatively high fibre intake compared to the average Western diet, as the average fibre intake is 12.8 g a day for women and 14.8 g a day for men in the UK (<LINK REF="REF-British-Nutrition-Foundation-2015" TYPE="REFERENCE">British Nutrition Foundation 2015</LINK>).</P>
<P>The control groups were characterised by low-fibre (2 to 3 g a day) (<LINK REF="STD-Alberts-1996b" TYPE="STUDY">Alberts 1996b</LINK>; <LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-Decosse-1989" TYPE="STUDY">Decosse 1989</LINK>; <LINK REF="STD-McKeown_x002d_Eyssen-1994" TYPE="STUDY">McKeown-Eyssen 1994</LINK> ), placebo (<LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>; <LINK REF="STD-MacLennan-1995" TYPE="STUDY">MacLennan 1995</LINK>), or a regular diet (<LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Types of outcome measures</HEADING>
<P>All of the included studies reported the number of participants with at least one recurrent adenoma. Two studies reported the number of participants with more than one adenomatous polyp (<LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>) and four studies reported the number of participants that had at least one adenomatous polyp of 1 cm or greater (<LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>; <LINK REF="STD-MacLennan-1995" TYPE="STUDY">MacLennan 1995</LINK>; <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>). Two studies reported the number of participants that developed colorectal cancer (CRC) although this was not a pre-defined endpoint (<LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>). Adverse events (other than CRC) were reported in two studies (<LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>). Only one of these two studies reported the number of participants that reported at least one adverse event (<LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>). Two studies reported outcomes that were not predefined in our protocol including compliance, [<SUP>3</SUP>H]thymidine labeling, dietary analysis and polyp number ratios (<LINK REF="STD-Alberts-1996b" TYPE="STUDY">Alberts 1996b</LINK>; <LINK REF="STD-Decosse-1989" TYPE="STUDY">Decosse 1989</LINK>). Therefore we did not extract data from these two studies.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2017-01-02 14:47:17 +0100" MODIFIED_BY="[Empty name]">
<P>We excluded 20 studies, out of which 15 were not RCTs. One study had a minority of participants who had had a procedure to remove polyps and data were unavailable for these participants, and furthermore, the control group received aspirin rather than placebo (<LINK REF="STD-Burn-2011a" TYPE="STUDY">Burn 2011a</LINK>). One study (<LINK REF="STD-Lanza-2001" TYPE="STUDY">Lanza 2001</LINK>) focused only on the changes in dietary intake for the included study <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>. In one study (<LINK REF="STD-Limburg-2011" TYPE="STUDY">Limburg 2011</LINK>), the intervention was a prebiotic supplement, and not dietary fibre. One article (<LINK REF="STD-Vitanzo-2000" TYPE="STUDY">Vitanzo 2000</LINK>) was only a summary of existing evidence. In <LINK REF="STD-Kunzmann-2015" TYPE="STUDY">Kunzmann 2015</LINK>, the author compared flexible sigmoidoscopy with usual medical care, which did not meet our inclusion criteria for interventions.</P>
<SUBSECTION>
<HEADING LEVEL="3">Studies awaiting classification</HEADING>
<P>We identified one conference abstract (<LINK REF="STD-Macrae-2014" TYPE="STUDY">Macrae 2014</LINK>), but we were unable to locate the full-text report or unpublished data for interim analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Ongoing studies</HEADING>
<P>We identified one ongoing study (<LINK REF="STD-Ishikawa-2000" TYPE="STUDY">Ishikawa 2000</LINK>), but we were unable to retrieve unpublished data for interim analysis.</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2017-01-02 14:47:52 +0100" MODIFIED_BY="[Empty name]">
<P>The risk of bias assessment across studies is shown in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<ALLOCATION MODIFIED="2017-01-02 14:47:25 +0100" MODIFIED_BY="[Empty name]">
<P>All studies were randomised. Six studies described the random sequence generation (<LINK REF="STD-Alberts-1996b" TYPE="STUDY">Alberts 1996b</LINK>; <LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>; <LINK REF="STD-Decosse-1989" TYPE="STUDY">Decosse 1989</LINK>; <LINK REF="STD-MacLennan-1995" TYPE="STUDY">MacLennan 1995</LINK>; <LINK REF="STD-McKeown_x002d_Eyssen-1994" TYPE="STUDY">McKeown-Eyssen 1994</LINK>; <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>) and were judged at low risk of selection bias; In <LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK> there was a large discrepancy in the number (175) of people randomised to the intervention and control group. Therefore we suspected the randomisation procedure may have been unsuccessful, and consequently rated this domain as high risk of bias.</P>
<P>Allocation concealment was described in two studies (<LINK REF="STD-Alberts-1996b" TYPE="STUDY">Alberts 1996b</LINK>; <LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>) and judged as low risk of bias, whilst no details were available in the remaining studies.</P>
</ALLOCATION>
<BLINDING MODIFIED="2017-01-02 14:47:30 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were aware of their treatment regimes in three studies (<LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-McKeown_x002d_Eyssen-1994" TYPE="STUDY">McKeown-Eyssen 1994</LINK>; <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>). Another study (<LINK REF="STD-MacLennan-1995" TYPE="STUDY">MacLennan 1995</LINK>) described the trial as being partially double-blinded, with no further details. One study (<LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>) blinded participants and investigators, but it was unclear if the assessors were blinded. There were no details on the blinding of outcome assessment for six studies (<LINK REF="STD-Alberts-1996b" TYPE="STUDY">Alberts 1996b</LINK>; <LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>; <LINK REF="STD-Decosse-1989" TYPE="STUDY">Decosse 1989</LINK>; <LINK REF="STD-MacLennan-1995" TYPE="STUDY">MacLennan 1995</LINK>; <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>). We judged detection bias to be low in one study (<LINK REF="STD-McKeown_x002d_Eyssen-1994" TYPE="STUDY">McKeown-Eyssen 1994</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2017-01-02 14:47:44 +0100" MODIFIED_BY="[Empty name]">
<P>We rated three studies (<LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>; <LINK REF="STD-MacLennan-1995" TYPE="STUDY">MacLennan 1995</LINK>; <LINK REF="STD-McKeown_x002d_Eyssen-1994" TYPE="STUDY">McKeown-Eyssen 1994</LINK>) as high risk of attrition bias due to high dropout rates (ranging from 17% to 27.8% of the total sample size), in total 267 out of 1290 participants. We considered it possible that the proportion of missing outcomes compared with observed events could have had a clinically relevant impact on the intervention effect estimate. Two studies (<LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-Decosse-1989" TYPE="STUDY">Decosse 1989</LINK>) reported moderate dropout rates (8.4% and 8.8% respectively), in total 300 out of 3508 participants. However, the reasons for loss to follow-up were not reported, thus we judged these studies as unclear risk of attrition bias. We rated two studies (<LINK REF="STD-Alberts-1996b" TYPE="STUDY">Alberts 1996b</LINK>; <LINK REF="STD-Decosse-1989" TYPE="STUDY">Decosse 1989</LINK>) as low risk of attrition bias due to low (5% to 6%) dropout rates (9 out of 162 participants in total); one of these two studies used intention-to-treat analysis (<LINK REF="STD-Decosse-1989" TYPE="STUDY">Decosse 1989</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2017-01-02 14:47:48 +0100" MODIFIED_BY="[Empty name]">
<P>We rated all the included studies as low risk of selective reporting bias, as all pre-defined primary outcomes appeared to have been reported.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2017-01-02 14:47:52 +0100" MODIFIED_BY="[Empty name]">
<P>For one study (<LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>), the recruitment was lower than intended as the original intended sample size to detect a 15% difference in new adenoma formation rate was 210 participants in each arm, but the number of people who completed the study in the treatment arm was 198, and 178 in the placebo arm. Another potential source of bias in this study was the limited frequency of colonoscopy follow-ups, as over half of the participants failed to provide data at follow-up as they did not receive colonoscopy. These (i.e. recruitment rate or limited frequency of colonoscopy follow-up) were not an issue in the other six studies (<LINK REF="STD-Alberts-1996b" TYPE="STUDY">Alberts 1996b</LINK>; <LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-Decosse-1989" TYPE="STUDY">Decosse 1989</LINK>; <LINK REF="STD-MacLennan-1995" TYPE="STUDY">MacLennan 1995</LINK>; <LINK REF="STD-McKeown_x002d_Eyssen-1994" TYPE="STUDY">McKeown-Eyssen 1994</LINK>; <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2017-01-02 15:11:06 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">1. Dietary fibre versus control</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1.1 Number of participants with at least one recurrent adenoma (within two to four years)</HEADING>
<P>All five included studies reported an outcome of the number of participants with at least one recurrent adenoma. There were no statistically significant differences between the treatment and the control (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>: n = 3641, 5 RCTs, RR 1.04, 95% CI 0.95 to 1.13). We rated the quality of evidence as low due to high risk of detection/attrition bias and adenoma being as a surrogate outcome for CRC (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). The best/worst case scenario sensitivity analysis that includes participants who were lost to follow-up by making assumptions as to the outcomes they had, showed that the pooled estimates were not robust as the conclusions drawn from the three analyses would differ, and therefore these missing data had an important impact on our findings (<LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.2 Number of participants with more than one adenoma (within three to four years)</HEADING>
<P>No statistically significant difference was found between the treatment and the control groups for the number of participants with more than one adenoma (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>: n = 2542, 2 RCTs, RR 1.06, 95% CI 0.94 to 1.20). We rated the quality of evidence as low due to high risk of detection/attrition bias and adenoma being as a surrogate outcome for CRC (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). The sensitivity analysis incorporating missing data in a best scenario favoured dietary fibre in lowering the risk of more than one adenoma (<LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>), however, the sensitivity analysis in a worst case scenario had a contrary result (<LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>) indicating that the missing data had an important impact on our findings.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.3 Number of participants with at least one adenoma 1 cm or greater (within three to four years)</HEADING>
<P>There was no statistically significant difference between the treatment and the control in the number of participants with at least one adenoma 1 cm or greater (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>: n = 3224, 4 RCTs, RR 0.99, 95% CI 0.82 to 1.20). We rated the quality of evidence as low due to high risk of detection/attrition bias and adenoma being as a surrogate outcome for CRC (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-007.03" TYPE="ANALYSIS">Analysis 7.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.4 Number of participants diagnosed with colorectal cancer (within three to four years)</HEADING>
<P>A statistically significantly higher number of participants were diagnosed with CRC in the dietary fibre group compared with the control group (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>: n = 2794, 2 RCTs, RR 2.70, 95% CI 1.07 to 6.85, NNTH 134, 95% CI 39 to 3247). The risk of being diagnosed with CRC was increased by 170% in the dietary fibre group relative to the control group. Calculated as the absolute risk increase, CRC was 1% higher in the dietary fibre group (RD 0.01, 95% CI 0.00 to 0.01). One-year data by <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK> revealed no significant difference in CRC rates (n = 1905, RR 1.98, 95% CI 0.36 to 10.77). We rated the quality of evidence as low due to high risk of detection/attrition bias, and under-powered data (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). The best/worst case scenario sensitivity analysis showed that the pooled estimate of effect was not robust, and the missing data had an important impact on our findings (<LINK REF="CMP-007.04" TYPE="ANALYSIS">Analysis 7.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">1.5 Number of participants that reported at least one adverse event</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Wheat bran fibre (WBF) versus control</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">2.1 Number of participants with at least one recurrent adenoma (within three to four years)</HEADING>
<P>The data available from two studies on wheat bran fibre showed no statistically significant difference between this treatment and the control group (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>: n = 1195, 2 RCTs, RR 1.01, 95% CI 0.87 to 1.18). The best/worst case scenario sensitivity analysis showed that the pooled estimate of effect was not robust. The missing data had important impact on our findings (<LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.2 Number of participants with more than one adenoma (within three to four years)</HEADING>
<P>We found no statistically significant difference between the treatment groups for the number of participants with more than one adenoma (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>: n = 637, 1 RCT, RR 1.11, 95% CI 0.97 to 1.29). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-008.02" TYPE="ANALYSIS">Analysis 8.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.3 Number of participants with at least one adenoma 1 cm or greater (within three to four years)</HEADING>
<P>No statistically significant difference was found between the wheat bran fibre and control groups in the number of participants with at least one adenoma 1 cm or greater (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>: n = 637, 1 RCT, RR 1.04, 95% CI 0.83 to 1.31). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-008.03" TYPE="ANALYSIS">Analysis 8.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.4 Number of participants diagnosed with colorectal cancer</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2.5 Number of participants that reported at least one adverse event</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Wheat bran fibre (WBF) and low fat diet versus control</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">3.1 Number of participants with at least one recurrent adenoma (within two years)</HEADING>
<P>There was no significant difference between the treatment groups in the number of participants with at least one recurrent adenoma (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>: n = 165, 1 RCT, RR 1.19, 95% CI 0.64 to 2.18). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-009.01" TYPE="ANALYSIS">Analysis 9.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.2 Number of participants with more than one adenoma</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.3 Number of participants with at least one adenoma 1 cm or greater</HEADING>
<P>In this subgroup, no study reported data for this outcome.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.4 Number of participants diagnosed with colorectal cancer</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3.5 Number of participants that reported at least one adverse event</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Wheat bran fibre with or without low fat diet versus control</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">4.1 Number of participants with at least one recurrent adenoma (within two to four years)</HEADING>
<P>No statistically significant difference was found between the wheat bran diet (with or without low fat) and the control groups in the number of participants with at least one recurrent adenoma (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>: n = 1360, 3 RCTs, RR 1.03, 95% CI 0.88 to 1.19). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4.2 Number of participants with more than one adenoma (within three years)</HEADING>
<P>Data from one study showed no statistically significant difference in the number of participants with more than one adenoma between the treatment and control groups (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>: n = 637, 1 RCT, RR 1.11, 95% CI 0.97 to 1.29). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4.3 Number of participants with at least one adenoma 1 cm or greater (within three to four years)</HEADING>
<P>We found no statistically significant difference in the treatment and control groups regarding the number of participants with at least one adenoma 1 cm or greater (<LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>: n = 943, 2 RCTs, RR 1.02, 95% CI 0.81 to 1.27). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4.4 Number of participants diagnosed with colorectal cancer</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4.5 Number of participants that reported at least one adverse event</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Comprehensive dietary intervention versus control</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">5.1 Number of participants with at least one recurrent adenoma (after four years)</HEADING>
<P>One study reported no statistically significant difference between a comprehensive dietary intervention and the control group on the number of participants with at least one recurrent adenoma after four years (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>: n = 1905, 1 RCT, RR 1.00, 95% CI 0.90 to 1.12). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-011.01" TYPE="ANALYSIS">Analysis 11.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.2 Number of participants with at least one recurrent adenoma (after eight years)</HEADING>
<P>After eight years, no statistically significant difference was found in the number of participants with at least one recurrent adenoma (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>: n = 1905, 1 RCT, RR 0.97, 95% CI 0.78 to 1.20). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-011.02" TYPE="ANALYSIS">Analysis 11.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.3 Number of participants with more than one adenoma (after four years)</HEADING>
<P>After four years, no statistically significant difference was found in the number of participants with more than one adenoma (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>: n = 1905, 1 RCT, RR 1.01, 95% CI 0.83 to 1.24).The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-011.03" TYPE="ANALYSIS">Analysis 11.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.4 Number of participants with more than one adenoma (after eight years)</HEADING>
<P>After eight years, there was still no statistically significant difference between the treatment and control groups in the number of participants with more than one adenoma (<LINK REF="CMP-005.04" TYPE="ANALYSIS">Analysis 5.4</LINK>: n = 1905, 1 RCT, RR 0.89, 95% CI 0.64 to 1.24). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-011.04" TYPE="ANALYSIS">Analysis 11.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.5 Number of participants with at least one adenoma 1 cm or greater (after four years)</HEADING>
<P>There was no statistically significant difference in the number of participants with at least one adenoma 1 cm or greater between the dietary intervention and control groups (<LINK REF="CMP-005.05" TYPE="ANALYSIS">Analysis 5.5</LINK>: n = 1905, 1 RCT, RR 0.88, 95% CI 0.60 to 1.28). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-011.05" TYPE="ANALYSIS">Analysis 11.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.6 Number of participants diagnosed with colorectal cancer</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5.7 Number of participants that reported at least one adverse event</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6. Ispaghula husk versus control</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">6.1 Number of participants with at least one recurrent adenoma (after three years)</HEADING>
<P>A statistically significantly higher number of participants in the ispaghula husk group (P = 0.05) had at least one recurrent adenoma than the control group (<LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>: n = 376, 1 RCT, RR 1.45, 95% CI 1.01 to 2.08, NNTH 11, 95% CI 5 to 495). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-012.01" TYPE="ANALYSIS">Analysis 12.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.2 Number of participants with more than one adenoma</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.3 Number of participants with at least one adenoma 1 cm or greater (after three years)</HEADING>
<P>We found no statistically significant difference in the number of participants with at least one adenoma 1 cm or greater between the two treatment groups (<LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>: n = 376, 1 RCT, RR 1.80, 95% CI 0.55 to 5.87). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-012.02" TYPE="ANALYSIS">Analysis 12.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.4 Number of participants diagnosed with colorectal cancer</HEADING>
<P>In this subgroup, no study reported data for this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6.5 Number of participants with at least one adverse effect (after three years)</HEADING>
<P>No statistically significant difference was found in the number of participants with at least one adverse effect, between the two groups (<LINK REF="CMP-006.03" TYPE="ANALYSIS">Analysis 6.3</LINK>: n = 376, 1 RCT, RR 0.90, 95% CI 0.18 to 4.40). The best/worst case scenario sensitivity analysis showed contrary results indicating that missing data had an important impact on our findings (<LINK REF="CMP-012.03" TYPE="ANALYSIS">Analysis 12.3</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2017-01-02 15:00:57 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2017-01-02 14:57:59 +0100" MODIFIED_BY="[Empty name]">
<P>Various clinical endpoints (such as CRC or presence of adenomatous polyps) are collected in various phases of clinical trials. CRC is relatively difficult to observe in a RCT, as it may take a long time to develop and, even if trials are conducted with sufficiently long follow-up periods, increasing numbers of participants may be lost to follow-up as the trial progresses. Due to these difficulties inherent in using CRC as an end point, several different biomarkers of CRC have been relied on in cancer chemoprevention trials (<LINK REF="REF-Einspahr-1997" TYPE="REFERENCE">Einspahr 1997</LINK>; <LINK REF="REF-Emerson-1993" TYPE="REFERENCE">Emerson 1993</LINK>). Studies in this review have focused on the presence of adenomatous polyps, clinically identifiable precursors of CRC (<LINK REF="REF-Einspahr-1997" TYPE="REFERENCE">Einspahr 1997</LINK>; <LINK REF="REF-Stryker-1987" TYPE="REFERENCE">Stryker 1987</LINK>; <LINK REF="REF-Winawer-1993a" TYPE="REFERENCE">Winawer 1993a</LINK>), as a surrogate outcome.</P>
<P>Data from five trials including 4798 participants, compared increased dietary fibre supplementation to a control group. Over a period of two to eight years, there was no evidence that dietary fibre reduced the recurrence of colorectal adenomas (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>: RR 1.04, 95% CI 0.95 to 1.13). In <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK> CRC was statistically significantly higher (17/1426; NNTH = 134) in the dietary fibre group compared with the control group (6/1368) at four years. However, <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK> reported one-year CRC data, and no statistically significant difference was found between the dietary fibre (4/958) and control (2/947) groups. The finding was expected given the low event rate and the relatively small sample size. Although the increase in the incidence of CRC at four years was small in absolute terms (number per 1000 people), an intervention such as dietary fibre is sold to the general population as 'healthy', therefore this could translate into fairly large numbers of people overall depending on the numbers of people following such lifestyle advice. However, the numbers of participants in the analyses for CRC were too small to be confident in the result. In addition, the results of all the meta-analyses were adversely affected by large numbers of participants being lost to follow-up (attrition bias); when we made assumptions about the outcomes of these missing participants (worst/best case scenarios) based on completer analyses, the result of all the analyses changed sufficiently to alter the conclusions that would be drawn.</P>
<P>In addition, results from the four-year Polyp Prevention Trial II (<LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>) were the most heavily weighted in the analysis, due to its large sample size and high event rate. In this study, increased consumption of dietary fibre from whole foods, vegetables and fruits, and decreased intake of fat, had no effect on the rate of recurrence of adenomas. A four-year subsequent follow-up revealed that there was no statistically significant difference in the number of participants with at least one recurrent adenoma (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>: n = 801, 1 RCT, RR 0.96, 95% CI 0.80 to 1.15). At eight years, the number of participants who were given the high fibre intervention who had more than one polyp was not statistically significantly different from the control group (<LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>). However, this particular analysis was under powered, thus we are unable to conclude if there was really no difference between groups.</P>
<P>While three other included studies that added wheat bran fibre (WBF) supplementation to the intervention reported no effect on recurrent adenomas (<LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-MacLennan-1995" TYPE="STUDY">MacLennan 1995</LINK>; <LINK REF="STD-McKeown_x002d_Eyssen-1994" TYPE="STUDY">McKeown-Eyssen 1994</LINK>),  the European Cancer Prevention study (<LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK>) actually reported an increase in recurrent adenomas in the ispaghula husk intervention group compared to controls. The biological basis of this finding is unclear.</P>
<P>This review has employed surrogate outcomes such as the occurrence of adenomatous polyps as a risk reference for CRC. However, any conclusions based on surrogate outcomes must be interpreted with caution. Although somatic mutation theory is a classical theory in cancer development, we should not ignore the role of carcinogenesis and other external factors, such as lifestyle, smoking history and alcohol consumption <LINK REF="REF-Baker-2007" TYPE="REFERENCE">Baker 2007</LINK>, which can lead to unequal conversion rate from adenomatous to cancer between experimental and control groups. Thus, readers should interpret the results with caution.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2017-01-02 14:58:10 +0100" MODIFIED_BY="[Empty name]">
<P>We included seven studies, however only five studies provided data for meta-analyses. Only two studies reported rates of CRC (<LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>); the primary outcome of the other studies was adenomas. One of these trials included only 100 participants, and was therefore very underpowered. The other trial recruited 2079 participants, but event rates were very low, therefore, any analyses of the benefits of dietary fibre in reducing the risk of CRC were underpowered. These limitations are a source of uncertainty in our results.</P>
<P>In addition, CRC develops typically 10 years after the adenoma begins to develop (<LINK REF="REF-Half-2009" TYPE="REFERENCE">Half 2009</LINK>). Consequently, the main outcome in the studies was the surrogate outcome of adenomatous polyp, as participants were followed-up for less than 10 years. There is a need to demonstrate that the effect of treatment on a surrogate endpoint predicts the effect of treatment on the true endpoint (i.e. CRC). The strength and direction of the relationship between the surrogate outcome and the definitive outcome over a specified time interval should be also be known (<LINK REF="REF-Grizzle-1999" TYPE="REFERENCE">Grizzle 1999</LINK>). Although most CRCs develop from an adenomatous polyp, only a small fraction of adenomas develop into cancer and better predictive biomarkers are needed or, in their absence, longer-term trials are needed.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2017-01-02 14:59:53 +0100" MODIFIED_BY="[Empty name]">
<P>Another potential confounding factor is the possibility that the consumption of dietary fibre was not high enough. However, the reported level of dietary fibre intake in several of the studies was comparable to historic levels of fibre consumption in South Africa where there is a low incidence of CRC (<LINK REF="REF-Segal-2000" TYPE="REFERENCE">Segal 2000</LINK>). In the Wheat Bran Fibre (WBF) trial, the intake of dietary fibre was increased to 27 g a day in the intervention group versus 18.2 g a day in the control group (<LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>). Dietary fibre in the Australian Polyp Prevention Trial was increased by 7 g a day in the treatment group (<LINK REF="STD-MacLennan-1995" TYPE="STUDY">MacLennan 1995</LINK>). When intensive nutritional counselling was provided, dietary fibre from whole foods, with or without WBF, increased to 30 g to 35 g a day (<LINK REF="STD-McKeown_x002d_Eyssen-1994" TYPE="STUDY">McKeown-Eyssen 1994</LINK>; <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>). It must be noted, however, that the Toronto Polyp Prevention Study was unable to achieve their goal of 50 g a day of dietary fibre (<LINK REF="STD-McKeown_x002d_Eyssen-1994" TYPE="STUDY">McKeown-Eyssen 1994</LINK>), suggesting that compliance with high levels of dietary fibre intake may be problematic in a Western population. Further, intake of dietary fibre from other sources may be reduced when high levels of WBF are part of the intervention (<LINK REF="REF-Ishikawa-2000b" TYPE="REFERENCE">Ishikawa 2000b</LINK>).</P>
<P>It has also been suggested that enrolling participants at an earlier age and prolonging the duration of the trial may help uncover the benefits of a high dietary fibre intake. The rationale for enrolling older participants rests on the observation that those who are already diagnosed with a colorectal adenoma have a higher risk of developing subsequent adenomas, thereby reducing the total number of participants needed in a clinical trial. The downside of employing data from a high risk population is that the external validity or generalisability of the trial, subsequently the systematic review, is limited and may not be applicable to the general population. There is a possibility that the high risk population is less responsive to fibre and that fibre may have beneficial effect in those who have yet to show signs of disease. Further, while prolonging the duration of a trial in a cohort that is already undergoing endoscopic surveillance may seem reasonable, the potential for subject 'burnout' from a comprehensive dietary intervention, intensive nutritional counselling and increased costs make this option less realistic.</P>
<P>For the risk of bias in included studies, we considered attrition bias a major concern. The sensitivity analysis in best and worst case scenarios showed contrary results, which means that the missing data had a significant impact on our results. Although the blinding of participants and outcome assessors was not well conducted among studies, we did not regard the performance or detection bias as significant, as the detection and performance bias has little impact on objective outcomes.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2017-01-02 15:00:10 +0100" MODIFIED_BY="[Empty name]">
<P>Despite the high prevalence of CRC in industrialised countries, the development of clinical trials designed to assess primary prevention strategies is hampered by the slow progression of the disease and the large number of participants required. Nevertheless, though CRC was not the primary outcome, two of the included studies reported an increase in the incidence of CRC in the fibre intervention groups (<LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK>; <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>).</P>
<P>Of the 14 cases in <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK> who had CRC, six were diagnosed within the first year and four of these six cases were in the intervention group. Thus, the difference between the CRC rates in the intervention and control groups (NNTH = 134) is more likely to be a chance occurrence given the wide confidence interval around NNTH (95% CI 39 to 3247). The wide confidence interval could have resulted from low participant numbers, a low event rate or any other uncertainty, thus the clinical significance of the above result is debatable and impact of fibre on CRC cannot be concluded on the basis of these numbers.</P>
<P>Outcome data were not reported separately according to gender and therefore our analyses were not subgrouped. <LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK> and <LINK REF="STD-Bonithon_x002d_Kopp-2000" TYPE="STUDY">Bonithon-Kopp 2000</LINK> performed baseline adjustment for gender and found no evidence that outcomes were affected. However, <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK> also adjusted for sex and reported that recurrence of adenomas in women was significantly higher in the fibre group with an unadjusted risk ratio of 1.30 (95% CI 1.04 to 1.63; P = 0.03). <LINK REF="STD-Jacobs-2006" TYPE="STUDY">Jacobs 2006</LINK> combined the results of both the <LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK> and <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK> studies to find the interaction between sex, fibre and adenoma recurrence. The pooled analysis reported the effects of dietary intervention using logistic regression models and found that colorectal adenoma recurrence in the fibre group for men was associated with significantly reduced risk of recurrence, odds ratio 0.81 (95% CI 0.67, 0.98). There may be potential for systematic gender-dependent errors, and as stated in the <LINK REF="STD-Jacobs-2006" TYPE="STUDY">Jacobs 2006</LINK> study, the mechanism for the occurrence of differential effects remains unclear, and further investigation is required.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2017-01-02 15:00:57 +0100" MODIFIED_BY="[Empty name]">
<P>Our findings from these five RCTs are at odds with some cohort studies that report benefits from dietary fibre. In the <LINK REF="REF-Aune-2011a" TYPE="REFERENCE">Aune 2011a</LINK> meta-analysis of cohort studies, the risk of CRC was significantly lower (RR 0.88, 95% CI 0.82 to 0.94) in participants measured by total high fibre intake, and also for intake of high whole grains. However, the authors found no statistically significant difference in cohorts comparing high versus low fruit fibre intake, high versus low vegetable fibre intake, or high versus low legume fibre intake. Additionally, no formal assessment of risk of bias was conducted and it is unclear if confounding variables affected the results, although attempts were made to adjust for these.</P>
<P>Other factors are likely to contribute to the reduced risk found in cohorts consuming higher dietary fibre. Typically, healthier diets are accompanied by healthier lifestyles and better nutrition, and the reverse is true for people consuming low fibre diets. It is plausible that those cohort-participants with higher total dietary fibre accrued benefits from consuming foods with higher nutrition, especially vitamin D, calcium and folate, which are associated with reduced risk of CRC (<LINK REF="REF-Pericleous-2013" TYPE="REFERENCE">Pericleous 2013</LINK>). The vitamin and mineral content of refined foods such as white bread, white rice, white pasta and breakfast cereals is greatly reduced once the bran and germ are removed (<LINK REF="REF-Heged_x00fc_s-1985" TYPE="REFERENCE">Hegedüs 1985</LINK>), and attempts are often made (depending on the legal requirements of individual countries) to restore nutrients lost during the manufacturing process (<LINK REF="REF-Bonner-1999" TYPE="REFERENCE">Bonner 1999</LINK>). Other potential confounding factors that increase the risk of CRC include smoking (<LINK REF="REF-Liang-2009" TYPE="REFERENCE">Liang 2009</LINK>), sedentary lifestyles (<LINK REF="REF-Slattery-2004" TYPE="REFERENCE">Slattery 2004</LINK>; <LINK REF="REF-Wolin-2009" TYPE="REFERENCE">Wolin 2009</LINK>) and obesity (<LINK REF="REF-Frezza-2006" TYPE="REFERENCE">Frezza 2006</LINK>) and it is these risk factors that are clustered in people with poor-quality, low-dietary-fibre diets (<LINK REF="REF-Burke-1997" TYPE="REFERENCE">Burke 1997</LINK>; <LINK REF="REF-Ma-2000" TYPE="REFERENCE">Ma 2000</LINK>; <LINK REF="REF-Poortinga-2007" TYPE="REFERENCE">Poortinga 2007</LINK>; <LINK REF="REF-Suh-2013" TYPE="REFERENCE">Suh 2013</LINK> ).</P>
<P>A number of explanations have been proposed for the apparent lack of association between dietary fibre and the development of CRC in clinical trials. Volunteer bias has been one such proposal. Participation in trials that entail nutritional interventions generally requires a significant commitment on the part of the participants. In addition, participants are likely to engage in healthier lifestyles that could potentially counteract any benefit derived from the dietary intervention. Though participants in the included trials were shown to consume more dietary fibre than the average American (approximately 15 g to 20 g a day versus 11.1 g to 13.4 g a day respectively) (<LINK REF="REF-Ganji-1995" TYPE="REFERENCE">Ganji 1995</LINK>; <LINK REF="REF-Lanza-1987" TYPE="REFERENCE">Lanza 1987</LINK>), there was no difference in smoking habits, body mass index, percentage of total caloric intake from fat, or use of multivitamins (<LINK REF="REF-Balluz-2000" TYPE="REFERENCE">Balluz 2000</LINK>; <LINK REF="REF-Chao-2000" TYPE="REFERENCE">Chao 2000</LINK>; <LINK REF="REF-Ganji-1995" TYPE="REFERENCE">Ganji 1995</LINK>; <LINK REF="REF-Kuczmarski-1997" TYPE="REFERENCE">Kuczmarski 1997</LINK>; <LINK REF="REF-Lyle-1998" TYPE="REFERENCE">Lyle 1998</LINK>; <LINK REF="REF-Ruchlin-1999" TYPE="REFERENCE">Ruchlin 1999</LINK>; <LINK REF="REF-Sundquist-2001" TYPE="REFERENCE">Sundquist 2001</LINK>). Consistent with previous reports (<LINK REF="REF-Hixson-1991" TYPE="REFERENCE">Hixson 1991</LINK>; <LINK REF="REF-Neugut-1993" TYPE="REFERENCE">Neugut 1993</LINK>; <LINK REF="REF-Winawer-1993b" TYPE="REFERENCE">Winawer 1993b</LINK>), there was also a high rate of recurrent adenomas (20% to 40%). Taken together, these observations suggest that volunteer bias did not play a significant role.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2017-01-02 15:01:12 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2017-01-02 15:01:05 +0100" MODIFIED_BY="[Empty name]">
<P>Both lifestyle and diet are considered to be important environmental factors that influence the risk of developing colorectal cancer (CRC), though it is unlikely that one component plays a dominant role. To date, the evidence from randomised controlled trials (RCTs) included in this review does not support that increased dietary fibre intake reduces the risk of CRC or reduces the risk of recurrence of adenomatous polyps within a two- to eight-year period compared with control groups. Nevertheless, the reliability of these data is questionable due to a variety of reasons such as the conduct of the trials, the large number of missing data, small sample sizes, surrogate outcome employed and so on, thus limiting our confidence in any findings derived from this data set. There is some indication that CRC may be increased by high fibre intake, but the data were insufficient and under-powered to support such an association. We have no reliable evidence to refute the use of dietary fibre.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2017-01-02 15:01:12 +0100" MODIFIED_BY="[Empty name]">
<P>One ongoing trial will provide new information regarding the association between dietary fibre intake and the development of new or recurrent colorectal adenomas or CRC (<LINK REF="REF-Ishikawa-2000b" TYPE="REFERENCE">Ishikawa 2000b</LINK>). This is the first "non-Western" trial, being carried out in Japan, in which dietary fibre and WBF has been included as an intervention for the prevention of recurrent colorectal adenomas. It remains to be seen whether the results from this trial will be consistent with the included studies in this review, in which using WBF did not add additional benefit. The internationally recognised healthy fibre intake, as recommended by the American Cancer Socity and the British Nutrition Foundation, is between 30 g to 40 g a day. Although we recognise the challenge of encouraging people to maintain a high level of high fibre intake, where possible, future trials should aim for the intervention group to have that level of intake and preferably higher. Longer trial duration will also help to identify the preferred endpoint of CRC, but we understand long-term trials may not be possible due to cost and other practical issues. Thus, we encourage the trial duration to be as long as resources allow.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2017-01-02 15:01:42 +0100" MODIFIED_BY="[Empty name]">
<P>We are grateful to:</P>
<OL>
<LI>the Cochrane Colorectal Cancer and Dr. Arne Ohlsson for advice on the protocol and final review;</LI>
<LI>trialists Dr D Alberts, V Jazmaji, Dr Faivre, Dr Bonithon-Kopp, and Dr I Akedo for responding to requests for further information;</LI>
<LI>Dr J Baron for expert assistance regarding completeness of our list of included studies.</LI>
</OL>
<P>The current review authors would like to thank Tracey Asano and Robin McLeod for their contribution to the earlier version of the review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2017-01-02 15:01:58 +0100" MODIFIED_BY="[Empty name]">
<P>Yibo Yao - none<BR/>Tao Suo - none<BR/>Roland Andersson - none<BR/>Yong Qing Cao - none<BR/>Chen Wang - none<BR/>Jingen Lu - none<BR/>Evelyne Chui - none</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-07-23 16:16:58 +0200" MODIFIED_BY="[Empty name]">
<P>Yibo Yao - screened the search results, helped write the report<BR/>Tao Suo - provided advice for study inclusion and helped write the report<BR/>Roland Andersson - provided advice for study inclusion<BR/>Yong Qing Cao - performed data extraction<BR/>Chen Wang - performed data extraction<BR/>Jingen Lu - screened the search results<BR/>Evelyne Chui - statistical support and helped write the report.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2017-01-02 15:02:10 +0100" MODIFIED_BY="[Empty name]">
<P>This updated review has been performed according to the required methodological expectations of Cochrane intervention reviews (MECIR).</P>
<P>We added sensitivity analysis in the 'Dealing with missing data' section to test whether the missing data has an important impact to the results. We stated in our text that "...for those data derived from completers only, we conducted sensitivity analysis in best/worst case scenario to assess the impact of missing data on the estimates of effect". We also added the results of sensitivity analysis for each outcomes in the 'Effects of interventions' section. We discussed the impact of missing data in the 'Discussion, Quality of the evidence' section by stating that "For the risk of bias in included studies, we considered the attrition bias as a major concern. The sensitivity analysis in best and worst case scenarios showed contrary results, which means the missing data did have a significant impact on our results<I>."</I>
</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-01-04 13:19:39 +0000" MODIFIED_BY="Henning Keinke Andersen">
<STUDIES MODIFIED="2017-01-02 15:34:08 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2017-01-02 15:30:27 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Alberts-1996b" MODIFIED="2017-01-02 15:28:45 +0100" MODIFIED_BY="[Empty name]" NAME="Alberts 1996b" YEAR="1996">
<REFERENCE MODIFIED="2016-06-06 04:09:17 +0200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 1970Author Affiliation: Department of Medicine, University of Arizona, Tucson 85724, USAConnective Phrase: 9138658Notes: Publication Type: Clinical Trial.  Clinical Trial, Phase II.  Comparative Study.  Journal Article.  Randomized Controlled Trial.  Research Support, U.S. Gov't, P.H.S&lt;/p&gt;" NOTES_MODIFIED="2016-06-06 04:09:17 +0200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alberts DS, Einspahr J, Ritenbaugh C, Aickin M, Rees-McGee S, Atwood J, et al</AU>
<TI>The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>1997</YR>
<VL>6</VL>
<NO>3</NO>
<PG>161-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4498399"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-02 15:28:45 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 5050Notes: Publication Type: Journal: ArticleCall Number: 1996023723&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:28:45 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Alberts DS, Ritenbaugh C, Story JA, Aickin M, Rees-McGee S, Buller MK, et al</AU>
<TI>Randomized, double-blinded, placebo-controlled study of effect of wheat bran fibre and calcium on fecal bile acids in patients with resected adenomatous colon polyps</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>1996</YR>
<VL>88</VL>
<NO>2</NO>
<PG>81-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431319"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431318"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alberts-2000" MODIFIED="2017-01-02 15:29:02 +0100" MODIFIED_BY="[Empty name]" NAME="Alberts 2000" YEAR="2000">
<REFERENCE MODIFIED="2017-01-02 15:29:02 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network [see comments]. New England Journal of Medicine 2000;342(16):1156-62.&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:29:02 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Alberts DS, Martinez ME, Roe DJ, Guillén-Rodríguez JM, Marshall JR, Van Leeuwen JB, et al</AU>
<TI>Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network</TI>
<SO>New England Journal of Medicine</SO>
<YR>2000</YR>
<VL>342</VL>
<NO>16</NO>
<PG>1156-62</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431296"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-12-01 16:58:52 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 7420Notes: Publication Type: Journal: Conference Paper&lt;/p&gt;" NOTES_MODIFIED="2016-12-01 16:58:52 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Earnest DL, Sampliner RE, Roe DJ, Leeuwen B, Guillen J, Reid M, et al</AU>
<TI>Progress report: The Arizona phase III study of the effect of wheat bran fiber on recurrence of adenomatous colon polyps</TI>
<SO>American Journal of Medicine</SO>
<YR>1999</YR>
<VL>106</VL>
<NO>1 A</NO>
<PG>43-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4498400"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-24 22:36:20 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 790Author Affiliation: Arizona Cancer Center, University of Arizona, Tucson, AZ, USA. emartinez@azcc.arizona.eduConnective Phrase: 16615116Notes: Publication Type: Journal Article.  Multicenter Study.  Randomized Controlled Trial.  Research Support, N.I.H., Extramural&lt;/p&gt;" NOTES_MODIFIED="2013-01-24 22:36:20 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinez ME, Giovannucci E, Jiang R, Henning SM, Jacobs ET, Thompson P, et al</AU>
<TI>Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence</TI>
<SO>International Journal of Cancer</SO>
<YR>2006</YR>
<VL>119</VL>
<NO>6</NO>
<PG>1440-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431297"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-23 15:30:07 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinez ME, Reid ME, Guillen-Rodrigugez J, Marshall JR, Sampliner R, Aickin M, et al</AU>
<TI>Design and baseline characteristics of study participants in the Wheat Bran Fiber Trial</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>1998</YR>
<VL>7</VL>
<PG>813-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431298"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431295"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bonithon_x002d_Kopp-2000" MODIFIED="2017-01-02 15:30:01 +0100" MODIFIED_BY="[Empty name]" NAME="Bonithon-Kopp 2000" YEAR="2000">
<REFERENCE MODIFIED="2017-01-02 15:29:33 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Bonithon-Kopp C, Kronborg O, Giacosa A, Ulrich R, Faivre J. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial.&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:29:33 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bonithon-Kopp C, Kronborg O, Giacosa A, Ulrich R, Faivre J</AU>
<TI>Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial</TI>
<SO>Lancet</SO>
<YR>2000</YR>
<VL>356</VL>
<NO>9238</NO>
<PG>1300-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431300"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-24 22:04:18 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 4230Notes: Publication Type: Journal: Note&lt;/p&gt;" NOTES_MODIFIED="2013-01-24 22:04:18 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Bonithon-Kopp C, Kronborg O, Giacosa A</AU>
<TI>Fibre supplementation increased the risk for recurrent adenomas, and calcium supplementation did not prevent recurrence</TI>
<SO>Evidence-Based Medicine</SO>
<YR>2001</YR>
<VL>6</VL>
<NO>3</NO>
<PG>90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431301"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-27 14:45:30 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faivre J, Boutron MC, Doyon F, Pignatelli M, Kronborg O, Giacosa A, et al</AU>
<TI>The ECP calcium fibre polyp prevention study preliminary report</TI>
<SO>European Journal of Cancer Prevention</SO>
<YR>1993</YR>
<VL>2</VL>
<PG>99-106</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431302"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-23 15:30:39 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faivre J, Couillault C, Kronborg O, Rath U, Giacosa A, De Oliveira H, et al</AU>
<TI>Chemoprevention of metachronous adenomas of the large bowel: design and interim results of a randomized trial of calcium and fibre</TI>
<SO>European Journal of Cancer Prevention</SO>
<YR>1997</YR>
<VL>6</VL>
<PG>132-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431303"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-02 15:30:01 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 7540Notes: Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:30:01 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Faivre J, Doyon F, Boutron MC</AU>
<TI>The ECP calcium fibre polyp prevention study. The ECP Colon Group</TI>
<SO>European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation (ECP)</SO>
<YR>1991</YR>
<VL>1 Suppl 2</VL>
<PG>83-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431304"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431299"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Decosse-1989" MODIFIED="2016-12-01 16:52:39 +0100" MODIFIED_BY="[Empty name]" NAME="Decosse 1989" YEAR="1989">
<REFERENCE MODIFIED="2016-12-01 16:52:39 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Decosse JJ, Miller HH, Lesser ML. Effect of Wheat Fiber and Vitamins C and E on Rectal Polyps in Patients with Familial Adenomatous Polyposis. Journal of the National Cancer Institute 1989;81:1290-1297.&lt;/p&gt;" NOTES_MODIFIED="2016-12-01 16:52:39 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Decosse JJ, Miller HH, Lesser ML</AU>
<TI>Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>1989</YR>
<VL>81</VL>
<PG>1290-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431333"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-06-03 06:26:24 +0200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 2560Connective Phrase: 2549260Notes: Publication Type: Clinical Trial.  Comment.  Editorial&lt;/p&gt;" NOTES_MODIFIED="2016-06-03 06:26:24 +0200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Greenwald P, Witkin KM</AU>
<TI>Familial adenomatous polyposis: a nutritional intervention trial</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>1989</YR>
<VL>81</VL>
<NO>17</NO>
<PG>1272-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431334"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431332"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacLennan-1995" MODIFIED="2017-01-02 08:46:33 +0100" MODIFIED_BY="[Empty name]" NAME="MacLennan 1995" YEAR="1995">
<REFERENCE MODIFIED="2017-01-02 08:46:33 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;MacLennan R, Macrae F, Bain C, Battistutta D. Randomized Trial of Intake of Fat, Fiber, and Beta Carotene to prevent Colorectal Adenomas. Journal of the National Cancer Institute 1995;87(23):1760-6.&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 08:46:33 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MacLennan R, Macrae F, Bain C, Battistutta D</AU>
<TI>Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>1995</YR>
<VL>87</VL>
<NO>23</NO>
<PG>1760-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431306"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431305"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McKeown_x002d_Eyssen-1994" MODIFIED="2013-06-11 16:12:31 +0200" MODIFIED_BY="[Empty name]" NAME="McKeown-Eyssen 1994" YEAR="1994">
<REFERENCE MODIFIED="2013-06-11 16:12:31 +0200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;McKeown-Eyssen GE, Bright-See E, Bruce WR, Jazmaji V. A Randomized Trial of a Low Fat High Fibre Diet in the Recurrence of Colorectal Polyps. Journal of Clinical Epidemiology 1994;47(5):525-536.&lt;/p&gt;" NOTES_MODIFIED="2013-06-11 16:12:31 +0200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>McKeown-Eyssen GE, Bright-See E, Bruce WR, Jazmaji V</AU>
<TI>A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1994</YR>
<VL>47</VL>
<NO>5</NO>
<PG>525-36</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431308"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431307"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schatzkin-2000" MODIFIED="2017-01-02 15:30:27 +0100" MODIFIED_BY="[Empty name]" NAME="Schatzkin 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-01-24 21:49:40 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 810Author Affiliation: Nutritional Epidemiology Branch, Division of Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. el33t@nih.govConnective Phrase: 16772456Notes: Publication Type: Journal Article.  Research Support, N.I.H., Intramural&lt;/p&gt;" NOTES_MODIFIED="2013-01-24 21:49:40 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lanza E, Hartman TJ, Albert PS, Shields R, Slattery M, Caan B, et al</AU>
<TI>High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the polyp prevention trial</TI>
<SO>Journal of Nutrition</SO>
<YR>2006</YR>
<VL>136</VL>
<NO>7</NO>
<PG>1896-903</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431310"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-02 15:30:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lanza E, Schatzkin A, Ballard-Barbash R, Clifford DC, Paskett E, Hayes D, et al</AU>
<TI>The Polyp Prevention Trial II: dietary intervention program and participant baseline dietary characteristics</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>1996</YR>
<VL>5</VL>
<PG>385-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431311"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-27 14:43:07 +0200" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 670Author Affiliation: Laboratory for Cancer Prevention, Centre for Cancer Research, National Cancer Institute, 6116 Executive Boulevard, Room 7206, Bethesda, MD 20892-8325, USAConnective Phrase: 17855692Notes: Publication Type: Journal Article.  Multicenter Study.  Randomized Controlled Trial&lt;/p&gt;" NOTES_MODIFIED="2013-06-27 14:43:07 +0200" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lanza E, Yu B, Murphy G, Albert PS, Caan B, Marshall JR</AU>
<TI>The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>9</NO>
<PG>1745-52</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431312"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-24 22:07:41 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 960Author Affiliation: Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, 200 Lothrop Street, Pittsburgh, PA 15213, USAConnective Phrase: 15758908Notes: Publication Type: Journal Article&lt;/p&gt;" NOTES_MODIFIED="2013-01-24 22:07:41 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pabby A, Schoen RE, Weissfeld JL, Burt R, Kikendall JW, Lance P, et al</AU>
<TI>Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2005</YR>
<VL>61</VL>
<NO>3</NO>
<PG>385-91</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431313"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-02 08:46:00 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group [see comments]. New England Journal of Medicine 2000;342(16):1149-55.&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 08:46:00 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, et al
</AU>
<TI>Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas</TI>
<SO>New England Journal of Medicine</SO>
<YR>2000</YR>
<VL>342</VL>
<NO>16</NO>
<PG>1149-55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431314"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-27 14:47:04 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schatzkin A, Lanza E, Freedman LS, Tangrea J, Cooper MR, Marshall JR, et al</AU>
<TI>The Polyp Prevention Trial I: rationale, design, recruitment, and baseline participant characteristics</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>1996</YR>
<VL>5</VL>
<PG>375-83</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431315"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431309"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2017-01-02 15:33:28 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Alberts-1996c" MODIFIED="2017-01-02 15:31:05 +0100" MODIFIED_BY="[Empty name]" NAME="Alberts 1996c" YEAR="1996">
<REFERENCE MODIFIED="2017-01-02 15:31:05 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 2080Author Affiliation: Cancer Prevention and Control Program, Arizona Cancer Center, University of Arizona, Tucson, 85724, USAConnective Phrase: 8600065Notes: Publication Type: Journal Article.  Review&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:31:05 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alberts DS, Lipkin M, Levin B</AU>
<TI>Genetic screening for colorectal cancer and intervention</TI>
<SO>International Journal of Cancer</SO>
<YR>1996</YR>
<VL>69</VL>
<NO>1</NO>
<PG>62-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431317"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431316"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Almendingen-2009" MODIFIED="2017-01-02 15:31:19 +0100" MODIFIED_BY="[Empty name]" NAME="Almendingen 2009" YEAR="2009">
<REFERENCE MODIFIED="2017-01-02 15:31:19 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 6220Notes: Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:31:19 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Almendingen K, Fausa O, Høstmark AT, Bratlie J, Mørkerid L, Aabakken L, et al</AU>
<TI>Serum nutrients and habitual dietary intake in colectomized FAP patients in Norway</TI>
<SO>European Journal of Nutrition</SO>
<YR>2009</YR>
<VL>48</VL>
<NO>3</NO>
<PG>129-36</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431323"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431322"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burn-2011a" MODIFIED="2017-01-02 15:31:35 +0100" MODIFIED_BY="[Empty name]" NAME="Burn 2011a" YEAR="2011">
<REFERENCE MODIFIED="2016-12-01 16:56:39 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 7170Notes: Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't&lt;/p&gt;" NOTES_MODIFIED="2016-12-01 16:56:39 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Burn J, Bishop DT, Chapman PD, Elliott F, Bertario L, Dunlop MG, et al</AU>
<TI>A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis</TI>
<SO>Cancer prevention research (Philadelphia, Pa.)</SO>
<YR>2011</YR>
<VL>4</VL>
<NO>5</NO>
<PG>655-65</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431325"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-02 15:31:35 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 460Author Affiliation: Institute of Human Genetics, Newcastle University, International Centre for Life, Central Pkwy., Newcastle upon Tyne NE1 3BZ, United Kingdom. john.burn@ncl.ac.ukConnective Phrase: 19073976Notes: Publication Type: Journal Article.  Multicenter Study.  Randomized Controlled Trial.  Research Support, Non-U.S. Gov't&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:31:35 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burn J, Bishop DT, Mecklin JP, Macrae F, Moslein G, Olschwang S, et al</AU>
<TI>Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. [Erratum appears in <I>New England Journal of Medicine</I> 2009 Apr 2;360(14):1470]</TI>
<SO>New England Journal of Medicine</SO>
<YR>2008</YR>
<VL>359</VL>
<NO>24</NO>
<PG>2567-78</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431326"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-24 22:34:15 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 2110Author Affiliation: CAPP Study Coordinating Centre, Dept Human Genetics, University of Newcastle upon Tyne, U.KConnective Phrase: 7577057Notes: Publication Type: Clinical Trial.  Journal Article.  Randomized Controlled Trial&lt;/p&gt;" NOTES_MODIFIED="2013-01-24 22:34:15 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burn J, Chapman PD, Mathers J, Bertario L, Bishop DT, Bulow S, et al</AU>
<TI>The protocol for a European double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: the CAPP study. Concerted Action Polyposis Prevention</TI>
<SO>European Journal of Cancer</SO>
<YR>1995</YR>
<VL>31A</VL>
<NO>7-8</NO>
<PG>1385-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431327"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-01-02 08:50:03 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 7120Notes: Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 08:50:03 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et al</AU>
<TI>Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2011</YR>
<VL>378</VL>
<NO>9809</NO>
<PG>2081-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431328"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-09-14 19:29:26 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mathers JC, Movahedi M, Macae F, Mecklin JP, Moeslein G, Olschwang S, et al</AU>
<TI>Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial</TI>
<SO>Lancet Oncology</SO>
<YR>2012</YR>
<VL>13</VL>
<PG>1242-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431329"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431324"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Campos-2005" MODIFIED="2017-01-02 15:31:51 +0100" MODIFIED_BY="[Empty name]" NAME="Campos 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-01-02 15:31:51 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 950Author Affiliation: Department of Gastroenterologoy, Colorectal Surgery Unit, Hospital das Clinicas, University of Sao Paulo Medical School, Brazil. fgcampos@osite.com.brConnective Phrase: 15762416Notes: Publication Type: Journal Article.  Review&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:31:51 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Campos FG, Logullo Waitzberg AG, Kiss DR, Waitzberg DL, Habr-Gama A, Gama-Rodrigues J</AU>
<TI>Diet and colorectal cancer: current evidence for etiology and prevention</TI>
<SO>Nutricion Hospitalaria</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>1</NO>
<PG>18-25</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431331"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431330"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dove_x002d_Edwin-2001" MODIFIED="2017-01-02 15:31:59 +0100" MODIFIED_BY="[Empty name]" NAME="Dove-Edwin 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-01-02 15:31:59 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 1480Author Affiliation: ICRF Family Cancer Clinic, St Mark's Hospital, Harrow, Middlesex, UKConnective Phrase: 11207507Notes: Publication Type: Journal Article.  Review&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:31:59 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dove-Edwin I, Thomas HJ</AU>
<TI>Review article: the prevention of colorectal cancer</TI>
<SO>Alimentary Pharmacology &amp; Therapeutics</SO>
<YR>2001</YR>
<VL>15</VL>
<NO>3</NO>
<PG>323-36</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431336"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431335"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Faivre-1998" MODIFIED="2017-01-02 15:32:12 +0100" MODIFIED_BY="[Empty name]" NAME="Faivre 1998" YEAR="1998">
<REFERENCE MODIFIED="2017-01-02 15:32:12 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 4720Notes: Publication Type: Journal: ReviewCall Number: 1998237288&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:32:12 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Faivre J, Giacosa A</AU>
<TI>Primary prevention of colorectal cancer through fibre supplementation</TI>
<SO>European Journal of Cancer Prevention</SO>
<YR>1998</YR>
<VL>7</VL>
<NO>Suppl 2</NO>
<PG>29-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431340"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431339"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Faivre-2002" MODIFIED="2017-01-02 08:52:23 +0100" MODIFIED_BY="[Empty name]" NAME="Faivre 2002" YEAR="2002">
<REFERENCE MODIFIED="2017-01-02 08:52:23 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 960&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 08:52:23 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Faivre J, Bonithon Kopp C</AU>
<TI>Effect of fibre and calcium supplementation on adenoma recurrence and growth</TI>
<SO>IARC Scientific Publications</SO>
<YR>2002</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431342"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431341"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-French-2003" MODIFIED="2017-01-02 15:32:25 +0100" MODIFIED_BY="[Empty name]" NAME="French 2003" YEAR="2003">
<REFERENCE MODIFIED="2017-01-02 15:32:25 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 840&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:32:25 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>French L, Kendall S, Stephens MB</AU>
<TI>Clinical inquiries. Does a high-fiber diet prevent colon cancer in at-risk patients?</TI>
<SO>Journal of Family Practice</SO>
<YR>2003</YR>
<VL>52</VL>
<NO>11</NO>
<PG>892-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431344"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431343"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gatof-2002" MODIFIED="2013-02-26 22:31:07 +0100" MODIFIED_BY="[Empty name]" NAME="Gatof 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-02-26 22:31:07 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 910&lt;/p&gt;" NOTES_MODIFIED="2013-02-26 22:31:07 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Gatof D, Ahnen D</AU>
<TI>Primary prevention of colorectal cancer: diet and drugs</TI>
<SO>Gastroenterology Clinics of North America</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>2</NO>
<PG>587-623, xi</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431346"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431345"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hirose-2004" MODIFIED="2013-02-26 22:29:33 +0100" MODIFIED_BY="[Empty name]" NAME="Hirose 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-02-26 22:29:33 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 300&lt;/p&gt;" NOTES_MODIFIED="2013-02-26 22:29:33 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hirose K, Tajima K</AU>
<TI>Evidence in favour of lifestyle intervention for cancer prevention with special reference to colorectal cancer</TI>
<SO>Environmental Health and Preventative Medicine</SO>
<YR>2004</YR>
<VL>9</VL>
<NO>4</NO>
<PG>130-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431348"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431347"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ho-1991" MODIFIED="2013-01-25 12:25:14 +0100" MODIFIED_BY="[Empty name]" NAME="Ho 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-01-25 12:25:14 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 5530Notes: Publication Type: Journal: Conference PaperCall Number: 1991154782&lt;/p&gt;" NOTES_MODIFIED="2013-01-25 12:25:14 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ho EE, Atwood JR, Benedict J, Ritenbaugh C, Sheehan ET, Abrams C, et al</AU>
<TI>A community-based feasibility study using wheat bran fiber supplementation to lower colon cancer risk</TI>
<SO>Preventive Medicine</SO>
<YR>1991</YR>
<VL>20</VL>
<NO>2</NO>
<PG>213-25</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431350"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431349"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jacobs-2006" MODIFIED="2017-01-02 15:32:37 +0100" MODIFIED_BY="[Empty name]" NAME="Jacobs 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-01-02 15:32:37 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 3490Notes: Publication Type: Journal: ArticleCall Number: 2006549618&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:32:37 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jacobs ET, Lanza E, Alberts DS, Hsu C-H, Jiang R, Schatzkin A, et al</AU>
<TI>Fiber, sex, and colorectal adenoma: results of a pooled analysis</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2006</YR>
<VL>83</VL>
<NO>2</NO>
<PG>343-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431352"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431351"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kunzmann-2015" MODIFIED="2016-12-01 16:57:42 +0100" MODIFIED_BY="[Empty name]" NAME="Kunzmann 2015" YEAR="2015">
<REFERENCE MODIFIED="2016-12-01 16:57:42 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Kunzmann, Andrew T&lt;br&gt;Coleman, Helen G&lt;br&gt;Huang, Wen-Yi&lt;br&gt;Kitahara, Cari M&lt;br&gt;Cantwell, Marie M&lt;br&gt;Berndt, Sonja I&lt;/p&gt;" NOTES_MODIFIED="2016-12-01 16:57:42 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kunzmann AT, Coleman HG, Huang WY, Kitahara CM, Cantwell MM, Berndt SI</AU>
<TI>Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2015</YR>
<VL>102</VL>
<PG>881-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4498402"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4498401"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lanza-2001" MODIFIED="2013-01-25 13:13:45 +0100" MODIFIED_BY="[Empty name]" NAME="Lanza 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-01-25 13:13:45 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 1410Author Affiliation: National Cancer Institute, Bethesda, MD, USA. el33t@nih.govConnective Phrase: 11522565Notes: Publication Type: Clinical Trial.  Journal Article.  Multicenter Study.  Randomized Controlled Trial&lt;/p&gt;" NOTES_MODIFIED="2013-01-25 13:13:45 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lanza E, Schatzkin A, Daston C, Corle D, Freedman L, Ballard-Barbash R, et al</AU>
<TI>Implementation of a 4-y, high-fiber, high-fruit-and-vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2001</YR>
<VL>74</VL>
<NO>3</NO>
<PG>387-401</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431354"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431353"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Limburg-2011" MODIFIED="2013-01-25 12:36:32 +0100" MODIFIED_BY="[Empty name]" NAME="Limburg 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-25 12:36:32 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 170Author Affiliation: Mayo Clinic Rochester, Rochester, MN 55905, USA. limburg.paul@mayo.eduConnective Phrase: 21209397Notes: Publication Type: Clinical Trial, Phase II.  Journal Article.  Multicenter Study.  Randomized Controlled Trial.  Research Support, N.I.H., Extramural&lt;/p&gt;" NOTES_MODIFIED="2013-01-25 12:36:32 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Limburg PJ, Mahoney MR, Ziegler KL, Sontag SJ, Schoen RE, Benya R, et al</AU>
<TI>Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention</TI>
<SO>Cancer Prevention Research</SO>
<YR>2011</YR>
<VL>4</VL>
<NO>2</NO>
<PG>259-69</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431356"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431355"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rock-2007" MODIFIED="2017-01-02 15:32:54 +0100" MODIFIED_BY="[Empty name]" NAME="Rock 2007" YEAR=", 2007">
<REFERENCE MODIFIED="2017-01-02 15:32:54 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 3320Notes: Publication Type: Journal: ReviewCall Number: 17302194&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:32:54 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Rock CL</AU>
<TI>Primary dietary prevention: is the fiber story over?</TI>
<SO>Recent Results in Cancer Research</SO>
<YR>2007</YR>
<VL>Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 174</VL>
<NO>171-7</NO>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431358"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431357"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sengupta-2001" MODIFIED="2017-01-02 15:33:08 +0100" MODIFIED_BY="[Empty name]" NAME="Sengupta 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-01-02 15:33:08 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 1420Author Affiliation: Department of Surgery, Colorectal Unit, Royal Melbourne Hospital and the University of Melbourne, Melbourne, AustraliaConnective Phrase: 11496083Notes: Publication Type: Journal Article.  Review&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:33:08 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sengupta S, Tjandra JJ, Gibson PR</AU>
<TI>Dietary fiber and colorectal neoplasia</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>2001</YR>
<VL>44</VL>
<NO>7</NO>
<PG>1016-33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431360"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431359"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shike-1999a" MODIFIED="2017-01-02 15:33:19 +0100" MODIFIED_BY="[Empty name]" NAME="Shike 1999a" YEAR="1999">
<REFERENCE MODIFIED="2017-01-02 15:33:19 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record Number: 1670Author Affiliation: Department of Medicine, GI-Nutrition Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USAConnective Phrase: 10089108Notes: Publication Type: Journal Article.  Review&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:33:19 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shike M</AU>
<TI>Diet and lifestyle in the prevention of colorectal cancer: an overview</TI>
<SO>American Journal of Medicine</SO>
<YR>1999</YR>
<VL>106</VL>
<NO>1A</NO>
<PG>11S-15S; discussion 50S-51S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431362"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431361"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vitanzo-2000" MODIFIED="2017-01-02 15:33:28 +0100" MODIFIED_BY="[Empty name]" NAME="Vitanzo 2000" YEAR="2000">
<REFERENCE MODIFIED="2017-01-02 15:33:28 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 4360Notes: Publication Type: Journal: Article&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:33:28 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Vitanzo PC Jr, Hong ES</AU>
<TI>Does a high-fiber dietary supplement of wheat bran reduce the recurrence rate of colorectal adenomas?</TI>
<SO>Journal of Family Practice</SO>
<YR>2000</YR>
<VL>49</VL>
<NO>7</NO>
<PG>656</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431364"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431363"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Witte-1996" MODIFIED="2013-01-25 12:45:02 +0100" MODIFIED_BY="[Empty name]" NAME="Witte 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-01-25 12:45:02 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 4940Notes: Publication Type: Journal: ArticleCall Number: 1996369657&lt;/p&gt;" NOTES_MODIFIED="2013-01-25 12:45:02 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Witte JS, Longnecker MP, Bird CL, Lee ER, Frankl HD, Haile RW</AU>
<TI>Relation of vegetable, fruit, and grain consumption to colorectal adenomatous polyps</TI>
<SO>American Journal of Epidemiology</SO>
<YR>1996</YR>
<VL>144</VL>
<NO>11</NO>
<PG>1015-25</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431366"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431365"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2016-12-01 16:59:54 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Macrae-2014" MODIFIED="2016-12-01 16:59:54 +0100" MODIFIED_BY="[Empty name]" NAME="Macrae 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-12-01 16:59:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Macrae FA, Boussioutas A, Clarke JM, Lockett T</AU>
<TI>A potential chemopreventative food for familial adenomatous polyposis: The AusFAP study</TI>
<SO>Journal of Gastroenterology and Hepatology</SO>
<YR>2014</YR>
<VL>29</VL>
<PG>128</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4498404"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4498403"/></IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2017-01-02 15:34:08 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ishikawa-2000" MODIFIED="2017-01-02 15:34:08 +0100" MODIFIED_BY="[Empty name]" NAME="Ishikawa 2000" YEAR="2000">
<REFERENCE MODIFIED="2017-01-02 15:34:08 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Record ID: 4350Notes: Publication Type: Journal: ArticleCall Number: 10945015&lt;/p&gt;" NOTES_MODIFIED="2017-01-02 15:34:08 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ishikawa H</AU>
<TI>Interventional trial for colorectal cancer prevention in Osaka</TI>
<SO>Gan To Kagaku Ryoho. Cancer &amp; Chemotherapy</SO>
<YR>2000</YR>
<VL>27</VL>
<NO>8</NO>
<PG>1185-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431368"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3431367"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2017-01-03 17:39:04 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2017-01-03 17:39:04 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Alberts-1996a" MODIFIED="2017-01-02 11:05:47 +0100" MODIFIED_BY="[Empty name]" NAME="Alberts 1996a" TYPE="JOURNAL_ARTICLE">
<AU>Alberts DS, Ritenbaugh C, Story JA</AU>
<TI>Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>1996</YR>
<VL>88</VL>
<PG>81-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Aoyama-2014" MODIFIED="2017-01-02 15:34:42 +0100" MODIFIED_BY="[Empty name]" NAME="Aoyama 2014" TYPE="JOURNAL_ARTICLE">
<AU>Aoyama N, Kawado M, Yamada H, Hashimoto S, Suzuki K, Wakai K, et al</AU>
<TI>Low intake of vegetables and fruits and risk of colorectal cancer: the Japan Collaborative Cohort Study</TI>
<SO>Journal of Epidemiology/Japan Epidemiological Association</SO>
<YR>2014</YR>
<VL>24</VL>
<NO>5</NO>
<PG>353-60</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:49:05 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="24857954"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Arnold-2005" MODIFIED="2013-06-24 12:04:57 +0200" MODIFIED_BY="[Empty name]" NAME="Arnold 2005" TYPE="JOURNAL_ARTICLE">
<AU>Arnold CN, Goel A, Blum HE, Boland CR</AU>
<TI>Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis</TI>
<SO>Cancer</SO>
<YR>2005</YR>
<VL>104</VL>
<NO>10</NO>
<PG>2035-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Aune-2011a" MODIFIED="2017-01-02 09:03:03 +0100" MODIFIED_BY="[Empty name]" NAME="Aune 2011a" TYPE="JOURNAL_ARTICLE">
<AU>Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E, et al</AU>
<TI>Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies</TI>
<SO>BMJ</SO>
<YR>2011</YR>
<VL>343</VL>
<PG>d6617</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Aune-2011b" MODIFIED="2017-01-02 09:02:54 +0100" MODIFIED_BY="[Empty name]" NAME="Aune 2011b" TYPE="JOURNAL_ARTICLE">
<AU>Aune D, Lau R, Chan DS, Vieira R, Greenwood DC, Kampman E, et al</AU>
<TI>Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies</TI>
<SO>Gastroenterology</SO>
<YR>2011</YR>
<VL>141</VL>
<NO>1</NO>
<PG>106-18</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:47:58 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="21600207"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Baker-2007" MODIFIED="2014-10-25 21:34:08 +0200" MODIFIED_BY="[Empty name]" NAME="Baker 2007" TYPE="JOURNAL_ARTICLE">
<AU>Baker SG, Kramer BS</AU>
<TI>Paradoxes in carcinogenesis: new opportunities for research directions</TI>
<SO>BMC Cancer</SO>
<YR>2007</YR>
<VL>6</VL>
<NO>7</NO>
<PG>151</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Balluz-2000" MODIFIED="2014-09-14 20:28:42 +0200" MODIFIED_BY="[Empty name]" NAME="Balluz 2000" TYPE="JOURNAL_ARTICLE">
<AU>Balluz LS, Kieszak SM, Philen RM, Mulinare J</AU>
<TI>Vitamin and mineral supplement use in the United States. Results from the third National Health and Nutrition Examination Survey</TI>
<SO>Archives of Family Medicine</SO>
<YR>2000</YR>
<VL>9</VL>
<NO>3</NO>
<PG>258-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bonner-1999" MODIFIED="2017-01-02 15:34:57 +0100" MODIFIED_BY="[Empty name]" NAME="Bonner 1999" TYPE="OTHER">
<AU>Bonner G, Warwick H, Barnardo M, Lobstein T</AU>
<TI>Fortification examined: how added nutrients can undermine good nutrition. A survey of 260 food products with added vitamins and minerals</TI>
<SO>The Food Commission</SO>
<YR>1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Borenstein-2010" MODIFIED="2017-01-02 11:00:12 +0100" MODIFIED_BY="[Empty name]" NAME="Borenstein 2010" TYPE="JOURNAL_ARTICLE">
<AU>Borenstein M, Hedges LV, Higgins JPT, Rothstein HR</AU>
<TI>A basic introduction to fixed-effect and random-effects models for meta-analysis</TI>
<SO>Research Synthesis Methods</SO>
<YR>2010</YR>
<VL>1</VL>
<PG>97-111</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boyle-2000" MODIFIED="2017-01-02 15:35:07 +0100" MODIFIED_BY="[Empty name]" NAME="Boyle 2000" TYPE="JOURNAL_ARTICLE">
<AU>Boyle P, Langman JS</AU>
<TI>ABC of colorectal cancer: epidemiology</TI>
<SO>BMJ</SO>
<YR>2000</YR>
<VL>321</VL>
<NO>(7264)</NO>
<PG>805&#8211;8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-British-Nutrition-Foundation-2015" MODIFIED="2017-01-02 15:35:22 +0100" MODIFIED_BY="[Empty name]" NAME="British Nutrition Foundation 2015" TYPE="OTHER">
<AU>British Nutrition Foundation</AU>
<TI>What is dietary fibre?</TI>
<SO>www.nutrition.org.uk/nutritionscience/nutrients/dietary-fibre.html</SO>
<YR>2015</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bunzel-2005" MODIFIED="2017-01-02 15:35:53 +0100" MODIFIED_BY="[Empty name]" NAME="Bunzel 2005" TYPE="JOURNAL_ARTICLE">
<AU>Bunzel M, Seiler A, Steinhart H</AU>
<TI>Characterization of dietary fiber lignins from fruits and vegetables using the DFRC method</TI>
<SO>Journal of Agricultural and Food Chemistry</SO>
<YR>2005</YR>
<VL>53</VL>
<NO>24</NO>
<PG>9553-9</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:37:06 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="16302776"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Burke-1997" MODIFIED="2014-09-17 18:10:20 +0200" MODIFIED_BY="[Empty name]" NAME="Burke 1997" TYPE="JOURNAL_ARTICLE">
<AU>Burke V, Milligan RA, Beilin LJ, Dunbar D, Spencer M, Balde E, et al</AU>
<TI>Clustering of health-related behaviors among 18-year-old Australians</TI>
<SO>Preventative Medicine</SO>
<YR>1997</YR>
<VL>26</VL>
<PG>724&#8211;33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burkitt-1971" NAME="Burkitt 1971" TYPE="JOURNAL_ARTICLE">
<AU>Burkitt DP</AU>
<TI>Epidemiology of cancer of the colon and rectum</TI>
<SO>Cancer</SO>
<YR>1971</YR>
<VL>28</VL>
<PG>3-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Center-2009" MODIFIED="2017-01-02 15:36:16 +0100" MODIFIED_BY="[Empty name]" NAME="Center 2009" TYPE="JOURNAL_ARTICLE">
<AU>Center MM, Jemal A, Smith RA, Ward E</AU>
<TI>Worldwide variations in colorectal cancer</TI>
<SO>CA: A Cancer Journal for Clinicians</SO>
<YR>2009</YR>
<VL>59</VL>
<NO>6</NO>
<PG>366-78</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:27:14 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="19897840"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chao-2000" MODIFIED="2014-09-14 20:28:50 +0200" MODIFIED_BY="[Empty name]" NAME="Chao 2000" TYPE="JOURNAL_ARTICLE">
<AU>Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, Calle EE</AU>
<TI>Cigarette smoking and colorectal cancer mortality in the Cancer Prevention Study II</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>2000</YR>
<VL>92</VL>
<PG>1888-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Corley-2013" MODIFIED="2017-01-02 15:36:28 +0100" MODIFIED_BY="[Empty name]" NAME="Corley 2013" TYPE="JOURNAL_ARTICLE">
<AU>Corley DA, Jensen CD, Marks AR, Zhao WK, De Boer J, Levin TR, et al</AU>
<TI>Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs</TI>
<SO>Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association</SO>
<YR>2013</YR>
<VL>11</VL>
<NO>2</NO>
<PG>172-80</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:30:00 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="22985608"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-CRUK-2012" MODIFIED="2017-01-02 15:36:56 +0100" MODIFIED_BY="[Empty name]" NAME="CRUK 2012" TYPE="OTHER">
<TI>Bowel cancer incidence statistics</TI>
<SO>www.cancerresearchuk.org</SO>
<YR>2008</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dhingra-2012" MODIFIED="2017-01-02 15:37:05 +0100" MODIFIED_BY="[Empty name]" NAME="Dhingra 2012" TYPE="JOURNAL_ARTICLE">
<AU>Dhingra D, Michael M, Rajput H, Patil R</AU>
<TI>Dietary fibre in foods: a review</TI>
<SO>Journal of Food Science and Technology</SO>
<YR>2012</YR>
<VL>49</VL>
<PG>255-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Donner-2002" MODIFIED="2016-12-01 17:01:43 +0100" MODIFIED_BY="[Empty name]" NAME="Donner 2002" TYPE="JOURNAL_ARTICLE">
<AU>Donner A, Klar N</AU>
<TI>Issues in the meta-analysis of cluster randomized trials</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>2971-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EFSA-2010" MODIFIED="2017-01-02 15:37:16 +0100" MODIFIED_BY="[Empty name]" NAME="EFSA 2010" TYPE="JOURNAL_ARTICLE">
<AU>EFSA Panel on Dietetic Products, Nutrition, and Allergies</AU>
<TI>Scientific opinion on dietary reference values for carbohydrates and dietary fibre</TI>
<SO>European Food Safety Authority</SO>
<YR>2010</YR>
<VL>8</VL>
<NO>3</NO>
<PG>1462</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egeberg-2010" MODIFIED="2014-09-17 18:10:56 +0200" MODIFIED_BY="[Empty name]" NAME="Egeberg 2010" TYPE="JOURNAL_ARTICLE">
<AU>Egeberg R, Olsen A, Loft S, Christensen J, Johnsen NF, Overvad K, et al</AU>
<TI>Intake of wholegrain products and risk of colorectal cancers in the Diet, Cancer and Health cohort study</TI>
<SO>British Journal of Cancer</SO>
<YR>2010</YR>
<VL>103</VL>
<NO>5</NO>
<PG>730&#8211;4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2013-06-24 14:59:29 +0200" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey-Smith G, Schneider M, Minder CSO</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>13</VL>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Einspahr-1997" MODIFIED="2014-09-14 20:28:59 +0200" MODIFIED_BY="[Empty name]" NAME="Einspahr 1997" TYPE="JOURNAL_ARTICLE">
<AU>Einspahr JG, Alberts DS, Gapstur SM, Bostick RM, Emerson SS, Gerner EW</AU>
<TI>Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>1997</YR>
<VL>6</VL>
<PG>37-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Emerson-1993" MODIFIED="2014-09-14 20:29:07 +0200" MODIFIED_BY="[Empty name]" NAME="Emerson 1993" TYPE="JOURNAL_ARTICLE">
<AU>Emerson SS, McGee DL, Fennerty B, Hixson L, Garewal H, Alberts D</AU>
<TI>Design and analysis of studies to reduce the incidence of colon polyps</TI>
<SO>Statistics in Medicine</SO>
<YR>1993</YR>
<VL>12</VL>
<PG>339-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Faivre-1997" MODIFIED="2016-10-10 03:28:14 +0200" MODIFIED_BY="[Empty name]" NAME="Faivre 1997" TYPE="JOURNAL_ARTICLE">
<AU>Faivre J, Couillault C, Kronborg O, Rath U, Giacosa A, De Oliveira H, et al</AU>
<TI>Chemoprevention of metachronous adenomas of the large bowel: design and interim results of a randomized trial of calcium and fibre</TI>
<SO>European Journal of Cancer Prevention</SO>
<YR>1997</YR>
<VL>6</VL>
<PG>132-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3431303"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ferguson-1996" MODIFIED="2013-06-11 16:40:41 +0200" MODIFIED_BY="[Empty name]" NAME="Ferguson 1996" TYPE="JOURNAL_ARTICLE">
<AU>Ferguson LR, Harris PJ</AU>
<TI>Studies on the role of specific dietary fibres in protection against colorectal cancer</TI>
<SO>Mutation Research</SO>
<YR>1996</YR>
<VL>350</VL>
<PG>173-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Frezza-2006" MODIFIED="2014-09-17 18:11:13 +0200" MODIFIED_BY="[Empty name]" NAME="Frezza 2006" TYPE="JOURNAL_ARTICLE">
<AU>Frezza EE, Wachtel MS, Chiriva&#8208;Internati M</AU>
<TI>Influence of obesity on the risk of developing colon cancer</TI>
<SO>Gut</SO>
<YR>2006</YR>
<VL>55</VL>
<NO>2</NO>
<PG>285&#8211;91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Friedenreich-1994" MODIFIED="2014-09-14 20:29:11 +0200" MODIFIED_BY="[Empty name]" NAME="Friedenreich 1994" TYPE="JOURNAL_ARTICLE">
<AU>Friedenreich CM, Brant RF, Riboli E</AU>
<TI>Influence of methodologic factors in a pooled analysis of 13 case-control studies of colorectal cancer and dietary fiber</TI>
<SO>Epidemiology</SO>
<YR>1994</YR>
<VL>5</VL>
<PG>66-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fu-2012" MODIFIED="2017-01-02 15:37:37 +0100" MODIFIED_BY="[Empty name]" NAME="Fu 2012" TYPE="JOURNAL_ARTICLE">
<AU>Fu Z, Shrubsole MJ, Smalley WE, Wu H, Chen Z, Shyr Y, et al</AU>
<TI>Lifestyle factors and their combined impact on the risk of colorectal polyps</TI>
<SO>American Journal of Epidemiology</SO>
<YR>2012</YR>
<VL>176</VL>
<NO>9</NO>
<PG>766-76</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:34:53 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="23079606"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fuchs-1999" MODIFIED="2017-01-02 15:37:47 +0100" MODIFIED_BY="[Empty name]" NAME="Fuchs 1999" TYPE="JOURNAL_ARTICLE">
<AU>Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ</AU>
<TI>Dietary fiber and the risk of colorectal cancer and adenoma in women</TI>
<SO>New England Journal of Medicine</SO>
<YR>1999</YR>
<VL>340</VL>
<PG>169-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fung-2010" MODIFIED="2013-06-24 12:49:46 +0200" MODIFIED_BY="[Empty name]" NAME="Fung 2010" TYPE="JOURNAL_ARTICLE">
<AU>Fung TT, Hu FB, Wu K, Chiuve SE, Fuchs CS, Giovannucci E</AU>
<TI>The Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets and colorectal cancer</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2010</YR>
<VL>92</VL>
<NO>6</NO>
<PG>1429-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ganji-1995" MODIFIED="2014-09-14 20:29:23 +0200" MODIFIED_BY="[Empty name]" NAME="Ganji 1995" TYPE="JOURNAL_ARTICLE">
<AU>Ganji V, Betts N</AU>
<TI>Fat, cholesterol, fiber and sodium intakes of US population: evaluation of diets reported in 1987-Nationwide Food Consumption Survey</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1995</YR>
<VL>49</VL>
<PG>915-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Giovannucci-2006" MODIFIED="2017-01-02 15:38:01 +0100" MODIFIED_BY="[Empty name]" NAME="Giovannucci 2006" TYPE="BOOK_SECTION">
<AU>Giovannucci E, Wu K</AU>
<TI>Cancers of the Colon and Rectum</TI>
<SO>Cancer. Epidemiology and Prevention. 3rd edition</SO>
<YR>2006</YR>
<PB>Oxford University Press</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GLOBOCAN-2008" MODIFIED="2017-01-02 15:38:54 +0100" MODIFIED_BY="[Empty name]" NAME="GLOBOCAN 2008" TYPE="COMPUTER_PROGRAM">
<TI>European Age-Standardised rates calculated by the Cancer Research UK Statistical Information Team</TI>
<SO>http://globocan.iarc.fr</SO>
<YR>2008</YR>
<PB>GLOBOCAN 2008</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gonzalez-2006" MODIFIED="2013-06-27 14:49:04 +0200" MODIFIED_BY="[Empty name]" NAME="Gonzalez 2006" TYPE="JOURNAL_ARTICLE">
<AU>Gonzalez CA</AU>
<TI>Nutrition and cancer: the current epidemiological evidence</TI>
<SO>British Journal of Nutrition</SO>
<YR>2006</YR>
<VL>96</VL>
<PG>42-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grizzle-1999" MODIFIED="2017-01-02 15:39:20 +0100" MODIFIED_BY="[Empty name]" NAME="Grizzle 1999" TYPE="BOOK_SECTION">
<AU>Grizzle WE, Shibata D, Manne U, Myers RB, Frost AR,
 Srivastava S, et al, editors</AU>
<TI>Molecular Pathology of Early Cancer</TI>
<SO>Molecular Pathology of Early Cancer</SO>
<YR>1999</YR>
<PB>IOS Press</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Half-2009" MODIFIED="2016-12-01 17:03:54 +0100" MODIFIED_BY="[Empty name]" NAME="Half 2009" TYPE="JOURNAL_ARTICLE">
<AU>Half E, Bercovich D, Rozen P</AU>
<TI>Familial adenomatous polyposis</TI>
<SO>Orphanet Journal of Rare Diseases</SO>
<YR>2009</YR>
<VL>4</VL>
<NO>22</NO>
<PG>1118-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harris-1993" MODIFIED="2013-02-26 22:18:05 +0100" MODIFIED_BY="[Empty name]" NAME="Harris 1993" TYPE="JOURNAL_ARTICLE">
<AU>Harris PJ, Ferguson LR</AU>
<TI>Dietary fibre: its composition and role in protection against colorectal cancer</TI>
<SO>Mutation Research</SO>
<YR>1993</YR>
<VL>290</VL>
<NO>1</NO>
<PG>97-110</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Heged_x00fc_s-1985" MODIFIED="2017-01-02 15:39:39 +0100" MODIFIED_BY="[Empty name]" NAME="Hegedüs 1985" TYPE="JOURNAL_ARTICLE">
<AU>M Hegedüs, B Pedersen, BO Eggum</AU>
<TI>Plant foods for human nutrition</TI>
<SO>Foods for Human Nutrition</SO>
<YR>1985</YR>
<VL>35</VL>
<PG>175-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Heine_x002d_Broring-2015" MODIFIED="2017-01-02 15:39:50 +0100" MODIFIED_BY="[Empty name]" NAME="Heine-Broring 2015" TYPE="JOURNAL_ARTICLE">
<AU>Heine-Broring RC, Winkels RM, Renkema JM, Kragt L, Van Orten-Luiten AC, Tigchelaar EF, et al</AU>
<TI>Dietary supplement use and colorectal cancer risk: a systematic review and meta-analyses of prospective cohort studies</TI>
<SO>International journal of Cancer. Journal International du Cancer</SO>
<YR>2015</YR>
<VL>136</VL>
<NO>10</NO>
<PG>2388-401</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:45:19 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="25335850"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2013-06-24 14:59:55 +0200" MODIFIED_BY="[Empty name]" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2016-11-28 15:03:33 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Altman DG, Sterne JAC, Editors</AU>
<TI>Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<YR>2011</YR>
<PB>Wiley</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hixson-1991" MODIFIED="2013-06-11 16:31:58 +0200" MODIFIED_BY="[Empty name]" NAME="Hixson 1991" TYPE="JOURNAL_ARTICLE">
<AU>Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS</AU>
<TI>Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>1991</YR>
<VL>37</VL>
<PG>125-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Howe-1992" MODIFIED="2014-09-14 20:29:30 +0200" MODIFIED_BY="[Empty name]" NAME="Howe 1992" TYPE="JOURNAL_ARTICLE">
<AU>Howe GR, Benito E, Castelleto R, Cornee J</AU>
<TI>Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>1992</YR>
<VL>84</VL>
<PG>1887-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Huxley-2013" MODIFIED="2013-06-24 14:22:24 +0200" MODIFIED_BY="[Empty name]" NAME="Huxley 2013" TYPE="JOURNAL_ARTICLE">
<AU>Huxley RR, Woodward M, Clifton P</AU>
<TI>The epidemiologic evidence and potential biological mechanisms for a protective effect of dietary fiber on the risk of colorectal cancer</TI>
<SO>Current Nutrition Reports</SO>
<YR>2013</YR>
<VL>2</VL>
<PG>63-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ishikawa-2000b" MODIFIED="2017-01-02 15:40:06 +0100" MODIFIED_BY="[Empty name]" NAME="Ishikawa 2000b" TYPE="JOURNAL_ARTICLE">
<AU>Ishikawa H, Akedo I, Nakamura T</AU>
<TI>Effects of the administration of wheat bran biscuit: changes in the diet</TI>
<SO>Biofactors</SO>
<YR>2000</YR>
<VL>12</VL>
<NO>1-4</NO>
<PG>299-303</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jasperson-2010" MODIFIED="2017-01-02 15:40:34 +0100" MODIFIED_BY="[Empty name]" NAME="Jasperson 2010" TYPE="JOURNAL_ARTICLE">
<AU>Jasperson KW, Tuohy TM, Neklason DW, Burt RW</AU>
<TI>Hereditary and familial colon cancer</TI>
<SO>Gastroenterology</SO>
<YR>2010</YR>
<VL>138</VL>
<NO>6</NO>
<PG>2044&#8211;58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jemal-2011" MODIFIED="2013-06-24 15:00:25 +0200" MODIFIED_BY="[Empty name]" NAME="Jemal 2011" TYPE="JOURNAL_ARTICLE">
<AU>Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D</AU>
<TI>Global cancer statistics</TI>
<SO>CA &#8211; A Cancer Journal for Clinicians</SO>
<YR>2011</YR>
<VL>61</VL>
<NO>2</NO>
<PG>69</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jung-2013" MODIFIED="2017-01-02 15:40:59 +0100" MODIFIED_BY="[Empty name]" NAME="Jung 2013" TYPE="JOURNAL_ARTICLE">
<AU>Jung S, Wu K, Giovannucci E, Spiegelman D, Willett WC, Smith-Warner SA</AU>
<TI>Carotenoid intake and risk of colorectal adenomas in a cohort of male health professionals</TI>
<SO>Cancer Causes &amp; Control: CCC</SO>
<YR>2013</YR>
<VL>24</VL>
<NO>4</NO>
<PG>705-17</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:43:52 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="23371557"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kritchevsky-1999" MODIFIED="2014-09-17 18:12:05 +0200" MODIFIED_BY="[Empty name]" NAME="Kritchevsky 1999" TYPE="JOURNAL_ARTICLE">
<AU>Kritchevsky D</AU>
<TI>Protective role of wheat bran fiber</TI>
<SO>American Journal of Medicine</SO>
<YR>1999</YR>
<VL>106</VL>
<PG>28-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kuczmarski-1997" MODIFIED="2017-01-02 09:22:47 +0100" MODIFIED_BY="[Empty name]" NAME="Kuczmarski 1997" TYPE="JOURNAL_ARTICLE">
<AU>Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP</AU>
<TI>Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994)</TI>
<SO>Obesity Research</SO>
<YR>1997</YR>
<VL>5</VL>
<PG>542-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lanza-1987" MODIFIED="2017-01-02 15:41:12 +0100" MODIFIED_BY="[Empty name]" NAME="Lanza 1987" TYPE="JOURNAL_ARTICLE">
<AU>Lanza E, Jones DY, Block G</AU>
<TI>Dietary fiber intake in the US population</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1987</YR>
<VL>46</VL>
<PG>790-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Liang-2009" MODIFIED="2014-04-29 12:01:26 +0200" MODIFIED_BY="[Empty name]" NAME="Liang 2009" TYPE="JOURNAL_ARTICLE">
<AU>Liang PS, Chen TY, Giovannucci E</AU>
<TI>Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis</TI>
<SO>International Journal of Cancer</SO>
<YR>2009</YR>
<VL>124</VL>
<NO>10</NO>
<PG>2406-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lupton-1999" MODIFIED="2013-06-11 16:29:19 +0200" MODIFIED_BY="[Empty name]" NAME="Lupton 1999" TYPE="JOURNAL_ARTICLE">
<AU>Lupton JR, Turner ND</AU>
<TI>Potential protective mechanisms of wheat bran fiber</TI>
<SO>American Journal of Medicine</SO>
<YR>1999</YR>
<VL>106</VL>
<PG>24S-27S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lyle-1998" MODIFIED="2014-09-14 20:29:52 +0200" MODIFIED_BY="[Empty name]" NAME="Lyle 1998" TYPE="JOURNAL_ARTICLE">
<AU>Lyle BJ, Mares-Perlman JA, Klein BE, Klein R, Greger JL</AU>
<TI>Supplement users differ from nonusers in demographic, lifestyle, dietary and health characteristics</TI>
<SO>Journal of Nutrition</SO>
<YR>1998</YR>
<VL>128</VL>
<NO>12</NO>
<PG>2355-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ma-2000" MODIFIED="2014-09-17 18:12:31 +0200" MODIFIED_BY="[Empty name]" NAME="Ma 2000" TYPE="JOURNAL_ARTICLE">
<AU>Ma J, Betts NM, Hampl JS</AU>
<TI>Clustering of lifestyle behaviors: the relationship between cigarette smoking, alcohol consumption, and dietary intake</TI>
<SO>American Journal of Health Promotion</SO>
<YR>2000</YR>
<VL>15</VL>
<NO>2</NO>
<PG>107&#8211;17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McCredie-1999" MODIFIED="2017-01-02 09:24:07 +0100" MODIFIED_BY="[Empty name]" NAME="McCredie 1999" TYPE="JOURNAL_ARTICLE">
<AU>McCredie M, Williams S, Coates M</AU>
<TI>Cancer mortality in migrants from the British Isles and continental Europe to New South Wales, Australia, 1975&#8211;1995</TI>
<SO>International Journal of Cancer</SO>
<YR>1999</YR>
<VL>83</VL>
<PG>179-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Michels-2000" MODIFIED="2014-09-14 20:29:56 +0200" MODIFIED_BY="[Empty name]" NAME="Michels 2000" TYPE="JOURNAL_ARTICLE">
<AU>Michels KB, Giovannucci E, Joshipura KJ, Rosner BA, Stampfer MJ</AU>
<TI>Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>2000</YR>
<VL>92</VL>
<PG>1740-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Murphy-2012" MODIFIED="2015-05-04 15:37:24 +0200" MODIFIED_BY="[Empty name]" NAME="Murphy 2012" TYPE="JOURNAL_ARTICLE">
<AU>Murphy N, Norat T, Ferrari P, Jenab M, Bueno-de-Mesquita B, Skeie G, et al</AU>
<TI>Dietary fibre intake and risks of cancers of the colon and rectum in the European prospective investigation into cancer and nutrition (EPIC)</TI>
<SO>PloS one</SO>
<YR>2012</YR>
<VL>7</VL>
<NO>6</NO>
<PG>e39361</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:37:23 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="22761771"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Neugut-1993" MODIFIED="2014-09-14 20:30:01 +0200" MODIFIED_BY="[Empty name]" NAME="Neugut 1993" TYPE="JOURNAL_ARTICLE">
<AU>Neugut AI, Jacobson JS, DeVivo I</AU>
<TI>Epidemiology of colorectal adenomatous polyps</TI>
<SO>Cancer Epidemiology, Biomarkers &amp; Prevention</SO>
<YR>1993</YR>
<VL>2</VL>
<PG>159-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pericleous-2013" MODIFIED="2017-01-02 09:25:01 +0100" MODIFIED_BY="[Empty name]" NAME="Pericleous 2013" TYPE="JOURNAL_ARTICLE">
<AU>Pericleous M, Mandair D, Caplin ME</AU>
<TI>Diet and supplements and their impact on colorectal cancer</TI>
<SO>Journal of Gastrointestinal Oncology</SO>
<YR>2013</YR>
<VL>4</VL>
<NO>4</NO>
<PG>409&#8211;23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Poortinga-2007" MODIFIED="2014-09-17 18:12:58 +0200" MODIFIED_BY="[Empty name]" NAME="Poortinga 2007" TYPE="JOURNAL_ARTICLE">
<AU>Poortinga W</AU>
<TI>The prevalence and clustering of four major lifestyle risk factors in an English adult population</TI>
<SO>Preventative Medicine</SO>
<YR>2007</YR>
<VL>44</VL>
<PG>124&#8211;8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Potter-1993" MODIFIED="2014-03-12 13:33:35 +0100" MODIFIED_BY="[Empty name]" NAME="Potter 1993" TYPE="JOURNAL_ARTICLE">
<AU>Potter JD, Slattery ML, Bostick RM, Gapstur SM</AU>
<TI>Colon cancer: a review of the epidemiology</TI>
<SO>Epidemiology Review</SO>
<YR>1993</YR>
<VL>15</VL>
<PG>499-545</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Prosky-2000" NAME="Prosky 2000" TYPE="JOURNAL_ARTICLE">
<AU>Prosky L</AU>
<TI>When is dietary fiber considered a functional food?</TI>
<SO>BioFactors</SO>
<YR>2000</YR>
<VL>12</VL>
<PG>289-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reddy-1999" MODIFIED="2017-01-02 15:41:28 +0100" MODIFIED_BY="[Empty name]" NAME="Reddy 1999" TYPE="JOURNAL_ARTICLE">
<AU>Reddy BS</AU>
<TI>Role of dietary fiber in colon cancer: an overview</TI>
<SO>American Journal of Medicine</SO>
<YR>1999</YR>
<VL>106</VL>
<PG>16-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2017-01-02 15:41:39 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager 5 (RevMan 5)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ries-2008" MODIFIED="2013-06-27 14:49:53 +0200" MODIFIED_BY="[Empty name]" NAME="Ries 2008" TYPE="OTHER">
<AU>Ries LAG, Melbert D, Krapcho M</AU>
<TI>SEER cancer statistics review, 1975&#8211;2005</TI>
<SO>National Cancer Institute</SO>
<YR>2008</YR>
<VL>Bethesda, MD</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ruchlin-1999" NAME="Ruchlin 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ruchlin HS</AU>
<TI>An analysis of smoking patterns among older adults</TI>
<SO>Medical Care</SO>
<YR>1999</YR>
<VL>37</VL>
<PG>615-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2011" MODIFIED="2017-01-02 15:42:05 +0100" MODIFIED_BY="[Empty name]" NAME="Schünemann 2011" TYPE="OTHER">
<AU>Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al</AU>
<TI>Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Segal-2000" MODIFIED="2017-01-02 15:42:16 +0100" MODIFIED_BY="[Empty name]" NAME="Segal 2000" TYPE="JOURNAL_ARTICLE">
<AU>Segal I, Walker AR, Wadee A</AU>
<TI>Persistent low prevalence of Western digestive diseases in Africa</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>2000</YR>
<VL>95</VL>
<PG>859-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shussman-2014" MODIFIED="2017-01-02 15:42:23 +0100" MODIFIED_BY="[Empty name]" NAME="Shussman 2014" TYPE="JOURNAL_ARTICLE">
<AU>Shussman N, Wexner SD</AU>
<TI>Colorectal polyps and polyposis syndromes</TI>
<SO>Gastroenterology Report</SO>
<YR>2014</YR>
<VL>2</VL>
<NO>1</NO>
<PG>1-15</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:31:51 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="24760231"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Slattery-2004" MODIFIED="2014-04-29 12:06:19 +0200" MODIFIED_BY="[Empty name]" NAME="Slattery 2004" TYPE="JOURNAL_ARTICLE">
<AU>Slattery ML</AU>
<TI>Physical activity and colorectal cancer</TI>
<SO>Sports Medicine</SO>
<YR>2004</YR>
<VL>34</VL>
<NO>4</NO>
<PG>239-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Song-2015" MODIFIED="2017-01-02 15:42:36 +0100" MODIFIED_BY="[Empty name]" NAME="Song 2015" TYPE="JOURNAL_ARTICLE">
<AU>Song Y, Liu M, Yang FG, Cui LH, Lu XY, Chen C</AU>
<TI>Dietary fibre and the risk of colorectal cancer: a case-control study</TI>
<SO>Asian Pacific Journal of Cancer Prevention: APJCP</SO>
<YR>2015</YR>
<VL>16</VL>
<NO>9</NO>
<PG>3747-52</PG>
<IDENTIFIERS MODIFIED="2016-10-13 06:27:50 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="25987032"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sowa-2000" NAME="Sowa 2000" TYPE="JOURNAL_ARTICLE">
<AU>Sowa Y, Sakai T</AU>
<TI>Butyrate as a model for "gene-regulating chemoprevention and chemotherapy"</TI>
<SO>BioFactors</SO>
<YR>2000</YR>
<VL>12</VL>
<PG>283-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sterne-2011" MODIFIED="2016-11-28 15:07:37 +0100" MODIFIED_BY="[Empty name]" NAME="Sterne 2011" TYPE="OTHER">
<AU>Sterne JAC, Egger M, Moher D, Editors</AU>
<TI>Chapter 10: Addressing reporting bias. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<YR>2011</YR>
<PB>Wiley</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stryker-1987" MODIFIED="2013-06-27 11:07:51 +0200" MODIFIED_BY="[Empty name]" NAME="Stryker 1987" TYPE="JOURNAL_ARTICLE">
<AU>Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL</AU>
<TI>Natural history of untreated colonic polyps</TI>
<SO>Gastroenterology</SO>
<YR>1987</YR>
<VL>93</VL>
<PG>1009-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Suh-2013" MODIFIED="2017-01-02 15:42:51 +0100" MODIFIED_BY="[Empty name]" NAME="Suh 2013" TYPE="JOURNAL_ARTICLE">
<AU>Suh SY, Lee JH, Park SS, Seo AR, Ahn HY, Bae WH, et al</AU>
<TI>Less healthy dietary pattern is associated with smoking in Korean men according to nationally representative data</TI>
<SO>Journal of Korean Medical Science</SO>
<YR>2013</YR>
<VL>28</VL>
<NO>6</NO>
<PG>869&#8211;75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sundquist-2001" MODIFIED="2014-09-14 20:30:11 +0200" MODIFIED_BY="[Empty name]" NAME="Sundquist 2001" TYPE="JOURNAL_ARTICLE">
<AU>Sundquist J, Winkleby MA, Pudaric S</AU>
<TI>Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2001</YR>
<VL>49</VL>
<NO>2</NO>
<PG>109-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Terry-2001" MODIFIED="2014-09-14 20:30:15 +0200" MODIFIED_BY="[Empty name]" NAME="Terry 2001" TYPE="JOURNAL_ARTICLE">
<AU>Terry P, Giovannucci E, Michels KB</AU>
<TI>Fruit, vegetables, dietary fiber, and risk of colorectal cancer</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>2001</YR>
<VL>93</VL>
<PG>525-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Trock-1990" MODIFIED="2017-01-02 15:43:03 +0100" MODIFIED_BY="[Empty name]" NAME="Trock 1990" TYPE="JOURNAL_ARTICLE">
<AU>Trock B, Lanza E, Greenwald P</AU>
<TI>Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>1990</YR>
<VL>82</VL>
<PG>650-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Trowell-1976" NAME="Trowell 1976" TYPE="JOURNAL_ARTICLE">
<AU>Trowell HC, Southgate TMS, Wolever TMS, Leeds AR, Gassull MA, Jenkins DJA</AU>
<TI>Dietary fiber redefined</TI>
<SO>Lancet</SO>
<YR>1976</YR>
<VL>1</VL>
<PG>976</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Winawer-1993a" MODIFIED="2017-01-02 15:43:12 +0100" MODIFIED_BY="[Empty name]" NAME="Winawer 1993a" TYPE="JOURNAL_ARTICLE">
<AU>Winawer SJ, Zauber AG, Ho MN, O'Brien MJ</AU>
<TI>Prevention of colorectal cancer by colonoscopic polypectomy</TI>
<SO>New England Journal of Medicine</SO>
<YR>1993</YR>
<VL>329</VL>
<NO>27</NO>
<PG>1977-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Winawer-1993b" MODIFIED="2017-01-02 15:43:18 +0100" MODIFIED_BY="[Empty name]" NAME="Winawer 1993b" TYPE="JOURNAL_ARTICLE">
<AU>Winawer SJ, Zauber AG, O'Brien MJ</AU>
<TI>Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps</TI>
<SO>New England Journal of Medicine</SO>
<YR>1993</YR>
<VL>328</VL>
<PG>901-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Winkels-2014" MODIFIED="2017-01-02 15:44:14 +0100" MODIFIED_BY="[Empty name]" NAME="Winkels 2014" TYPE="JOURNAL_ARTICLE">
<AU>Winkels RM, Heine-Broring RC, van Zutphen M, van Harten-Gerritsen S, Kok DE, van Duijnhoven FJ, et al</AU>
<TI>The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life</TI>
<SO>BMC cancer</SO>
<YR>2014</YR>
<VL>14</VL>
<PG>374</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:33:24 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="24886284"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wolin-2009" MODIFIED="2014-09-17 18:14:00 +0200" MODIFIED_BY="[Empty name]" NAME="Wolin 2009" TYPE="JOURNAL_ARTICLE">
<AU>Wolin KY, Yan Y, Colditz GA, Lee IM</AU>
<TI>Physical activity and colon cancer prevention: a meta-analysis</TI>
<SO>British Journal of Cancer</SO>
<YR>2009</YR>
<VL>100</VL>
<NO>4</NO>
<PG>611&#8211;6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wrieden-2007" MODIFIED="2017-01-02 15:44:30 +0100" MODIFIED_BY="[Empty name]" NAME="Wrieden 2007" TYPE="JOURNAL_ARTICLE">
<AU>Wrieden WL, Anderson AS, Longbottom PJ, Valentine K, Stead M, Caraher M, et al</AU>
<TI>The impact of a community-based food skills intervention on cooking confidence, food preparation methods and dietary choices - an exploratory trial</TI>
<SO>Public Health Nutrition</SO>
<YR>2007</YR>
<VL>10</VL>
<NO>2</NO>
<PG>203-11</PG>
<IDENTIFIERS MODIFIED="2015-05-04 15:46:35 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="17261231"/></IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2014-09-14 20:33:26 +0200" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Asano-2002" MODIFIED="2014-09-14 20:33:26 +0200" MODIFIED_BY="[Empty name]" NAME="Asano 2002" TYPE="OTHER">
<AU>Asano Tracey K., McLeod Robin S</AU>
<TI>Dietary fibre for the prevention of colorectal adenomas and carcinomas</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>1</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2014-09-14 20:33:24 +0200" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD003430"/><IDENTIFIER TYPE="OTHER" VALUE="CD003430"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2013-06-27 10:55:29 +0200" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2017-01-03 17:37:07 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-01-03 17:37:07 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2017-01-02 15:03:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alberts-1996b">
<CHAR_METHODS MODIFIED="2017-01-02 15:02:16 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomisation numbers were computer-generated</P>
<P>Blindness: only one of the biostatisticians had access to the uncoded list of participant names, agent codes, and agent identities<BR/>Median duration: 3 months' run-in period + 9 months' treatment duration<BR/>
</P>
<P>Setting: USA</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 15:03:46 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: age 50-75 years, a complete colonoscopy with colonic polyp removal within 24 months of study entry, no history of invasive cancer, severe metabolic disorders, or other life-threatening acute or chronic diseases, a performance status of 0-1 (Southwest Oncology Group performance status criteria) adequate dietary intakes of calories and protein<BR/>
</P>
<P>N = 100</P>
<P>Sex: % male: 49.4</P>
<P>Age: mean: 66-70 years</P>
<P>Exclusion criteria: dietary fibre intake of &#8805; 30.0 g/d or elemental calcium intake of &#8805; 2.0 g/d, serum creatinine levels of &#8805; 1.3 mg/dL, and serum bilirubin levels of &#8805; 2.0 mg/dL</P>
<P>Baseline dietary fibre intake g/day: 15.6-20.0<BR/>Baseline characteristics similar for each group: not tested<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 15:03:21 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low fibre/low calcium group: WBF 2.0 g + 250 mg calcium per day. N = 24.2</LI>
<LI>High fibre/low calcium group: WBF 13.5 g + 250 mg calcium per day. N = 26.3</LI>
<LI>Low fibre/high calcium group: WBF 2.0 g + 1500 mg calcium per day. N = 21.4</LI>
<LI>High fibre/high calcium group: WBF 13.5 g + 1500 mg calcium per day. N = 22</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 15:03:30 +0100" MODIFIED_BY="[Empty name]">
<P>Unable to use:</P>
<P>Compliance</P>
<P>[<SUP>3</SUP>H]thymidine labeling of normal colonic epithelial cells in 24-h outgrowth culture</P>
<P>[<SUP>3</SUP>H]thymidine labeling in crypt organ culture<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-06 06:09:22 +0200" MODIFIED_BY="[Empty name]">
<P>None. <BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alberts-2000">
<CHAR_METHODS MODIFIED="2017-01-02 15:04:04 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomized<BR/>Blindness: "double"<BR/>Median duration: 34 months (high-fibre group) and 36 months (low-fibre group) to last follow-up colonoscopy<BR/>
</P>
<P>Setting: outpatients, multicenter, USA</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 15:04:14 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: age 40-80 yrs, removal of &#8805; 1 colonic adenoma(s) &gt; = 3 mm at colonoscopy within 3 months of study entry, adequate nutritional status, normal renal and liver function</P>
<P>Exclusion criteria: invasive cancer &#8804; 5 years, &#8805; 2 first degree relatives with CRC previous colon resection</P>
<P>N = 1429</P>
<P>Sex: % male (low-fibre group/high-fibre group): 65.2/67.1</P>
<P>Age: mean (low-fibre group/high-fibre group): 66.0/66.8 years</P>
<P>Baseline dietary fibre intake g/day: ~19 g<BR/>Baseline characteristics similar for each group: yes<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>High-fibre group: WBF 13.5 g/d. N = 802</LI>
<LI>Low-fibre group: WBF 2.0 g/d. N = 627</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]">
<P>Adenoma recurrence</P>
<P>Adenoma size</P>
<P>Multiple adenomas</P>
<P>Colorectal cancer occurrence</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Adenoma defined as recurrent if found during any endoscopic procedure after the 1-year colonoscopy</LI>
<LI>Colonoscopy +/- polypectomy at 1 and 3 years after randomisation</LI>
</OL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bonithon_x002d_Kopp-2000">
<CHAR_METHODS MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised after stratification according to centre, in a 3-group parallel design<BR/>Blindness: double<BR/>Duration: 3 years' follow-up<BR/>
</P>
<P>Setting: multicenter in 10 countries (Belgium, Denmark, France, Germany, Ireland, Israel, Italy, Portugal, Spain, and the UK)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: complete colonoscopy demonstrating &gt;= 2 adenomas or 1 adenoma &#8805; 5 mm, age 35-75, at entry with a complete colonoscopy and a clean colon (<LINK REF="REF-Faivre-1997" TYPE="REFERENCE">Faivre 1997</LINK>), no debilitating disease
<BR/>
Exclusion criteria: FAP, IBD, colonic resection, CRC, contraindication to calcium or fibre.</P>
<P>N = 665</P>
<P>Sex: % male (calcium/fibre/placebo) 65.9/64.6/60.1</P>
<P>Age: mean (calcium/fibre/placebo) 58.8/59.1/59.3 years</P>
<P>Baseline dietary fibre intake g/day: ~19 g</P>
<P>Baseline characteristics similar for each group: yes</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Calcium gluconolactate and carbonate 2 g twice daily. N = 218</LI>
<LI>Ispaghula husk 3.5 g/d. N = 226</LI>
<LI>Control group: placebo. N = 221</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]">
<P>Adenoma recurrence</P>
<P>Adenoma size</P>
<P>Adverse effects<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Colonoscopy +/- polypectomy 3 years after randomisation</LI>
<LI>Adenoma defined as recurrent if found during any endoscopic procedure at least 1 year after the index colonoscopy</LI>
<LI>552/640 underwent the 3-year colonoscopy (86%)</LI>
<LI>Stopped treatment: calcium/fibre/placebo: 20%/17%/14%. Overall, 69%/79%/82% were &#8805; 80% compliant with treatment</LI>
<LI>Baseline dietary fibre was approximately 20 g/d</LI>
</OL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Decosse-1989">
<CHAR_METHODS MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomly assigned based on a table of random numbers<BR/>Blindness: quote: "Only the pharmacist and the statistician knew the treatment allocations. One patient, a nurse, obtained a chemical analysis of her placebo capsule; all other patients and investigators remained blinded." (p.1291)<BR/>Duration: 4 years<BR/>
</P>
<P>Setting: USA</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: adults with familial adenomatous polyposis; each of these participants had had a total colectomy and ileorectal anastomosis at least 1 year before entry into the trial<BR/>Exclusion criteria: not stated</P>
<P>N = 62. (4 participants withdrew from the study early)</P>
<P>Sex: % male 36.2</P>
<P>Age: mean (Group 1/Group 2/Group 3) 35.2/31.0/34.7 years<BR/>Baseline dietary fibre intake g/d: not reported<BR/>Baseline characteristics similar for each group: no, the gender distribution was not similar<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low-fibre supplement (2.2 g/d) + placebo. N = 22</LI>
<LI>Low-fibre supplement (2.2 g/d) + ascorbic acid (4 g/d) and alpha-tocopherol (400 mg/d). N = 16</LI>
<LI>High-fibre supplement (22.5 g/d) + ascorbic acid (4 g/d) and alpha-tocopherol (400 mg/d). N = 20</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]">
<P>Unable to use:</P>
<P>Adverse events (no adverse symptoms or findings could be attributed to the treatment agents)</P>
<P>Compliance</P>
<P>Dietary analysis</P>
<P>Polyp number ratios<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]">
<P>This study was supported by Public Health Service grants CA-31711 and CA-43601 from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-03 17:36:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-MacLennan-1995">
<CHAR_METHODS MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised trial with a 2 x 2 x 2 factorial design<BR/>Blindness: unclear<BR/>Duration: 48 months<BR/>
</P>
<P>Setting: multicenter, Australia</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 15:04:50 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: age 30-74 yrs, &#8805; one adenoma, polyp-free colon post colonoscopy<BR/>Exclusion criteria: IBD, bowel resection, FAP, cancer, medically supervised diet</P>
<P>N = 424*</P>
<P>Sex: % male (monitoring at 24 months/48 months) 66.7/68.0</P>
<P>Age: mean (monitoring at 24 months/48 months) 56.3/55.9 years<BR/>Baseline dietary fibre intake g/d: not reported<BR/>Baseline characteristics similar for each group: yes<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 15:04:50 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>WBF 25 g /d. N = 193*</LI>
<LI>No WBF supplement. N = 197*</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 15:04:50 +0100" MODIFIED_BY="[Empty name]">
<P>Adenoma recurrence</P>
<P>Adenoma size</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-03 17:36:59 +0100" MODIFIED_BY="[Empty name]">
<P>Other Interventions arms not used:</P>
<OL>
<LI>Fat reduction to 25% of total energy, baseline counselling by dietician then periodic further counselling</LI>
<LI>BC 20 mg/d</LI>
</OL>
<P>Control:</P>
<OL>
<LI>Unmodified diet</LI>
<LI>Placebo capsule daily</LI>
</OL>
<P>*The study randomised 424 participants, however, they did not report the number of participants in each group. Only data from 390 participants were reported with 193 in the WBF group and 197 in the WBF supplement group, respectively. So we conducted the sensitivity analysis based on 390 participants<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McKeown_x002d_Eyssen-1994">
<CHAR_METHODS MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised<BR/>Blindness: no<BR/>Duration: 24 months<BR/>
</P>
<P>Setting: 7 Toronto hospitals, Canada</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: &#8805; 1 pathologically confirmed colorectal adenomatous polyp, after polypectomy for adenomatous colorectal polyps, age &lt; 85 years<BR/>Exclusion criteria: FAP, celiacs, severe osteoporosis, cancer &lt; 5 years, medical or dietary treatment for IBD, diverticular disease, renal or liver disease, anaemia, gallbladder disease, hiatal hernia</P>
<P>N = 201</P>
<P>Sex: % male (low fat, high fibre diet/normal diet) 56.6/52.9</P>
<P>Age: mean 57.9/57.7 years</P>
<P>Baseline dietary fibre intake g/d: 18 g (intervention), 15 g (control)</P>
<P>Baseline characteristics similar for each group: protein, carbohydrates. vitamin D, riboflavin and total calories significantly higher in the intervention group; majority of baseline markers were not significantly different</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Low fat, high fibre diet: dietary targets of 20% of calories from fat sources and at least 50 g of dietary fibre/d, high WBF snack 20 g of fibre per 100 g package available, monthly nutritional counselling. N = 99</LI>
<LI>Normal diet: low WBF snack of 3 g of fibre per 50 g package, counselling on Canadian guidelines for a nutritionally balanced diet every 4 months. N = 102</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]">
<P>Adenoma recurrence</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Colonoscopy +/- polypectomy 2 years after randomisation</LI>
<LI>Adenoma defined as recurrent if it occurs in a region of the colon documented as free of polyps at the initial examination</LI>
<LI>165/201 had follow-up colonoscopy. Of these 165 participants, 23 withdrew from counselling (10 in the control group and 13 in the treatment group)</LI>
<LI>Treatment group reduced fat intake to approximately 25% of calories, increased fibre by 6.9 g per 1000 kcal and fruit and vegetables by 66%</LI>
<LI>No adverse effects reported</LI>
</OL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schatzkin-2000">
<CHAR_METHODS MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised<BR/>Blindness: no<BR/>Duration: 4 years (with a further follow-up after an additional 4 years)<BR/>
</P>
<P>Setting: 8 clinical centres, USA<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: &#8805; 1 large bowel adenoma removed within 6 months, polyp-free colon post colonoscopy, age &#8805; 35 years<BR/>Exclusion criteria: CRC, bowel resection, IBD, FAP, weight &gt; 150% of recommended, lipid-lowering drugs<BR/>N = 2079</P>
<P>Sex: % male (intervention/control) 65.8/63.2</P>
<P>Age: mean (intervention/control) 61.0/61.1</P>
<P>Baseline dietary fibre intake g/d: not reported</P>
<P>Baseline characteristics similar for each group: yes<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Treatment: dietary targets of 20% of calories from fat, 18 g of dietary fibre/1000 kcal, and 5-8 servings of fruits and vegetables/d. Over 50 h of dietary counselling. N = 1037</LI>
<LI>Control: general dietary guidelines with no additional information provided. N = 1042</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]">
<P>Adenoma recurrence</P>
<P>Colorectal cancer occurrence</P>
<P>Adenoma size</P>
<P>Multiple adenomas<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Colonoscopy +/- polypectomy at 1 and 4 years after randomisation.</LI>
<LI>Adenoma defined as recurrent if it was found during any endoscopic procedure after the 1-year colonoscopy</LI>
<LI>Treatment group reduced fat intake to approximately 25% of calories, doubled fibre intake to 30-35 g/d</LI>
<LI>Adverse effects not reported</LI>
</OL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BC: beta carotene<BR/>CRC: colorectal cancer<BR/>IBD: inflammatory bowel disease<BR/>FAP: familial adenomatous polyposis<BR/>ITT: intention-to-treat<BR/>RCT: randomised controlled trial<BR/>WBF: wheat bran fibre<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alberts-1996c">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Almendingen-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burn-2011a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were diagnosed with Lynch syndrome in this study. Only a minority of participants had a procedure to remove polyps and data were unavailable for the few participants who had the procedure. Furthermore, the control group intervention was aspirin rather than placebo.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Campos-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dove_x002d_Edwin-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Faivre-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Faivre-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-French-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gatof-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hirose-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ho-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Feasibility study, not RCT. Outcome measures were not by direct visualisation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jacobs-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT, but pooled analysis from two trials which has been included by our review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kunzmann-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>The interventions did not meet inclusion criteria: flexible sigmoidoscopy vs usual medical care.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lanza-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Article is only on the changes in dietary intake for included study <LINK REF="STD-Schatzkin-2000" TYPE="STUDY">Schatzkin 2000</LINK>.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Limburg-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>The intervention was ORAFTI_Synergy1 prebiotic supplement, and not dietary fibre</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rock-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sengupta-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shike-1999a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Review article</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vitanzo-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>This is only a summary of the included <LINK REF="STD-Alberts-2000" TYPE="STUDY">Alberts 2000</LINK> study. No additional new data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Witte-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Macrae-2014">
<CHAR_METHODS MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Double blind, randomised, cross-over placebo-controlled trial<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with Familial Adenomatous Polyposis (FAP)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-06-06 11:54:47 +0200" MODIFIED_BY="[Empty name]">
<P>Dietary butyrylated high amylose maize starch vs placebo<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>No details</P>
<P>This is a conference abstract, awaiting full report</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Awaiting full report</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2017-01-02 15:18:51 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2017-01-02 15:18:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ishikawa-2000">
<CHAR_STUDY_NAME MODIFIED="2013-02-27 16:42:26 +0100" MODIFIED_BY="[Empty name]">
<P>Ishikawa 2000</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-02-27 16:40:53 +0100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-02-27 16:41:07 +0100" MODIFIED_BY="[Empty name]">
<P>People with CRA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-02 15:18:51 +0100" MODIFIED_BY="[Empty name]">
<P>Wheat bran fibre</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Rate of CRA, CRC</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-02-27 16:42:08 +0100" MODIFIED_BY="[Empty name]">
<P>1997</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-02-27 16:42:32 +0100" MODIFIED_BY="[Empty name]">
<P>NA</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Authors of this review tried to contact Dr Ishikawa (last email sent on 6 April 2016) for further information, but have not received a reply.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>CRA: colorectal adenoma<BR/>CRC: colorectal cancer<BR/>RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2017-01-03 17:37:07 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2017-01-03 17:37:07 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:03:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alberts-1996b">
<DESCRIPTION>
<P>Randomisation numbers were computer-generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Alberts-2000">
<DESCRIPTION>
<P>The sequence generation was described as randomised, however, there was a large discrepancy (175 people) in the number of between intervention and control group suggesting that randomisation was not generated successfully and may be biased.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bonithon_x002d_Kopp-2000">
<DESCRIPTION>
<P>Randomisation after stratification according to centre, in a 3-group parallel design</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-01 18:51:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Decosse-1989">
<DESCRIPTION>
<P>Participants were randomly assigned based on a table of random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-03 17:37:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-MacLennan-1995">
<DESCRIPTION>
<P>Randomized trial with a 2 x 2 x 2 factorial design, following pre-randomisation stratification. Randomisation was computerised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McKeown_x002d_Eyssen-1994">
<DESCRIPTION>
<P>Randomised by stratification</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schatzkin-2000">
<DESCRIPTION>
<P>Randomisation stratified by clinical centre. Assignment done by a computer programme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:03:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alberts-1996b">
<DESCRIPTION>
<P>Only one of the biostatisticians had access to the uncoded list of participant names, agent codes, and agent identities.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-06 10:00:59 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alberts-2000">
<DESCRIPTION>
<P>"The treatment assignments were not revealed to the participants, their physicians, or members of the study staff."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bonithon_x002d_Kopp-2000">
<DESCRIPTION>
<P>Independent randomisation centre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Decosse-1989">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacLennan-1995">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McKeown_x002d_Eyssen-1994">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schatzkin-2000">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-02 15:03:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alberts-1996b">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Alberts-2000">
<DESCRIPTION>
<P>Described as double-blind but participants were aware of receiving cereal</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bonithon_x002d_Kopp-2000">
<DESCRIPTION>
<P>Participants, staff in the clinical centre, and study investigators were not aware of the treatment assignments.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-08-22 13:26:19 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Decosse-1989">
<DESCRIPTION>
<P>"Only the pharmacist and the statistician knew the treatment allocations. One patient, a nurse, obtained a chemical analysis of her placebo capsule; all other patients and investigators remained blinded." (p.1291)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacLennan-1995">
<DESCRIPTION>
<P>Described as partially double-blind but did not state who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-McKeown_x002d_Eyssen-1994">
<DESCRIPTION>
<P>Participants were aware of the details of their diet</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-08-22 13:27:43 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schatzkin-2000">
<DESCRIPTION>
<P>Participants were aware of treatment regimens.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2013-02-10 16:33:54 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-01-02 15:03:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alberts-1996b">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alberts-2000">
<DESCRIPTION>
<P>Described as double-blind but not stated who was blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-08-22 13:25:05 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bonithon_x002d_Kopp-2000">
<DESCRIPTION>
<P>It is unclear if outcome assessors were blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Decosse-1989">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacLennan-1995">
<DESCRIPTION>
<P>Described as partially double-blind but did not state who was blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McKeown_x002d_Eyssen-1994">
<DESCRIPTION>
<P>The endoscopist performed both the initial and follow-up examinations without knowledge of the participants's dietary assignment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-08-22 13:27:49 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schatzkin-2000">
<DESCRIPTION>
<P>Participants were aware of allocation, but were told not to tell the endoscopist.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-02 15:04:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alberts-1996b">
<DESCRIPTION>
<P>5 participants dropped out of the study during the first 3 months of post randomisation treatment because of supplement adherence problems, 2 participants refused participation in the rectal mucosal biopsy procedures<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alberts-2000">
<DESCRIPTION>
<P>Reasons for loss to follow-up not reported, 126 out of 1429 participants (8.8%) dropped out from the study early</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bonithon_x002d_Kopp-2000">
<DESCRIPTION>
<P>Full reasons for loss to follow-up not given. High attrition rate 17.0%, 113 out of 665 participants dropped out from the study early.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Decosse-1989">
<DESCRIPTION>
<P>4 participants withdrew from the study early. ITT analysis was used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-MacLennan-1995">
<DESCRIPTION>
<P>Full reasons for loss to follow-up not given. High attrition rate (27.8%), 118 participants lost to follow-up at 48 months</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-McKeown_x002d_Eyssen-1994">
<DESCRIPTION>
<P>Reasons for loss to follow-up not described. High attrition rate (17.9%) 36 out of 201 participants lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-10-10 02:52:54 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schatzkin-2000">
<DESCRIPTION>
<P>Reasons for loss to follow-up were reported, 174 out of 2079 participants (8.4%) dropped out from the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alberts-1996b">
<DESCRIPTION>
<P>It appears all pre-defined outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alberts-2000">
<DESCRIPTION>
<P>All measured outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-06 10:33:41 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bonithon_x002d_Kopp-2000">
<DESCRIPTION>
<P>All measured outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-06 10:34:49 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Decosse-1989">
<DESCRIPTION>
<P>All measured outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-06 11:11:36 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-MacLennan-1995">
<DESCRIPTION>
<P>All measured outcomes were reported. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McKeown_x002d_Eyssen-1994">
<DESCRIPTION>
<P>All measured outcomes were reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-06 10:56:04 +0200" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schatzkin-2000">
<DESCRIPTION>
<P>All measured outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alberts-1996b">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alberts-2000">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-10-17 17:03:32 +0200" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bonithon_x002d_Kopp-2000">
<DESCRIPTION>
<P>Recruitment was lower than intended. The original intended sample size to detect a 15% difference in new adenoma formation rate was 210 participants in each arm, but the number of people who completed the study in the treatment arm was 198, and 178 in the placebo arm.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Decosse-1989">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacLennan-1995">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McKeown_x002d_Eyssen-1994">
<DESCRIPTION>
<P>No details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-02 15:04:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schatzkin-2000">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2016-06-06 15:08:46 +0200" MODIFIED_BY="Grade Profiler">Dietary fibre (all study interventions) versus control for the prevention of colorectal adenomas and carcinomas</TITLE>
<TABLE COLS="7" ROWS="23">
<TR>
<TD COLSPAN="7">
<P>
<B>Dietary fibre (all study interventions) versus control for the prevention of colorectal adenomas and carcinomas</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> people with a history of colorectal adenomas<BR/>
<B>Settings: </B>out-patient setting<BR/>
<B>Intervention:</B> dietary fibre (all study interventions) versus control<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Dietary fibre (all study interventions) versus control</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Number </B>of participants<B> with at least one recurrent adenoma</B>
<BR/>Follow-up: 2 to 4 years</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.04 </B>
<BR/>(0.95 to 1.13)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>3641<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>349 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>363 per 1000</B>
<BR/>(332 to 395)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>295 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>307 per 1000</B>
<BR/>(280 to 333)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Number of </B>participants<B> with more than one adenoma</B>
<BR/>Follow-up: 3 to 4 years</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.06 </B>
<BR/>(0.94 to 1.20)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>2542<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>250 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>265 per 1000</B>
<BR/>(235 to 300)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>340 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>360 per 1000</B>
<BR/>(320 to 408)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Number </B>of participants<B> with at least one adenoma 1 cm or greater</B>
</P>
<P>Follow up: 3 to 4 years</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.99 </B>
<BR/>(0.82 to 1.20)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>3224<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>102 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>101 per 1000</B>
<BR/>(84 to 122)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>60 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>59 per 1000</B>
<BR/>(49 to 72)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Number </B>of participants<B> diagnosed with colorectal cancer</B>
<BR/>Follow-up: 3 to 4 years</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 2.70 </B>
<BR/>(1.07 to 6.85)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>2794<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low<SUP>a,c</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>The incidence of colorectal cancer is very low, so when risk was calculated by risk difference (RD), the difference between groups was very small. RD = 0.01, 95% CI 0.00 to 0.01</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>4 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>12 per 1000</B>
<BR/>(4 to 14)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>5 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>14 per 1000</B>
<BR/>(5 to 16)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RD:</B> Risk difference; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP> Risk of bias: downgraded by one level due to high risk of detection/performance bias and attrition bias.<BR/>
<SUP>b</SUP> Indirectness: downgraded by one level as adenoma was a surrogate outcome for CRC.<BR/>
<SUP>c</SUP> Imprecision: downgraded by one level as the data was under powered and the sample size was below the optimal information size.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-01-02 15:49:20 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2017-01-02 09:52:46 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Dietary fibre (all study interventions) versus control</NAME>
<DICH_OUTCOME CHI2="4.2064825159909525" CI_END="1.1325277859977223" CI_START="0.9519201698095101" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0383044073685426" ESTIMABLE="YES" EVENTS_1="672" EVENTS_2="625" I2="4.9086740573866345" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.054048866011537154" LOG_CI_START="-0.021399471011453196" LOG_EFFECT_SIZE="0.01632469750004199" METHOD="MH" MODIFIED="2016-11-16 07:11:49 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.37878217193828356" P_Q="1.0" P_Z="0.39635347851526115" Q="0.0" RANDOM="NO" SCALE="6.642641866226171" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1852" TOTAL_2="1789" WEIGHT="100.00000000000001" Z="0.8481517398811244">
<NAME>Number of participants with at least one recurrent adenoma</NAME>
<GROUP_LABEL_1>Any Dietary fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours dietary fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1767248372535204" CI_START="0.8291503093216295" EFFECT_SIZE="0.987766046589576" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="153" LOG_CI_END="0.07067492024926698" LOG_CI_START="-0.08136673290965028" LOG_EFFECT_SIZE="-0.005345906330191674" ORDER="830" O_E="0.0" SE="0.08931001968386919" STUDY_ID="STD-Alberts-2000" TOTAL_1="468" TOTAL_2="421" VAR="0.007976279615933102" WEIGHT="25.3528079259269"/>
<DICH_DATA CI_END="2.0827706317107193" CI_START="1.0072079949930335" EFFECT_SIZE="1.4483726150392817" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="36" LOG_CI_END="0.31864144523953913" LOG_CI_START="0.003119164446486643" LOG_EFFECT_SIZE="0.16088030484301288" ORDER="833" O_E="0.0" SE="0.18533934959831835" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="198" TOTAL_2="178" VAR="0.03435067450952767" WEIGHT="5.967197186570693"/>
<DICH_DATA CI_END="1.547397004716376" CI_START="0.7931246055154074" EFFECT_SIZE="1.1078260869565217" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="46" LOG_CI_END="0.18960175186214684" LOG_CI_START="-0.10065857657070698" LOG_EFFECT_SIZE="0.04447158764571994" ORDER="831" O_E="0.0" SE="0.17050035373325667" STUDY_ID="STD-MacLennan-1995" TOTAL_1="150" TOTAL_2="156" VAR="0.02907037062316565" WEIGHT="7.097709291920204"/>
<DICH_DATA CI_END="2.1820805500459652" CI_START="0.6436301784695171" EFFECT_SIZE="1.1850961538461537" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" LOG_CI_END="0.33887077823893863" LOG_CI_START="-0.19136360093796412" LOG_EFFECT_SIZE="0.07375358865048723" ORDER="832" O_E="0.0" SE="0.31146229903102024" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="78" TOTAL_2="87" VAR="0.09700876371768867" WEIGHT="2.380790519168048"/>
<DICH_DATA CI_END="1.1222498856690128" CI_START="0.8988833971482498" EFFECT_SIZE="1.0043763187567682" ESTIMABLE="YES" EVENTS_1="380" EVENTS_2="374" LOG_CI_END="0.050089569829253534" LOG_CI_START="-0.04629664114713556" LOG_EFFECT_SIZE="0.0018964643410590073" ORDER="834" O_E="0.0" SE="0.0566177374469702" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.0032055681936140512" WEIGHT="59.20149507641417"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6175574766258788" CI_END="1.202734521174048" CI_START="0.9428780167473808" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0649093576442068" ESTIMABLE="YES" EVENTS_1="355" EVENTS_2="311" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.0801697763732262" LOG_CI_START="-0.025544489744359786" LOG_EFFECT_SIZE="0.0273126433144332" METHOD="MH" MODIFIED="2016-11-16 07:11:49 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4319565907327271" P_Q="1.0" P_Z="0.3111729525480804" Q="0.0" RANDOM="NO" SCALE="5.318194808038256" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1296" TOTAL_2="1246" WEIGHT="100.0" Z="1.0127639189082454">
<NAME>Number of participants with more than one adenoma</NAME>
<GROUP_LABEL_1>Any Dietary fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours dietary fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.286076824845673" CI_START="0.965615174426787" EFFECT_SIZE="1.1143856143856143" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="154" LOG_CI_END="0.10926691229737752" LOG_CI_START="-0.015195918016301803" LOG_EFFECT_SIZE="0.047035497140537876" MODIFIED="2013-02-21 23:33:53 +0100" MODIFIED_BY="[Empty name]" ORDER="841" O_E="0.0" SE="0.07311008262720164" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.005345084181756252" WEIGHT="50.859229069564456"/>
<DICH_DATA CI_END="1.2389480923413916" CI_START="0.8294081065158793" EFFECT_SIZE="1.0137029107881335" ESTIMABLE="YES" EVENTS_1="161" EVENTS_2="157" LOG_CI_END="0.09305311131396743" LOG_CI_START="-0.08123172421927752" LOG_EFFECT_SIZE="0.00591069354734498" ORDER="842" O_E="0.0" SE="0.10237577511607782" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.010480799330617739" WEIGHT="49.14077093043554"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9904643278901784" CI_END="1.1993574204737592" CI_START="0.8195346643040163" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9914206881886686" ESTIMABLE="YES" EVENTS_1="173" EVENTS_2="161" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.07894862647479997" LOG_CI_START="-0.08643267211475815" LOG_EFFECT_SIZE="-0.00374202281997908" METHOD="MH" MODIFIED="2017-01-02 09:45:49 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5743882584770338" P_Q="1.0" P_Z="0.929324471447728" Q="0.0" RANDOM="NO" SCALE="33.03512263892173" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1644" TOTAL_2="1580" WEIGHT="100.0" Z="0.08869479220486758">
<NAME>Number of participants with at least one adenoma 1 cm or greater</NAME>
<GROUP_LABEL_1>Any Dietary fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours dietary fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3100205633704611" CI_START="0.8329541832579813" EFFECT_SIZE="1.0445990180032734" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="94" LOG_CI_END="0.11727811282235115" LOG_CI_START="-0.07937888635488374" LOG_EFFECT_SIZE="0.01894961323373371" MODIFIED="2013-02-21 23:29:36 +0100" MODIFIED_BY="[Empty name]" ORDER="837" O_E="0.0" SE="0.11551729478455362" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.013344245394341458" WEIGHT="59.70576960604979"/>
<DICH_DATA CI_END="5.869066657731736" CI_START="0.5508084236332144" EFFECT_SIZE="1.797979797979798" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7685690420268934" LOG_CI_START="-0.25899942660420516" LOG_EFFECT_SIZE="0.2547848077113441" ORDER="838" O_E="0.0" SE="0.6035988050198617" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="198" TOTAL_2="178" VAR="0.36433151742140507" WEIGHT="2.5214392899584523"/>
<DICH_DATA CI_END="1.8627656059439075" CI_START="0.2845145939504528" EFFECT_SIZE="0.728" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.27015821053261235" LOG_CI_START="-0.545895451906538" LOG_EFFECT_SIZE="-0.13786862068696282" MODIFIED="2013-02-22 12:26:12 +0100" MODIFIED_BY="[Empty name]" ORDER="839" O_E="0.0" SE="0.4793539608475347" STUDY_ID="STD-MacLennan-1995" TOTAL_1="150" TOTAL_2="156" VAR="0.22978021978021979" WEIGHT="5.867877135474712"/>
<DICH_DATA CI_END="1.2847948230180468" CI_START="0.5981073488296107" EFFECT_SIZE="0.8766100760231614" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="53" LOG_CI_END="0.10883377798190887" LOG_CI_START="-0.22322086146259404" LOG_EFFECT_SIZE="-0.05719354174034259" ORDER="840" O_E="0.0" SE="0.19505053890667548" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.03804471272778452" WEIGHT="31.904913968517043"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.1576253086594722" CI_END="5.693806269703608" CI_START="1.1191608729185665" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="2.524338565848626" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.7554026863040805" LOG_CI_START="0.04889251834170786" LOG_EFFECT_SIZE="0.4021476023228942" METHOD="MH" MODIFIED="2017-01-02 09:52:46 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.9242130792714981" P_Q="0.7508686952593348" P_Z="0.02566562111505148" Q="0.10080254279160114" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="2384" TOTAL_2="2315" WEIGHT="200.0" Z="2.231234178257394">
<NAME>Number of participants diagnosed with colorectal cancer</NAME>
<GROUP_LABEL_1>Any Dietary fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours dietary fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="10.768221244467306" CI_START="0.3629818929585714" DF="0" EFFECT_SIZE="1.977035490605428" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="1.032143970009936" LOG_CI_START="-0.4401150388325154" LOG_EFFECT_SIZE="0.2960144655887102" MODIFIED="2017-01-02 09:52:46 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4306111852195159" STUDIES="1" TAU2="0.0" TOTAL_1="958" TOTAL_2="947" WEIGHT="100.0" Z="0.7881462269507891">
<NAME>One-
year data</NAME>
<DICH_DATA CI_END="10.768221244467306" CI_START="0.3629818929585714" EFFECT_SIZE="1.977035490605428" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.032143970009936" LOG_CI_START="-0.4401150388325154" LOG_EFFECT_SIZE="0.2960144655887102" MODIFIED="2014-02-07 01:59:43 +0100" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="0.8648122295936858" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.7479001924548018" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.05956364350181097" CI_END="6.847583831487743" CI_START="1.0677415508947643" DF="1" EFFECT_SIZE="2.703969263899765" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="6" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.8355373578051046" LOG_CI_START="0.028466143513238687" LOG_EFFECT_SIZE="0.43200175065917173" MODIFIED="2016-06-06 14:52:49 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8071869560677464" P_Z="0.03588541131817588" STUDIES="2" TAU2="0.0" TOTAL_1="1426" TOTAL_2="1368" WEIGHT="100.0" Z="2.098223446844504">
<NAME>Up to 4 years</NAME>
<DICH_DATA CI_END="15.072473886713887" CI_START="0.6576942335267787" EFFECT_SIZE="3.1485042735042734" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.178184540116366" LOG_CI_START="-0.18197596589272602" LOG_EFFECT_SIZE="0.4981042871118199" ORDER="835" O_E="0.0" SE="0.7989650141328322" STUDY_ID="STD-Alberts-2000" TOTAL_1="468" TOTAL_2="421" VAR="0.6383450938082766" WEIGHT="34.357870007830854"/>
<DICH_DATA CI_END="7.852161723777082" CI_START="0.7777852831751153" EFFECT_SIZE="2.471294363256785" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="4" LOG_CI_END="0.8949892357854169" LOG_CI_START="-0.10914027859188355" LOG_EFFECT_SIZE="0.3929244785967666" MODIFIED="2013-02-22 12:51:28 +0100" MODIFIED_BY="[Empty name]" ORDER="836" O_E="0.0" SE="0.5898306472664859" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.34790019245480175" WEIGHT="65.64212999216915"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2017-01-02 09:46:27 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Wheat bran fibre versus control</NAME>
<DICH_OUTCOME CHI2="0.35555738467028253" CI_END="1.1841503191961298" CI_START="0.8683431901453329" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0140260676049613" ESTIMABLE="YES" EVENTS_1="217" EVENTS_2="199" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.07340683638490929" LOG_CI_START="-0.0613085972552158" LOG_EFFECT_SIZE="0.00604911956484673" METHOD="MH" MODIFIED="2016-11-16 07:12:14 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5509841869654404" P_Q="1.0" P_Z="0.8602811323035349" Q="0.0" RANDOM="NO" SCALE="5.553116589246313" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="618" TOTAL_2="577" WEIGHT="100.0" Z="0.17601630585175748">
<NAME>Number of participants with at least one recurrent adenoma</NAME>
<GROUP_LABEL_1>Wheat bran fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours wheat bran fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1767248372535204" CI_START="0.8291503093216295" EFFECT_SIZE="0.987766046589576" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="153" LOG_CI_END="0.07067492024926698" LOG_CI_START="-0.08136673290965028" LOG_EFFECT_SIZE="-0.005345906330191674" ORDER="843" O_E="0.0" SE="0.08931001968386919" STUDY_ID="STD-Alberts-2000" TOTAL_1="468" TOTAL_2="421" VAR="0.007976279615933102" WEIGHT="78.12759271517369"/>
<DICH_DATA CI_END="1.547397004716376" CI_START="0.7931246055154074" EFFECT_SIZE="1.1078260869565217" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="46" LOG_CI_END="0.18960175186214684" LOG_CI_START="-0.10065857657070698" LOG_EFFECT_SIZE="0.04447158764571994" ORDER="844" O_E="0.0" SE="0.17050035373325667" STUDY_ID="STD-MacLennan-1995" TOTAL_1="150" TOTAL_2="156" VAR="0.02907037062316565" WEIGHT="21.872407284826302"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.286076824845673" CI_START="0.965615174426787" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1143856143856143" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="154" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.10926691229737752" LOG_CI_START="-0.015195918016301803" LOG_EFFECT_SIZE="0.047035497140537876" METHOD="MH" MODIFIED="2016-11-16 07:12:14 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.13850745272110676" Q="0.0" RANDOM="NO" SCALE="5.382013589427119" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="338" TOTAL_2="299" WEIGHT="100.00000000000001" Z="1.4813720716145224">
<NAME>Number of participants with more than one adenoma</NAME>
<GROUP_LABEL_1>Wheat bran fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours wheat bran fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.286076824845673" CI_START="0.965615174426787" EFFECT_SIZE="1.1143856143856143" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="154" LOG_CI_END="0.10926691229737752" LOG_CI_START="-0.015195918016301803" LOG_EFFECT_SIZE="0.047035497140537876" MODIFIED="2013-02-21 23:36:53 +0100" MODIFIED_BY="[Empty name]" ORDER="846" O_E="0.0" SE="0.07311008262720164" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.005345084181756252" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3100205633704611" CI_START="0.8329541832579813" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0445990180032734" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="94" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.11727811282235115" LOG_CI_START="-0.07937888635488374" LOG_EFFECT_SIZE="0.01894961323373371" METHOD="MH" MODIFIED="2017-01-02 09:46:27 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.7056392246632913" Q="0.0" RANDOM="NO" SCALE="5.315696530104045" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="338" TOTAL_2="299" WEIGHT="100.00000000000001" Z="0.37771917210644657">
<NAME>Number of participants with at least one adenoma 1 cm or greater</NAME>
<GROUP_LABEL_1>Wheat bran fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours wheat bran fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3100205633704611" CI_START="0.8329541832579813" EFFECT_SIZE="1.0445990180032734" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="94" LOG_CI_END="0.11727811282235115" LOG_CI_START="-0.07937888635488374" LOG_EFFECT_SIZE="0.01894961323373371" MODIFIED="2013-02-21 23:35:48 +0100" MODIFIED_BY="[Empty name]" ORDER="845" O_E="0.0" SE="0.11551729478455362" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.013344245394341458" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2017-01-02 15:46:32 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Wheat bran fibre and low fat diet versus control</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.1820805500459652" CI_START="0.6436301784695171" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1850961538461537" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.33887077823893863" LOG_CI_START="-0.19136360093796412" LOG_EFFECT_SIZE="0.07375358865048723" METHOD="MH" MODIFIED="2016-11-16 07:12:44 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5855835873724313" Q="0.0" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="78" TOTAL_2="87" WEIGHT="100.0" Z="0.5452470951051224">
<NAME>Number of participants with at least one recurrent adenoma</NAME>
<GROUP_LABEL_1>WBR &amp; Low fat</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours WBR &amp; Low fat</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1820805500459652" CI_START="0.6436301784695171" EFFECT_SIZE="1.1850961538461537" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" LOG_CI_END="0.33887077823893863" LOG_CI_START="-0.19136360093796412" LOG_EFFECT_SIZE="0.07375358865048723" ORDER="847" O_E="0.0" SE="0.31146229903102024" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="78" TOTAL_2="87" VAR="0.09700876371768867" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2017-01-02 15:46:49 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Wheat bran fibre with or without low fat diet versus control</NAME>
<DICH_OUTCOME CHI2="0.5972368673429098" CI_END="1.1923206686729533" CI_START="0.8823964955594858" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0257190549171624" ESTIMABLE="YES" EVENTS_1="234" EVENTS_2="215" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.0763930724396544" LOG_CI_START="-0.054336225366369534" LOG_EFFECT_SIZE="0.011028423536642443" METHOD="MH" MODIFIED="2016-11-16 07:13:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7418424498963578" P_Q="1.0" P_Z="0.7408800764385733" Q="0.0" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="696" TOTAL_2="664" WEIGHT="100.0" Z="0.3306881211914077">
<NAME>Number of participants with at least one recurrent adenoma</NAME>
<GROUP_LABEL_1>WBR with/without low fat</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours WBR with/without low fat</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1767248372535204" CI_START="0.8291503093216295" EFFECT_SIZE="0.987766046589576" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="153" LOG_CI_END="0.07067492024926698" LOG_CI_START="-0.08136673290965028" LOG_EFFECT_SIZE="-0.005345906330191674" ORDER="848" O_E="0.0" SE="0.08931001968386919" STUDY_ID="STD-Alberts-2000" TOTAL_1="468" TOTAL_2="421" VAR="0.007976279615933102" WEIGHT="72.7874133160511"/>
<DICH_DATA CI_END="1.547397004716376" CI_START="0.7931246055154074" EFFECT_SIZE="1.1078260869565217" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="46" LOG_CI_END="0.18960175186214684" LOG_CI_START="-0.10065857657070698" LOG_EFFECT_SIZE="0.04447158764571994" ORDER="849" O_E="0.0" SE="0.17050035373325667" STUDY_ID="STD-MacLennan-1995" TOTAL_1="150" TOTAL_2="156" VAR="0.02907037062316565" WEIGHT="20.377383891267122"/>
<DICH_DATA CI_END="2.1820805500459652" CI_START="0.6436301784695171" EFFECT_SIZE="1.1850961538461537" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" LOG_CI_END="0.33887077823893863" LOG_CI_START="-0.19136360093796412" LOG_EFFECT_SIZE="0.07375358865048723" ORDER="850" O_E="0.0" SE="0.31146229903102024" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="78" TOTAL_2="87" VAR="0.09700876371768867" WEIGHT="6.835202792681789"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.286076824845673" CI_START="0.965615174426787" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1143856143856143" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="154" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.10926691229737752" LOG_CI_START="-0.015195918016301803" LOG_EFFECT_SIZE="0.047035497140537876" METHOD="MH" MODIFIED="2016-11-16 07:13:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.13850745272110676" Q="0.0" RANDOM="NO" SCALE="5.51827870343619" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="338" TOTAL_2="299" WEIGHT="100.00000000000001" Z="1.4813720716145224">
<NAME>Number of participants with more than one adenoma</NAME>
<GROUP_LABEL_1>WBR with/without low fat</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours WBR with/without low fat</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.286076824845673" CI_START="0.965615174426787" EFFECT_SIZE="1.1143856143856143" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="154" LOG_CI_END="0.10926691229737752" LOG_CI_START="-0.015195918016301803" LOG_EFFECT_SIZE="0.047035497140537876" MODIFIED="2013-02-21 23:39:05 +0100" MODIFIED_BY="[Empty name]" ORDER="853" O_E="0.0" SE="0.07311008262720164" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.005345084181756252" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.5409584838455888" CI_END="1.267341307290078" CI_START="0.8149349876950966" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0162680614197848" ESTIMABLE="YES" EVENTS_1="118" EVENTS_2="104" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.1028935903462048" LOG_CI_START="-0.0888770361820644" LOG_EFFECT_SIZE="0.007008277082070179" METHOD="MH" MODIFIED="2017-01-02 09:47:25 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.46203585706487105" P_Q="1.0" P_Z="0.8860894519164514" Q="0.0" RANDOM="NO" SCALE="5.65952451926225" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="488" TOTAL_2="455" WEIGHT="100.0" Z="0.14325416695147705">
<NAME>Number of participants with at least one adenoma 1 cm or greater</NAME>
<GROUP_LABEL_1>WBR with/without low fat</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours WBR with/without low fat</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3100205633704611" CI_START="0.8329541832579813" EFFECT_SIZE="1.0445990180032734" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="94" LOG_CI_END="0.11727811282235115" LOG_CI_START="-0.07937888635488374" LOG_EFFECT_SIZE="0.01894961323373371" MODIFIED="2013-02-21 23:38:16 +0100" MODIFIED_BY="[Empty name]" ORDER="851" O_E="0.0" SE="0.11551729478455362" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.013344245394341458" WEIGHT="91.05147048080997"/>
<DICH_DATA CI_END="1.8627656059439075" CI_START="0.2845145939504528" EFFECT_SIZE="0.728" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.27015821053261235" LOG_CI_START="-0.545895451906538" LOG_EFFECT_SIZE="-0.13786862068696282" MODIFIED="2013-02-22 12:39:45 +0100" MODIFIED_BY="[Empty name]" ORDER="852" O_E="0.0" SE="0.4793539608475347" STUDY_ID="STD-MacLennan-1995" TOTAL_1="150" TOTAL_2="156" VAR="0.22978021978021979" WEIGHT="8.94852951919003"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2017-01-02 09:47:52 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Comprehensive dietary intervention versus control</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.122249885669013" CI_START="0.8988833971482498" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0043763187567682" ESTIMABLE="YES" EVENTS_1="380" EVENTS_2="374" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.05008956982925362" LOG_CI_START="-0.04629664114713556" LOG_EFFECT_SIZE="0.0018964643410590073" METHOD="MH" MODIFIED="2016-11-16 07:14:35 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.9385223133634424" Q="0.0" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="958" TOTAL_2="947" WEIGHT="100.00000000000001" Z="0.07712725230688153">
<NAME>Number of participants with at least one recurrent adenoma (4 years)</NAME>
<GROUP_LABEL_1>Comprehensive dietary intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comprehensive dietary intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1222498856690128" CI_START="0.8988833971482498" EFFECT_SIZE="1.0043763187567682" ESTIMABLE="YES" EVENTS_1="380" EVENTS_2="374" LOG_CI_END="0.050089569829253534" LOG_CI_START="-0.04629664114713556" LOG_EFFECT_SIZE="0.0018964643410590073" ORDER="854" O_E="0.0" SE="0.0566177374469702" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.0032055681936140512" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1946781289726222E-30" CI_END="1.1964478911624328" CI_START="0.7837281859525665" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.968343913765924" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="147" I2="100.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="0.0778937885546204" LOG_CI_START="-0.10583453401101521" LOG_EFFECT_SIZE="-0.013970372728197402" METHOD="MH" MODIFIED="2016-11-16 07:14:35 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="1.0" P_Z="0.7656540847808058" Q="0.0" RANDOM="NO" SCALE="5.35" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="958" TOTAL_2="947" WEIGHT="100.0" Z="0.29806430511643806">
<NAME>Number of participants with at least one recurrent adenoma (8 years)</NAME>
<GROUP_LABEL_1>Comprehensive dietary intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comprehensive dietary intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1964478911624326" CI_START="0.7837281859525664" EFFECT_SIZE="0.9683439137659239" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="147" LOG_CI_END="0.07789378855462033" LOG_CI_START="-0.10583453401101528" LOG_EFFECT_SIZE="-0.013970372728197452" MODIFIED="2016-11-15 03:56:05 +0100" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.1079229261449188" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.011647357987681599" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2389480923413916" CI_START="0.8294081065158793" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0137029107881335" ESTIMABLE="YES" EVENTS_1="161" EVENTS_2="157" I2="0.0" I2_Q="100.00000000000001" ID="CMP-005.03" LOG_CI_END="0.09305311131396743" LOG_CI_START="-0.08123172421927752" LOG_EFFECT_SIZE="0.00591069354734498" METHOD="MH" MODIFIED="2016-11-16 07:14:35 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.8942405285901008" Q="2.871217588637574E-34" RANDOM="NO" SCALE="6.195645218818343" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="958" TOTAL_2="947" WEIGHT="100.0" Z="0.13294038395256316">
<NAME>Number of participants with more than one adenoma (4 years)</NAME>
<GROUP_LABEL_1>Comprehensive dietary intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comprehensive dietary intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2389480923413916" CI_START="0.8294081065158793" EFFECT_SIZE="1.0137029107881335" ESTIMABLE="YES" EVENTS_1="161" EVENTS_2="157" LOG_CI_END="0.09305311131396743" LOG_CI_START="-0.08123172421927752" LOG_EFFECT_SIZE="0.00591069354734498" ORDER="856" O_E="0.0" SE="0.10237577511607782" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.010480799330617739" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2367497344336682" CI_START="0.637928950258194" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8882333363589604" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="69" I2="0.0" I2_Q="100.0" ID="CMP-005.04" LOG_CI_END="0.09228182578050437" LOG_CI_START="-0.19522768840904922" LOG_EFFECT_SIZE="-0.051472931314272434" METHOD="MH" MODIFIED="2016-11-16 07:14:35 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.4828125682336296" Q="6.752441649367159E-33" RANDOM="NO" SCALE="5.7" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="958" TOTAL_2="947" WEIGHT="100.0" Z="0.701786108463631">
<NAME>Number of participants with more than one adenoma (8 years)</NAME>
<GROUP_LABEL_1>Comprehensive dietary intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comprehensive dietary intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2367497344336682" CI_START="0.637928950258194" EFFECT_SIZE="0.8882333363589604" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="69" LOG_CI_END="0.09228182578050437" LOG_CI_START="-0.19522768840904922" LOG_EFFECT_SIZE="-0.051472931314272434" MODIFIED="2016-11-15 03:56:18 +0100" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.16888451182999198" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.028521978336054705" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2847948230180468" CI_START="0.5981073488296107" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8766100760231614" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="53" I2="0.0" I2_Q="0.0" ID="CMP-005.05" LOG_CI_END="0.10883377798190887" LOG_CI_START="-0.22322086146259404" LOG_EFFECT_SIZE="-0.05719354174034259" METHOD="MH" MODIFIED="2017-01-02 09:47:52 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.4995654098572596" Q="0.0" RANDOM="NO" SCALE="5.695634254216857" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="958" TOTAL_2="947" WEIGHT="100.0" Z="0.6751737132592895">
<NAME>Number of participants with at least one adenoma 1 cm or greater</NAME>
<GROUP_LABEL_1>Comprehensive dietary intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comprehensive dietary intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2847948230180468" CI_START="0.5981073488296107" EFFECT_SIZE="0.8766100760231614" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="53" LOG_CI_END="0.10883377798190887" LOG_CI_START="-0.22322086146259404" LOG_EFFECT_SIZE="-0.05719354174034259" ORDER="855" O_E="0.0" SE="0.19505053890667548" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.03804471272778452" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2017-01-02 09:48:17 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Ispaghula husk versus control</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.0827706317107193" CI_START="1.0072079949930335" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4483726150392817" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="36" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="0.31864144523953913" LOG_CI_START="0.003119164446486643" LOG_EFFECT_SIZE="0.16088030484301288" METHOD="MH" MODIFIED="2016-11-16 07:14:54 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.04563916781644969" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="198" TOTAL_2="178" WEIGHT="100.0" Z="1.9987152889589097">
<NAME>Number of participants with at least one recurrent adenoma</NAME>
<GROUP_LABEL_1>Ispaghula husk</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Ispaghula husk</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0827706317107193" CI_START="1.0072079949930335" EFFECT_SIZE="1.4483726150392817" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="36" LOG_CI_END="0.31864144523953913" LOG_CI_START="0.003119164446486643" LOG_EFFECT_SIZE="0.16088030484301288" ORDER="857" O_E="0.0" SE="0.18533934959831835" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="198" TOTAL_2="178" VAR="0.03435067450952767" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.869066657731736" CI_START="0.5508084236332144" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.797979797979798" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="0.7685690420268934" LOG_CI_START="-0.25899942660420516" LOG_EFFECT_SIZE="0.2547848077113441" METHOD="MH" MODIFIED="2017-01-02 09:48:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.3310788635033789" Q="0.0" RANDOM="NO" SCALE="5.732068757666405" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="198" TOTAL_2="178" WEIGHT="100.0" Z="0.9719431106862294">
<NAME>Number of participants with at least one adenoma 1 cm or greater</NAME>
<GROUP_LABEL_1>Ispaghula husk</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Ispaghula husk</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.869066657731736" CI_START="0.5508084236332144" EFFECT_SIZE="1.797979797979798" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7685690420268934" LOG_CI_START="-0.25899942660420516" LOG_EFFECT_SIZE="0.2547848077113441" ORDER="859" O_E="0.0" SE="0.6035988050198617" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="198" TOTAL_2="178" VAR="0.36433151742140507" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.397183225387034" CI_START="0.1837955793654092" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.898989898989899" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" I2="0.0" I2_Q="100.0" ID="CMP-006.03" LOG_CI_END="0.6431745625304723" LOG_CI_START="-0.7356649384357467" LOG_EFFECT_SIZE="-0.04624518795263712" METHOD="MH" MODIFIED="2016-11-16 07:14:54 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.8954024979695436" Q="2.935876944635975E-34" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="198" TOTAL_2="178" WEIGHT="100.0" Z="0.131471288401499">
<NAME>Number of participants with at least one adverse effect</NAME>
<GROUP_LABEL_1>Ispaghula husk</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Ispaghula husk</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.397183225387034" CI_START="0.1837955793654092" EFFECT_SIZE="0.898989898989899" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6431745625304723" LOG_CI_START="-0.7356649384357467" LOG_EFFECT_SIZE="-0.04624518795263712" ORDER="858" O_E="0.0" SE="0.8099371482331649" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="198" TOTAL_2="178" VAR="0.6559981840880716" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2017-01-02 15:47:15 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Sensitivity analysis 1. Dietary fibre (all study interventions) versus control</NAME>
<DICH_OUTCOME CHI2="438.7692446783533" CI_END="1.0861867941839576" CI_START="0.9916146888294772" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0378240601977835" ESTIMABLE="YES" EVENTS_1="2521" EVENTS_2="2265" I2="96.80925676313915" I2_Q="99.40758451623024" ID="CMP-007.01" LOG_CI_END="0.035904518353588696" LOG_CI_START="-0.0036570486344107184" LOG_EFFECT_SIZE="0.016123734859588998" METHOD="MH" MODIFIED="2016-11-16 07:19:50 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="6.661338147750939E-16" P_Q="-1.3322676295501878E-15" P_Z="0.1101302261578746" Q="337.6008991651108" RANDOM="NO" SCALE="3.37" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="6566" TOTAL_2="6147" WEIGHT="300.0" Z="1.5976080841617595">
<NAME>Number of participants with at least one recurrent adenoma</NAME>
<GROUP_LABEL_1>Any dietary fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours any dietary fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.206482515990952" CI_END="1.132527785997722" CI_START="0.9519201698095099" DF="4" EFFECT_SIZE="1.0383044073685423" ESTIMABLE="YES" EVENTS_1="672" EVENTS_2="625" I2="4.908674057386614" ID="CMP-007.01.01" LOG_CI_END="0.05404886601153707" LOG_CI_START="-0.0213994710114533" LOG_EFFECT_SIZE="0.016324697500041896" MODIFIED="2016-11-14 09:36:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3787821719382837" P_Z="0.3963534785152639" STUDIES="5" TAU2="0.0" TOTAL_1="1852" TOTAL_2="1789" WEIGHT="99.99999999999999" Z="0.8481517398811195">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.1767248372535204" CI_START="0.8291503093216295" EFFECT_SIZE="0.987766046589576" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="153" LOG_CI_END="0.07067492024926698" LOG_CI_START="-0.08136673290965028" LOG_EFFECT_SIZE="-0.005345906330191674" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="830" O_E="0.0" SE="0.08931001968386919" STUDY_ID="STD-Alberts-2000" TOTAL_1="468" TOTAL_2="421" VAR="0.007976279615933102" WEIGHT="25.352807925926896"/>
<DICH_DATA CI_END="2.0827706317107193" CI_START="1.0072079949930335" EFFECT_SIZE="1.4483726150392817" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="36" LOG_CI_END="0.31864144523953913" LOG_CI_START="0.003119164446486643" LOG_EFFECT_SIZE="0.16088030484301288" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="833" O_E="0.0" SE="0.18533934959831835" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="198" TOTAL_2="178" VAR="0.03435067450952767" WEIGHT="5.967197186570692"/>
<DICH_DATA CI_END="1.547397004716376" CI_START="0.7931246055154074" EFFECT_SIZE="1.1078260869565217" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="46" LOG_CI_END="0.18960175186214684" LOG_CI_START="-0.10065857657070698" LOG_EFFECT_SIZE="0.04447158764571994" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="831" O_E="0.0" SE="0.17050035373325667" STUDY_ID="STD-MacLennan-1995" TOTAL_1="150" TOTAL_2="156" VAR="0.02907037062316565" WEIGHT="7.097709291920202"/>
<DICH_DATA CI_END="2.1820805500459652" CI_START="0.6436301784695171" EFFECT_SIZE="1.1850961538461537" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" LOG_CI_END="0.33887077823893863" LOG_CI_START="-0.19136360093796412" LOG_EFFECT_SIZE="0.07375358865048723" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="832" O_E="0.0" SE="0.31146229903102024" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="78" TOTAL_2="87" VAR="0.09700876371768867" WEIGHT="2.3807905191680474"/>
<DICH_DATA CI_END="1.1222498856690128" CI_START="0.8988833971482498" EFFECT_SIZE="1.0043763187567682" ESTIMABLE="YES" EVENTS_1="380" EVENTS_2="374" LOG_CI_END="0.050089569829253534" LOG_CI_START="-0.04629664114713556" LOG_EFFECT_SIZE="0.0018964643410590073" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="834" O_E="0.0" SE="0.0566177374469702" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.0032055681936140512" WEIGHT="59.201495076414155"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="76.41071724550326" CI_END="0.6644314357495589" CI_START="0.5690938265686218" DF="4" EFFECT_SIZE="0.6149177410541998" ESTIMABLE="YES" EVENTS_1="672" EVENTS_2="1015" I2="94.76513224297028" ID="CMP-007.01.02" LOG_CI_END="-0.1775498282832552" LOG_CI_START="-0.24481612551752965" LOG_EFFECT_SIZE="-0.21118297690039237" MODIFIED="2016-11-14 11:10:56 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.1102230246251565E-15" P_Z="8.342520276443168E-35" STUDIES="5" TAU2="0.0" TOTAL_1="2357" TOTAL_2="2179" WEIGHT="100.0" Z="12.306639309464524">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.42527369345683486" CI_START="0.3147367764162856" EFFECT_SIZE="0.3658541668113838" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="359" LOG_CI_END="-0.37133148100543123" LOG_CI_START="-0.5020525076063755" LOG_EFFECT_SIZE="-0.4366919943059034" MODIFIED="2016-11-14 11:10:56 +0100" MODIFIED_BY="[Empty name]" ORDER="830" O_E="0.0" SE="0.07678617810491234" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.0058961171479593195" WEIGHT="38.056796534345835"/>
<DICH_DATA CI_END="1.0534930139294654" CI_START="0.5846206856576591" EFFECT_SIZE="0.7847890214184943" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="69" LOG_CI_END="0.02263165999922755" LOG_CI_START="-0.23312582204728013" LOG_EFFECT_SIZE="-0.1052470810240263" MODIFIED="2016-11-14 11:10:56 +0100" MODIFIED_BY="[Empty name]" ORDER="833" O_E="0.0" SE="0.15023321097407288" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="226" TOTAL_2="211" VAR="0.022570017679580293" WEIGHT="6.7401837006697765"/>
<DICH_DATA CI_END="0.7670370555392976" CI_START="0.4308788172240649" EFFECT_SIZE="0.5748913108212733" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="87" LOG_CI_END="-0.11518365478960048" LOG_CI_START="-0.36564485608297087" LOG_EFFECT_SIZE="-0.2404142554362857" MODIFIED="2016-11-14 11:10:56 +0100" MODIFIED_BY="[Empty name]" ORDER="831" O_E="0.0" SE="0.14712214944266744" STUDY_ID="STD-MacLennan-1995" TOTAL_1="193" TOTAL_2="197" VAR="0.021644926856630574" WEIGHT="8.132191459953779"/>
<DICH_DATA CI_END="0.9531118707941044" CI_START="0.33493499847983976" EFFECT_SIZE="0.5650048875855328" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="31" LOG_CI_END="-0.02085612137935692" LOG_CI_START="-0.47503946920390516" LOG_EFFECT_SIZE="-0.24794779529163105" MODIFIED="2016-11-14 11:10:56 +0100" MODIFIED_BY="[Empty name]" ORDER="832" O_E="0.0" SE="0.26678954675597055" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="99" TOTAL_2="102" VAR="0.0711766622582562" WEIGHT="2.8840080700461947"/>
<DICH_DATA CI_END="0.9037738083855527" CI_START="0.7333979332244085" EFFECT_SIZE="0.8141411690685572" ESTIMABLE="YES" EVENTS_1="380" EVENTS_2="469" LOG_CI_END="-0.04394024879641752" LOG_CI_START="-0.13466031825119937" LOG_EFFECT_SIZE="-0.08930028352380842" MODIFIED="2016-11-14 11:10:56 +0100" MODIFIED_BY="[Empty name]" ORDER="834" O_E="0.0" SE="0.05328941786932516" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.0028397620568515513" WEIGHT="44.186820234984424"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="71.62113619570465" CI_END="1.8756870397088987" CI_START="1.6018537463930669" DF="4" EFFECT_SIZE="1.7333713715238925" ESTIMABLE="YES" EVENTS_1="1177" EVENTS_2="625" I2="94.41505648685884" ID="CMP-007.01.03" LOG_CI_END="0.2731603776113887" LOG_CI_START="0.20462286129003854" LOG_EFFECT_SIZE="0.2388916194507136" MODIFIED="2016-11-14 11:11:18 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="9.880984919163893E-15" P_Z="1.685470288417048E-42" STUDIES="5" TAU2="0.0" TOTAL_1="2357" TOTAL_2="2179" WEIGHT="99.99999999999999" Z="13.663143792270496">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="2.9736642240732656" CI_START="2.2126819333370773" EFFECT_SIZE="2.5651068407412843" ESTIMABLE="YES" EVENTS_1="502" EVENTS_2="153" LOG_CI_END="0.4732919279166378" LOG_CI_START="0.34491898983130925" LOG_EFFECT_SIZE="0.4091054588739735" MODIFIED="2016-11-14 11:11:18 +0100" MODIFIED_BY="[Empty name]" ORDER="830" O_E="0.0" SE="0.07540689928761403" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.005686200460172366" WEIGHT="26.69364123110872"/>
<DICH_DATA CI_END="3.136135328592035" CI_START="1.5861532244894903" EFFECT_SIZE="2.2303343166175025" ESTIMABLE="YES" EVENTS_1="86" EVENTS_2="36" LOG_CI_END="0.49639479482639626" LOG_CI_START="0.20034513842674828" LOG_EFFECT_SIZE="0.3483699666265722" MODIFIED="2016-11-14 11:11:18 +0100" MODIFIED_BY="[Empty name]" ORDER="833" O_E="0.0" SE="0.17390103363858714" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="226" TOTAL_2="211" VAR="0.03024156950056902" WEIGHT="5.787669881798053"/>
<DICH_DATA CI_END="2.736505126778818" CI_START="1.5229356725688283" EFFECT_SIZE="2.0414507772020727" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="46" LOG_CI_END="0.4371962661199143" LOG_CI_START="0.1826815595156864" LOG_EFFECT_SIZE="0.3099389128178004" MODIFIED="2016-11-14 11:11:18 +0100" MODIFIED_BY="[Empty name]" ORDER="831" O_E="0.0" SE="0.14950319852744004" STUDY_ID="STD-MacLennan-1995" TOTAL_1="193" TOTAL_2="197" VAR="0.02235120636993515" WEIGHT="7.07660219002394"/>
<DICH_DATA CI_END="4.0933272522488355" CI_START="1.4627857312406198" EFFECT_SIZE="2.446969696969697" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="16" LOG_CI_END="0.6120764668941013" LOG_CI_START="0.1651807153564047" LOG_EFFECT_SIZE="0.388628591125253" MODIFIED="2016-11-14 11:11:18 +0100" MODIFIED_BY="[Empty name]" ORDER="832" O_E="0.0" SE="0.26250877662289057" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="99" TOTAL_2="102" VAR="0.06891085780404665" WEIGHT="2.4498154468192874"/>
<DICH_DATA CI_END="1.3711747761701898" CI_START="1.1090912432249878" EFFECT_SIZE="1.2331901464013326" ESTIMABLE="YES" EVENTS_1="459" EVENTS_2="374" LOG_CI_END="0.13709281546677074" LOG_CI_START="0.04496727635572089" LOG_EFFECT_SIZE="0.09103004591124582" MODIFIED="2016-11-14 11:11:18 +0100" MODIFIED_BY="[Empty name]" ORDER="834" O_E="0.0" SE="0.05411499770260403" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.0029284329763528396" WEIGHT="57.99227125025"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="628.4363647151558" CI_END="1.1098079551358413" CI_START="0.9843914890871217" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.045220314362912" ESTIMABLE="YES" EVENTS_1="1608" EVENTS_2="1340" I2="99.20437449505864" I2_Q="99.61689809228592" ID="CMP-007.02" LOG_CI_END="0.04524783352483683" LOG_CI_START="-0.006832149803121271" LOG_EFFECT_SIZE="0.019207841860857805" METHOD="MH" MODIFIED="2016-11-16 07:19:50 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="-6.661338147750939E-16" P_Q="-2.220446049250313E-15" P_Z="0.1482542274484269" Q="522.0543045409847" RANDOM="NO" SCALE="18.15673550368661" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="4974" TOTAL_2="4584" WEIGHT="300.0" Z="1.4457254347012143">
<NAME>Number of participants with more than one adenoma</NAME>
<GROUP_LABEL_1>Any dietary fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours any dietary fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6175574766258788" CI_END="1.202734521174048" CI_START="0.9428780167473808" DF="1" EFFECT_SIZE="1.0649093576442068" ESTIMABLE="YES" EVENTS_1="355" EVENTS_2="311" I2="0.0" ID="CMP-007.02.01" LOG_CI_END="0.0801697763732262" LOG_CI_START="-0.025544489744359786" LOG_EFFECT_SIZE="0.0273126433144332" MODIFIED="2016-11-14 10:02:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4319565907327271" P_Z="0.3111729525480804" STUDIES="2" TAU2="0.0" TOTAL_1="1296" TOTAL_2="1246" WEIGHT="100.0" Z="1.0127639189082454">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.286076824845673" CI_START="0.965615174426787" EFFECT_SIZE="1.1143856143856143" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="154" LOG_CI_END="0.10926691229737752" LOG_CI_START="-0.015195918016301803" LOG_EFFECT_SIZE="0.047035497140537876" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="841" O_E="0.0" SE="0.07311008262720164" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.005345084181756252" WEIGHT="50.859229069564456"/>
<DICH_DATA CI_END="1.2389480923413916" CI_START="0.8294081065158793" EFFECT_SIZE="1.0137029107881335" ESTIMABLE="YES" EVENTS_1="161" EVENTS_2="157" LOG_CI_END="0.09305311131396743" LOG_CI_START="-0.08123172421927752" LOG_EFFECT_SIZE="0.00591069354734498" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="842" O_E="0.0" SE="0.10237577511607782" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.010480799330617739" WEIGHT="49.14077093043554"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="47.532255635363356" CI_END="0.47401721413961884" CI_START="0.38483441966533966" DF="1" EFFECT_SIZE="0.4271043660685304" ESTIMABLE="YES" EVENTS_1="355" EVENTS_2="718" I2="97.89616548461038" ID="CMP-007.02.02" LOG_CI_END="-0.32420588644807036" LOG_CI_START="-0.4147260915141157" LOG_EFFECT_SIZE="-0.36946598898109306" MODIFIED="2016-11-14 11:12:04 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="5.409783732091E-12" P_Z="1.287586857965794E-57" STUDIES="2" TAU2="0.0" TOTAL_1="1839" TOTAL_2="1669" WEIGHT="100.0" Z="15.99952256818392">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.3582863326452277" CI_START="0.2763538293154757" EFFECT_SIZE="0.3146645833548908" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="482" LOG_CI_END="-0.44576975831441" LOG_CI_START="-0.5585345132097312" LOG_EFFECT_SIZE="-0.5021521357620706" MODIFIED="2016-11-14 11:12:04 +0100" MODIFIED_BY="[Empty name]" ORDER="841" O_E="0.0" SE="0.06623857522005086" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.004387548847182336" WEIGHT="69.6787333556615"/>
<DICH_DATA CI_END="0.8214715961893051" CI_START="0.5720225105509835" EFFECT_SIZE="0.6854927022212053" ESTIMABLE="YES" EVENTS_1="161" EVENTS_2="236" LOG_CI_END="-0.08540744845717278" LOG_CI_START="-0.24258688027041145" LOG_EFFECT_SIZE="-0.16399716436379214" MODIFIED="2016-11-14 11:12:04 +0100" MODIFIED_BY="[Empty name]" ORDER="842" O_E="0.0" SE="0.0923279762978321" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.008524455207253045" WEIGHT="30.321266644338486"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="43.79651921615397" CI_END="2.76987182697318" CI_START="2.2252578356265516" DF="1" EFFECT_SIZE="2.4826757715523993" ESTIMABLE="YES" EVENTS_1="898" EVENTS_2="311" I2="97.71671352450502" ID="CMP-007.02.03" LOG_CI_END="0.4424596729900175" LOG_CI_START="0.3473803389584609" LOG_EFFECT_SIZE="0.3949200059742392" MODIFIED="2016-11-14 11:12:11 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="3.6436076378265625E-11" P_Z="1.330094886354705E-59" STUDIES="2" TAU2="0.0" TOTAL_1="1839" TOTAL_2="1669" WEIGHT="100.0" Z="16.2817503165715">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="3.846013721568709" CI_START="2.9012547285739063" EFFECT_SIZE="3.3403990024937658" ESTIMABLE="YES" EVENTS_1="658" EVENTS_2="154" LOG_CI_END="0.5850108293540842" LOG_CI_START="0.4625858612940064" LOG_EFFECT_SIZE="0.5237983453240453" MODIFIED="2016-11-14 11:12:11 +0100" MODIFIED_BY="[Empty name]" ORDER="841" O_E="0.0" SE="0.07191303225185526" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.005171484207656375" WEIGHT="52.464010106606395"/>
<DICH_DATA CI_END="1.8424391672585994" CI_START="1.280583631384892" EFFECT_SIZE="1.5360330202875763" ESTIMABLE="YES" EVENTS_1="240" EVENTS_2="157" LOG_CI_END="0.26539315744829145" LOG_CI_START="0.1074079463053825" LOG_EFFECT_SIZE="0.186400551876837" MODIFIED="2016-11-14 11:12:11 +0100" MODIFIED_BY="[Empty name]" ORDER="842" O_E="0.0" SE="0.09280129506475245" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.008612080365695246" WEIGHT="47.5359898933936"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="716.1849860807092" CI_END="1.071697330358721" CI_START="0.9181489593429178" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9919565457213552" ESTIMABLE="YES" EVENTS_1="1133" EVENTS_2="980" I2="98.46408397079125" I2_Q="99.71469674580172" ID="CMP-007.03" LOG_CI_END="0.03007214886879273" LOG_CI_START="-0.03708685368701388" LOG_EFFECT_SIZE="-0.003507352409110551" METHOD="MH" MODIFIED="2017-01-02 09:48:59 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="5.551115123125783E-16" P_Q="-1.3322676295501878E-15" P_Z="0.8377934788066057" Q="701.0084780210823" RANDOM="NO" SCALE="33.04" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="6160" TOTAL_2="5734" WEIGHT="300.0" Z="0.20471669147361737">
<NAME>Number of participants with at least one adenoma 1 cm or greater</NAME>
<GROUP_LABEL_1>Any dietary fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours any dietary fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.9904643278901784" CI_END="1.1993574204737594" CI_START="0.8195346643040164" DF="3" EFFECT_SIZE="0.9914206881886687" ESTIMABLE="YES" EVENTS_1="173" EVENTS_2="161" I2="0.0" ID="CMP-007.03.01" LOG_CI_END="0.07894862647480005" LOG_CI_START="-0.0864326721147581" LOG_EFFECT_SIZE="-0.0037420228199790315" MODIFIED="2016-11-14 10:13:11 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5743882584770338" P_Z="0.9293244714477289" STUDIES="4" TAU2="0.0" TOTAL_1="1644" TOTAL_2="1580" WEIGHT="100.00000000000001" Z="0.08869479220486644">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.3100205633704611" CI_START="0.8329541832579813" EFFECT_SIZE="1.0445990180032734" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="94" LOG_CI_END="0.11727811282235115" LOG_CI_START="-0.07937888635488374" LOG_EFFECT_SIZE="0.01894961323373371" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="837" O_E="0.0" SE="0.11551729478455362" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.013344245394341458" WEIGHT="59.705769606049806"/>
<DICH_DATA CI_END="5.869066657731736" CI_START="0.5508084236332144" EFFECT_SIZE="1.797979797979798" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7685690420268934" LOG_CI_START="-0.25899942660420516" LOG_EFFECT_SIZE="0.2547848077113441" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="838" O_E="0.0" SE="0.6035988050198617" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="198" TOTAL_2="178" VAR="0.36433151742140507" WEIGHT="2.521439289958453"/>
<DICH_DATA CI_END="1.8627656059439075" CI_START="0.2845145939504528" EFFECT_SIZE="0.728" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.27015821053261235" LOG_CI_START="-0.545895451906538" LOG_EFFECT_SIZE="-0.13786862068696282" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="839" O_E="0.0" SE="0.4793539608475347" STUDY_ID="STD-MacLennan-1995" TOTAL_1="150" TOTAL_2="156" VAR="0.22978021978021979" WEIGHT="5.867877135474713"/>
<DICH_DATA CI_END="1.2847948230180468" CI_START="0.5981073488296107" EFFECT_SIZE="0.8766100760231614" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="53" LOG_CI_END="0.10883377798190887" LOG_CI_START="-0.22322086146259404" LOG_EFFECT_SIZE="-0.05719354174034259" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="0.19505053890667548" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.03804471272778452" WEIGHT="31.90491396851705"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.176671725951126" CI_END="0.26095673252306084" CI_START="0.19290867015400706" DF="3" EFFECT_SIZE="0.2243675917746558" ESTIMABLE="YES" EVENTS_1="173" EVENTS_2="658" I2="58.19789291529271" ID="CMP-007.03.02" LOG_CI_END="-0.5834314941336907" LOG_CI_START="-0.7146482528360298" LOG_EFFECT_SIZE="-0.6490398734848603" MODIFIED="2016-11-14 11:12:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0664749443196454" P_Z="0.0" STUDIES="4" TAU2="0.0" TOTAL_1="2258" TOTAL_2="2077" WEIGHT="100.0" Z="19.389212005251018">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.24646244528612085" CI_START="0.17157604303495166" EFFECT_SIZE="0.20563815579534575" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="422" LOG_CI_END="-0.6082492469650363" LOG_CI_START="-0.7655433522918906" LOG_EFFECT_SIZE="-0.6868962996284635" MODIFIED="2016-11-14 11:12:29 +0100" MODIFIED_BY="[Empty name]" ORDER="837" O_E="0.0" SE="0.092395336087373" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.008536898130698613" WEIGHT="66.70879792642093"/>
<DICH_DATA CI_END="0.4234408158147875" CI_START="0.09623473183115289" EFFECT_SIZE="0.20186558239655586" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="37" LOG_CI_END="-0.3732072822901705" LOG_CI_START="-1.016668159559349" LOG_EFFECT_SIZE="-0.6949377209247597" MODIFIED="2016-11-14 11:12:29 +0100" MODIFIED_BY="[Empty name]" ORDER="838" O_E="0.0" SE="0.37797210449062785" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="226" TOTAL_2="211" VAR="0.14286291177307409" WEIGHT="5.389608889354543"/>
<DICH_DATA CI_END="0.3009696281156722" CI_START="0.06521550933652592" EFFECT_SIZE="0.14009956314131872" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="51" LOG_CI_END="-0.5214773283506339" LOG_CI_START="-1.1856491095090866" LOG_EFFECT_SIZE="-0.8535632189298603" MODIFIED="2016-11-14 11:12:29 +0100" MODIFIED_BY="[Empty name]" ORDER="839" O_E="0.0" SE="0.39013779195581527" STUDY_ID="STD-MacLennan-1995" TOTAL_1="193" TOTAL_2="197" VAR="0.152207496712159" WEIGHT="7.1087199020568095"/>
<DICH_DATA CI_END="0.43799134093668896" CI_START="0.23247951215789378" EFFECT_SIZE="0.31909875159634077" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="148" LOG_CI_END="-0.35853447538765265" LOG_CI_START="-0.6336153143818979" LOG_EFFECT_SIZE="-0.49607489488477524" MODIFIED="2016-11-14 11:12:29 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="0.16158384649733348" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.026109339448873833" WEIGHT="20.792873282167726"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="16.616751039351268" CI_END="4.84761102322426" CI_START="3.5589969526550016" DF="3" EFFECT_SIZE="4.153628878379957" ESTIMABLE="YES" EVENTS_1="787" EVENTS_2="161" I2="81.9459291837767" ID="CMP-007.03.03" LOG_CI_END="0.6855277643668356" LOG_CI_START="0.5513276161449856" LOG_EFFECT_SIZE="0.6184276902559106" MODIFIED="2016-11-14 11:12:36 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="8.472993068820989E-4" P_Z="6.121697571842766E-73" STUDIES="4" TAU2="0.0" TOTAL_1="2258" TOTAL_2="2077" WEIGHT="100.0" Z="18.064003892754684">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="5.790999753749952" CI_START="3.9492332133523353" EFFECT_SIZE="4.782259776091686" ESTIMABLE="YES" EVENTS_1="575" EVENTS_2="94" LOG_CI_END="0.7627535464659176" LOG_CI_START="0.596512780807052" LOG_EFFECT_SIZE="0.6796331636364847" MODIFIED="2016-11-14 11:12:36 +0100" MODIFIED_BY="[Empty name]" ORDER="837" O_E="0.0" SE="0.09765064865307932" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.00953564918236714" WEIGHT="61.194913829394146"/>
<DICH_DATA CI_END="23.204747882149277" CI_START="3.0426794196090228" EFFECT_SIZE="8.402654867256636" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="4" LOG_CI_END="1.3655768542036084" LOG_CI_START="0.48325619697562494" LOG_EFFECT_SIZE="0.9244165255896166" MODIFIED="2016-11-14 11:12:36 +0100" MODIFIED_BY="[Empty name]" ORDER="838" O_E="0.0" SE="0.5182795216134097" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="226" TOTAL_2="211" VAR="0.26861366252382485" WEIGHT="2.3995639462687746"/>
<DICH_DATA CI_END="9.76922073838081" CI_START="2.666231900261633" EFFECT_SIZE="5.103626943005182" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="10" LOG_CI_END="0.989859922724039" LOG_CI_START="0.42589792025563705" LOG_EFFECT_SIZE="0.707878921489838" MODIFIED="2016-11-14 11:12:36 +0100" MODIFIED_BY="[Empty name]" ORDER="839" O_E="0.0" SE="0.3312740719068748" STUDY_ID="STD-MacLennan-1995" TOTAL_1="193" TOTAL_2="197" VAR="0.10974251071776124" WEIGHT="5.740345552310378"/>
<DICH_DATA CI_END="3.2542293236205846" CI_START="1.7535539098684316" EFFECT_SIZE="2.3888211640981787" ESTIMABLE="YES" EVENTS_1="126" EVENTS_2="53" LOG_CI_END="0.5124481541551555" LOG_CI_START="0.24391912202732158" LOG_EFFECT_SIZE="0.37818363809123856" MODIFIED="2016-11-14 11:12:36 +0100" MODIFIED_BY="[Empty name]" ORDER="840" O_E="0.0" SE="0.1577352827120364" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.024880419412246047" WEIGHT="30.6651766720267"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="303.83996188645347" CI_END="1.3061279996352568" CI_START="1.0133318593829055" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1504525694101733" ESTIMABLE="YES" EVENTS_1="555" EVENTS_2="420" I2="97.36703495144933" I2_Q="98.34088870823739" ID="CMP-007.04" LOG_CI_END="0.11598573958172036" LOG_CI_START="0.005751697182838379" LOG_EFFECT_SIZE="0.060868718382279335" METHOD="MH" MODIFIED="2017-01-02 09:50:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.6653345369377348E-15" P_Q="3.3306690738754696E-16" P_Z="0.03042640911000231" Q="301.3661605960171" RANDOM="NO" SCALE="378.7487611749078" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="8136" TOTAL_2="7737" WEIGHT="600.0" Z="2.16449461923368">
<NAME>Number of participants diagnosed with colorectal cancer</NAME>
<GROUP_LABEL_1>Any dietary fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours any dietary fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="10.768221244467306" CI_START="0.3629818929585714" DF="0" EFFECT_SIZE="1.977035490605428" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-007.04.01" LOG_CI_END="1.032143970009936" LOG_CI_START="-0.4401150388325154" LOG_EFFECT_SIZE="0.2960144655887102" MODIFIED="2017-01-02 09:49:58 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4306111852195159" STUDIES="1" TAU2="0.0" TOTAL_1="958" TOTAL_2="947" WEIGHT="100.0" Z="0.7881462269507891">
<NAME>One-
year data - completers only</NAME>
<DICH_DATA CI_END="10.768221244467306" CI_START="0.3629818929585714" EFFECT_SIZE="1.977035490605428" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.032143970009936" LOG_CI_START="-0.4401150388325154" LOG_EFFECT_SIZE="0.2960144655887102" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="0.8648122295936858" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.7479001924548018" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.11221648859217" CI_START="0.01530022312956797" DF="0" EFFECT_SIZE="0.04143594229985386" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="97" I2="0.0" ID="CMP-007.04.02" LOG_CI_END="-0.9499433250899085" LOG_CI_START="-1.8153022356377266" LOG_EFFECT_SIZE="-1.3826227803638178" MODIFIED="2017-01-02 09:50:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="3.7753186591877016E-10" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="99.99999999999999" Z="6.2630448954462405">
<NAME>One-
year data - best case scenario</NAME>
<DICH_DATA CI_END="0.11221648859217" CI_START="0.015300223129567955" EFFECT_SIZE="0.04143594229985386" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="97" LOG_CI_END="-0.9499433250899085" LOG_CI_START="-1.815302235637727" LOG_EFFECT_SIZE="-1.3826227803638178" MODIFIED="2016-11-14 11:20:59 +0100" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="0.5083161076514807" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.2583852652979517" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="169.07934271786178" CI_START="10.284509121501843" DF="0" EFFECT_SIZE="41.70009643201543" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="2" I2="0.0" ID="CMP-007.04.03" LOG_CI_END="2.228090550875928" LOG_CI_START="1.012183567697187" LOG_EFFECT_SIZE="1.6201370592865574" MODIFIED="2017-01-02 09:50:10 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="1.759391654280005E-7" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="100.0" Z="5.223113823919038">
<NAME>One-
year data - worst case scenario</NAME>
<DICH_DATA CI_END="169.07934271786178" CI_START="10.284509121501847" EFFECT_SIZE="41.70009643201543" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="2" LOG_CI_END="2.228090550875928" LOG_CI_START="1.012183567697187" LOG_EFFECT_SIZE="1.6201370592865574" MODIFIED="2016-11-14 11:21:07 +0100" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="0.7142297807558297" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.5101241797185205" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.05956364350181097" CI_END="6.847583831487743" CI_START="1.0677415508947643" DF="1" EFFECT_SIZE="2.703969263899765" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="6" I2="0.0" ID="CMP-007.04.04" LOG_CI_END="0.8355373578051046" LOG_CI_START="0.028466143513238687" LOG_EFFECT_SIZE="0.43200175065917173" MODIFIED="2016-11-14 10:22:42 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8071869560677464" P_Z="0.03588541131817588" STUDIES="2" TAU2="0.0" TOTAL_1="1426" TOTAL_2="1368" WEIGHT="100.0" Z="2.098223446844504">
<NAME>Up to 4 years - completers only</NAME>
<DICH_DATA CI_END="15.072473886713887" CI_START="0.6576942335267787" EFFECT_SIZE="3.1485042735042734" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.178184540116366" LOG_CI_START="-0.18197596589272602" LOG_EFFECT_SIZE="0.4981042871118199" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="835" O_E="0.0" SE="0.7989650141328322" STUDY_ID="STD-Alberts-2000" TOTAL_1="468" TOTAL_2="421" VAR="0.6383450938082766" WEIGHT="34.357870007830854"/>
<DICH_DATA CI_END="7.852161723777082" CI_START="0.7777852831751153" EFFECT_SIZE="2.471294363256785" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="4" LOG_CI_END="0.8949892357854169" LOG_CI_START="-0.10914027859188355" LOG_EFFECT_SIZE="0.3929244785967666" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="836" O_E="0.0" SE="0.5898306472664859" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.34790019245480175" WEIGHT="65.64212999216915"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.60688059075853" CI_END="0.07820749761651237" CI_START="0.030276891894828795" DF="1" EFFECT_SIZE="0.048660866727794995" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="307" I2="86.85400686827025" ID="CMP-007.04.05" LOG_CI_END="-1.1067516098891044" LOG_CI_START="-1.5188887098260895" LOG_EFFECT_SIZE="-1.312820159857597" MODIFIED="2016-11-14 11:21:17 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.00581465268559056" P_Z="8.843180433408868E-36" STUDIES="2" TAU2="0.0" TOTAL_1="1839" TOTAL_2="1669" WEIGHT="100.0" Z="12.486525633787524">
<NAME>Up to 4 years - best case scenario</NAME>
<DICH_DATA CI_END="0.05546997129087485" CI_START="0.012479518066126414" EFFECT_SIZE="0.026310425858430846" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="208" LOG_CI_END="-1.2559420588952381" LOG_CI_START="-1.9038021859086658" LOG_EFFECT_SIZE="-1.5798721224019519" MODIFIED="2016-11-14 11:21:17 +0100" MODIFIED_BY="[Empty name]" ORDER="835" O_E="0.0" SE="0.38055624556703743" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.14482305604007928" WEIGHT="70.27341374910256"/>
<DICH_DATA CI_END="0.19338209818570928" CI_START="0.053271051339614676" EFFECT_SIZE="0.10149713139105618" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="99" LOG_CI_END="-0.7135837320059139" LOG_CI_START="-1.2735087320402563" LOG_EFFECT_SIZE="-0.9935462320230852" MODIFIED="2016-11-14 11:21:17 +0100" MODIFIED_BY="[Empty name]" ORDER="836" O_E="0.0" SE="0.32890271669362403" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.10817699704844633" WEIGHT="29.726586250897444"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.206862271282684" CI_END="142.03771110209792" CI_START="27.32499428708778" DF="1" EFFECT_SIZE="62.299114314858826" ESTIMABLE="YES" EVENTS_1="430" EVENTS_2="6" I2="80.79457554475212" ID="CMP-007.04.06" LOG_CI_END="2.1524036651521214" LOG_CI_START="1.4365600798226" LOG_EFFECT_SIZE="1.7944818724873606" MODIFIED="2016-11-14 11:21:26 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.022497948620571306" P_Z="8.657219927572328E-23" STUDIES="2" TAU2="0.0" TOTAL_1="1839" TOTAL_2="1669" WEIGHT="99.99999999999999" Z="9.826503758823804">
<NAME>Up to 4 years - worst case scenario</NAME>
<DICH_DATA CI_END="533.043401556732" CI_START="33.33285706998227" EFFECT_SIZE="133.29613466334163" ESTIMABLE="YES" EVENTS_1="341" EVENTS_2="2" LOG_CI_END="2.72676257167049" LOG_CI_START="1.5228725400796488" LOG_EFFECT_SIZE="2.1248175558750693" MODIFIED="2016-11-14 11:21:26 +0100" MODIFIED_BY="[Empty name]" ORDER="835" O_E="0.0" SE="0.7071709639082279" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.5000907721948922" WEIGHT="36.00346699188789"/>
<DICH_DATA CI_END="60.65597983785806" CI_START="8.240704344910775" EFFECT_SIZE="22.3572806171649" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="4" LOG_CI_END="1.7828736227222228" LOG_CI_START="0.9159643330606073" LOG_EFFECT_SIZE="1.3494189778914152" MODIFIED="2016-11-14 11:21:26 +0100" MODIFIED_BY="[Empty name]" ORDER="836" O_E="0.0" SE="0.5092268080174256" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.259311942003616" WEIGHT="63.996533008112095"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2017-01-02 15:47:38 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Sensitivity analysis 2. Wheat bran fibre versus control</NAME>
<DICH_OUTCOME CHI2="365.16465554489776" CI_END="1.109117435939587" CI_START="0.9556613673916659" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0295342079930925" ESTIMABLE="YES" EVENTS_1="1028" EVENTS_2="844" I2="98.63075466804447" I2_Q="99.4418593922703" ID="CMP-008.01" LOG_CI_END="0.04497753269591458" LOG_CI_START="-0.019695969989716323" LOG_EFFECT_SIZE="0.012640781353099153" METHOD="MH" MODIFIED="2016-11-16 07:20:11 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="2.3314683517128287E-15" P_Q="3.3306690738754696E-16" P_Z="0.44357465834012266" Q="358.3326445526456" RANDOM="NO" SCALE="5.55" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="2608" TOTAL_2="2225" WEIGHT="300.0" Z="0.7661708477102296">
<NAME>Number of participants with at least one recurrent adenoma</NAME>
<GROUP_LABEL_1>Wheat bran fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours wheat bran fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.35555738467028253" CI_END="1.1841503191961298" CI_START="0.8683431901453329" DF="1" EFFECT_SIZE="1.0140260676049613" ESTIMABLE="YES" EVENTS_1="217" EVENTS_2="199" I2="0.0" ID="CMP-008.01.01" LOG_CI_END="0.07340683638490929" LOG_CI_START="-0.0613085972552158" LOG_EFFECT_SIZE="0.00604911956484673" MODIFIED="2016-11-14 10:29:31 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5509841869654404" P_Z="0.8602811323035349" STUDIES="2" TAU2="0.0" TOTAL_1="618" TOTAL_2="577" WEIGHT="100.0" Z="0.17601630585175748">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.1767248372535204" CI_START="0.8291503093216295" EFFECT_SIZE="0.987766046589576" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="153" LOG_CI_END="0.07067492024926698" LOG_CI_START="-0.08136673290965028" LOG_EFFECT_SIZE="-0.005345906330191674" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="843" O_E="0.0" SE="0.08931001968386919" STUDY_ID="STD-Alberts-2000" TOTAL_1="468" TOTAL_2="421" VAR="0.007976279615933102" WEIGHT="78.12759271517369"/>
<DICH_DATA CI_END="1.547397004716376" CI_START="0.7931246055154074" EFFECT_SIZE="1.1078260869565217" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="46" LOG_CI_END="0.18960175186214684" LOG_CI_START="-0.10065857657070698" LOG_EFFECT_SIZE="0.04447158764571994" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="844" O_E="0.0" SE="0.17050035373325667" STUDY_ID="STD-MacLennan-1995" TOTAL_1="150" TOTAL_2="156" VAR="0.02907037062316565" WEIGHT="21.872407284826302"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.416574349931195" CI_END="0.4598698771948756" CI_START="0.35256372031976074" DF="1" EFFECT_SIZE="0.4026579625026889" ESTIMABLE="YES" EVENTS_1="217" EVENTS_2="446" I2="86.51668610307564" ID="CMP-008.01.02" LOG_CI_END="-0.33736503703717247" LOG_CI_START="-0.4527623797155804" LOG_EFFECT_SIZE="-0.39506370837637644" MODIFIED="2016-11-14 11:21:50 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0064626109570916634" P_Z="4.623106641057065E-41" STUDIES="2" TAU2="0.0" TOTAL_1="995" TOTAL_2="824" WEIGHT="100.0" Z="13.419904168407065">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.42527369345683486" CI_START="0.3147367764162856" EFFECT_SIZE="0.3658541668113838" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="359" LOG_CI_END="-0.37133148100543123" LOG_CI_START="-0.5020525076063755" LOG_EFFECT_SIZE="-0.4366919943059034" MODIFIED="2016-11-14 11:21:50 +0100" MODIFIED_BY="[Empty name]" ORDER="843" O_E="0.0" SE="0.07678617810491234" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.0058961171479593195" WEIGHT="82.3936574212074"/>
<DICH_DATA CI_END="0.7670370555392976" CI_START="0.4308788172240649" EFFECT_SIZE="0.5748913108212733" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="87" LOG_CI_END="-0.11518365478960048" LOG_CI_START="-0.36564485608297087" LOG_EFFECT_SIZE="-0.2404142554362857" MODIFIED="2016-11-14 11:21:50 +0100" MODIFIED_BY="[Empty name]" ORDER="844" O_E="0.0" SE="0.14712214944266744" STUDY_ID="STD-MacLennan-1995" TOTAL_1="193" TOTAL_2="197" VAR="0.021644926856630574" WEIGHT="17.606342578792606"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.8610961866636573" CI_END="2.8015138149186996" CI_START="2.1520012917549485" DF="1" EFFECT_SIZE="2.4553739732623976" ESTIMABLE="YES" EVENTS_1="594" EVENTS_2="199" I2="46.268225835620235" ID="CMP-008.01.03" LOG_CI_END="0.44739276841635395" LOG_CI_START="0.33284252768295647" LOG_EFFECT_SIZE="0.3901176480496551" MODIFIED="2016-11-14 11:21:56 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.17249853044294872" P_Z="1.1862442136091312E-40" STUDIES="2" TAU2="0.0" TOTAL_1="995" TOTAL_2="824" WEIGHT="100.0" Z="13.349889708051405">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="2.9736642240732656" CI_START="2.2126819333370773" EFFECT_SIZE="2.5651068407412843" ESTIMABLE="YES" EVENTS_1="502" EVENTS_2="153" LOG_CI_END="0.4732919279166378" LOG_CI_START="0.34491898983130925" LOG_EFFECT_SIZE="0.4091054588739735" MODIFIED="2016-11-14 11:21:56 +0100" MODIFIED_BY="[Empty name]" ORDER="843" O_E="0.0" SE="0.07540689928761403" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.005686200460172366" WEIGHT="79.04485880727896"/>
<DICH_DATA CI_END="2.736505126778818" CI_START="1.5229356725688283" EFFECT_SIZE="2.0414507772020727" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="46" LOG_CI_END="0.4371962661199143" LOG_CI_START="0.1826815595156864" LOG_EFFECT_SIZE="0.3099389128178004" MODIFIED="2016-11-14 11:21:56 +0100" MODIFIED_BY="[Empty name]" ORDER="844" O_E="0.0" SE="0.14950319852744004" STUDY_ID="STD-MacLennan-1995" TOTAL_1="193" TOTAL_2="197" VAR="0.02235120636993515" WEIGHT="20.95514119272105"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="591.403278396141" CI_END="1.1381249556212967" CI_START="0.9868761300197045" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.05980580847738" ESTIMABLE="YES" EVENTS_1="1046" EVENTS_2="790" I2="99.66182128624246" I2_Q="99.65987403542319" ID="CMP-008.02" LOG_CI_END="0.056189946204628326" LOG_CI_START="-0.005737355359685115" LOG_EFFECT_SIZE="0.025226295422471588" METHOD="MH" MODIFIED="2016-11-16 07:20:11 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="-8.881784197001252E-16" P_Q="-4.440892098500626E-16" P_Z="0.11031121108258647" Q="588.0174430341954" RANDOM="NO" SCALE="45.30288590392497" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1942" TOTAL_2="1553" WEIGHT="300.0" Z="1.5967958959123787">
<NAME>Number of participants with more than one adenoma</NAME>
<GROUP_LABEL_1>Wheat bran fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours wheat bran fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.286076824845673" CI_START="0.965615174426787" DF="0" EFFECT_SIZE="1.1143856143856143" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="154" I2="0.0" ID="CMP-008.02.01" LOG_CI_END="0.10926691229737752" LOG_CI_START="-0.015195918016301803" LOG_EFFECT_SIZE="0.047035497140537876" MODIFIED="2016-11-14 10:37:53 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.13850745272110676" STUDIES="1" TAU2="0.0" TOTAL_1="338" TOTAL_2="299" WEIGHT="100.00000000000001" Z="1.4813720716145224">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.286076824845673" CI_START="0.965615174426787" EFFECT_SIZE="1.1143856143856143" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="154" LOG_CI_END="0.10926691229737752" LOG_CI_START="-0.015195918016301803" LOG_EFFECT_SIZE="0.047035497140537876" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="846" O_E="0.0" SE="0.07311008262720164" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.005345084181756252" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.3582863326452277" CI_START="0.2763538293154757" DF="0" EFFECT_SIZE="0.3146645833548908" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="482" I2="0.0" ID="CMP-008.02.02" LOG_CI_END="-0.44576975831441" LOG_CI_START="-0.5585345132097312" LOG_EFFECT_SIZE="-0.5021521357620706" MODIFIED="2016-11-14 11:22:09 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="3.1093245248903214E-68" STUDIES="1" TAU2="0.0" TOTAL_1="802" TOTAL_2="627" WEIGHT="100.0" Z="17.455810581367423">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.3582863326452277" CI_START="0.2763538293154757" EFFECT_SIZE="0.3146645833548908" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="482" LOG_CI_END="-0.44576975831441" LOG_CI_START="-0.5585345132097312" LOG_EFFECT_SIZE="-0.5021521357620706" MODIFIED="2016-11-14 11:22:09 +0100" MODIFIED_BY="[Empty name]" ORDER="846" O_E="0.0" SE="0.06623857522005086" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.004387548847182336" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.846013721568709" CI_START="2.9012547285739063" DF="0" EFFECT_SIZE="3.3403990024937658" ESTIMABLE="YES" EVENTS_1="658" EVENTS_2="154" I2="0.0" ID="CMP-008.02.03" LOG_CI_END="0.5850108293540842" LOG_CI_START="0.4625858612940064" LOG_EFFECT_SIZE="0.5237983453240453" MODIFIED="2016-11-14 11:22:14 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="3.943471366173024E-63" STUDIES="1" TAU2="0.0" TOTAL_1="802" TOTAL_2="627" WEIGHT="99.99999999999999" Z="16.77151169838174">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="3.846013721568709" CI_START="2.9012547285739063" EFFECT_SIZE="3.3403990024937658" ESTIMABLE="YES" EVENTS_1="658" EVENTS_2="154" LOG_CI_END="0.5850108293540842" LOG_CI_START="0.4625858612940064" LOG_EFFECT_SIZE="0.5237983453240453" MODIFIED="2016-11-14 11:22:14 +0100" MODIFIED_BY="[Empty name]" ORDER="846" O_E="0.0" SE="0.07191303225185526" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.005171484207656375" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="551.862123624313" CI_END="1.139560318770612" CI_START="0.9493807586582682" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.040132991482965" ESTIMABLE="YES" EVENTS_1="797" EVENTS_2="610" I2="99.63759063824399" I2_Q="99.63564608958978" ID="CMP-008.03" LOG_CI_END="0.05673731803409385" LOG_CI_START="-0.02255957448538437" LOG_EFFECT_SIZE="0.01708887177435472" METHOD="MH" MODIFIED="2017-01-02 09:56:51 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="-1.1102230246251565E-15" P_Q="1.7763568394002505E-15" P_Z="0.39824272300160457" Q="548.91684783847" RANDOM="NO" SCALE="28.9177285766589" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1942" TOTAL_2="1553" WEIGHT="300.0" Z="0.8447638274332403">
<NAME>Number of participants with at least one adenoma 1 cm or greater</NAME>
<GROUP_LABEL_1>Wheat bran fibre</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours wheat bran fibre</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3100205633704611" CI_START="0.8329541832579813" DF="0" EFFECT_SIZE="1.0445990180032734" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="94" I2="0.0" ID="CMP-008.03.01" LOG_CI_END="0.11727811282235115" LOG_CI_START="-0.07937888635488374" LOG_EFFECT_SIZE="0.01894961323373371" MODIFIED="2016-11-14 10:42:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7056392246632913" STUDIES="1" TAU2="0.0" TOTAL_1="338" TOTAL_2="299" WEIGHT="100.00000000000001" Z="0.37771917210644657">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.3100205633704611" CI_START="0.8329541832579813" EFFECT_SIZE="1.0445990180032734" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="94" LOG_CI_END="0.11727811282235115" LOG_CI_START="-0.07937888635488374" LOG_EFFECT_SIZE="0.01894961323373371" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="845" O_E="0.0" SE="0.11551729478455362" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.013344245394341458" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.24646244528612085" CI_START="0.17157604303495166" DF="0" EFFECT_SIZE="0.20563815579534575" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="422" I2="0.0" ID="CMP-008.03.02" LOG_CI_END="-0.6082492469650363" LOG_CI_START="-0.7655433522918906" LOG_EFFECT_SIZE="-0.6868962996284635" MODIFIED="2016-11-14 11:22:25 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.0867532739464452E-65" STUDIES="1" TAU2="0.0" TOTAL_1="802" TOTAL_2="627" WEIGHT="100.0" Z="17.118149540163014">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.24646244528612085" CI_START="0.17157604303495166" EFFECT_SIZE="0.20563815579534575" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="422" LOG_CI_END="-0.6082492469650363" LOG_CI_START="-0.7655433522918906" LOG_EFFECT_SIZE="-0.6868962996284635" MODIFIED="2016-11-14 11:22:25 +0100" MODIFIED_BY="[Empty name]" ORDER="845" O_E="0.0" SE="0.092395336087373" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.008536898130698613" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.790999753749952" CI_START="3.9492332133523353" DF="0" EFFECT_SIZE="4.782259776091686" ESTIMABLE="YES" EVENTS_1="575" EVENTS_2="94" I2="0.0" ID="CMP-008.03.03" LOG_CI_END="0.7627535464659176" LOG_CI_START="0.596512780807052" LOG_EFFECT_SIZE="0.6796331636364847" MODIFIED="2016-11-14 11:22:32 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="8.462844146721469E-58" STUDIES="1" TAU2="0.0" TOTAL_1="802" TOTAL_2="627" WEIGHT="100.0" Z="16.02563027362343">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="5.790999753749952" CI_START="3.9492332133523353" EFFECT_SIZE="4.782259776091686" ESTIMABLE="YES" EVENTS_1="575" EVENTS_2="94" LOG_CI_END="0.7627535464659176" LOG_CI_START="0.596512780807052" LOG_EFFECT_SIZE="0.6796331636364847" MODIFIED="2016-11-14 11:22:32 +0100" MODIFIED_BY="[Empty name]" ORDER="845" O_E="0.0" SE="0.09765064865307932" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.00953564918236714" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2017-01-02 15:48:24 +0100" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Sensitivity analysis 3. Wheat bran fibre and low fat diet versus control</NAME>
<DICH_OUTCOME CHI2="15.340797669663536" CI_END="1.6196531124771398" CI_START="0.8899776555976089" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2006061302208044" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="63" I2="86.96286827408588" I2_Q="86.95951951536469" ID="CMP-009.01" LOG_CI_END="0.20942200993234425" LOG_CI_START="-0.050620896919668354" LOG_EFFECT_SIZE="0.07940055650633794" METHOD="MH" MODIFIED="2016-11-14 11:22:54 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="4.6643498316112364E-4" P_Q="4.6735461852420723E-4" P_Z="0.23134689451925428" Q="15.336858195957268" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="276" TOTAL_2="291" WEIGHT="300.0" Z="1.1968965659457316">
<NAME>Number of participants with at least one recurrent adenoma</NAME>
<GROUP_LABEL_1>WBR &amp; Low fat</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.1820805500459652" CI_START="0.6436301784695171" DF="0" EFFECT_SIZE="1.1850961538461537" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" I2="0.0" ID="CMP-009.01.01" LOG_CI_END="0.33887077823893863" LOG_CI_START="-0.19136360093796412" LOG_EFFECT_SIZE="0.07375358865048723" MODIFIED="2016-11-14 10:47:03 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5855835873724313" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="87" WEIGHT="100.0" Z="0.5452470951051224">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="2.1820805500459652" CI_START="0.6436301784695171" EFFECT_SIZE="1.1850961538461537" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" LOG_CI_END="0.33887077823893863" LOG_CI_START="-0.19136360093796412" LOG_EFFECT_SIZE="0.07375358865048723" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="847" O_E="0.0" SE="0.31146229903102024" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="78" TOTAL_2="87" VAR="0.09700876371768867" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9531118707941043" CI_START="0.3349349984798398" DF="0" EFFECT_SIZE="0.5650048875855328" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="31" I2="0.0" ID="CMP-009.01.02" LOG_CI_END="-0.02085612137935697" LOG_CI_START="-0.4750394692039051" LOG_EFFECT_SIZE="-0.24794779529163105" MODIFIED="2016-11-14 11:22:49 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.03235741214528133" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="102" WEIGHT="100.0" Z="2.139967267163822">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.9531118707941044" CI_START="0.33493499847983976" EFFECT_SIZE="0.5650048875855328" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="31" LOG_CI_END="-0.02085612137935692" LOG_CI_START="-0.47503946920390516" LOG_EFFECT_SIZE="-0.24794779529163105" MODIFIED="2016-11-14 11:22:49 +0100" MODIFIED_BY="[Empty name]" ORDER="847" O_E="0.0" SE="0.26678954675597055" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="99" TOTAL_2="102" VAR="0.0711766622582562" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.0933272522488355" CI_START="1.4627857312406198" DF="0" EFFECT_SIZE="2.446969696969697" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="16" I2="0.0" ID="CMP-009.01.03" LOG_CI_END="0.6120764668941013" LOG_CI_START="0.1651807153564047" LOG_EFFECT_SIZE="0.388628591125253" MODIFIED="2016-11-14 11:22:54 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="6.523974719783084E-4" STUDIES="1" TAU2="0.0" TOTAL_1="99" TOTAL_2="102" WEIGHT="100.0" Z="3.4088399334616963">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="4.0933272522488355" CI_START="1.4627857312406198" EFFECT_SIZE="2.446969696969697" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="16" LOG_CI_END="0.6120764668941013" LOG_CI_START="0.1651807153564047" LOG_EFFECT_SIZE="0.388628591125253" MODIFIED="2016-11-14 11:22:54 +0100" MODIFIED_BY="[Empty name]" ORDER="847" O_E="0.0" SE="0.26250877662289057" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="99" TOTAL_2="102" VAR="0.06891085780404665" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2017-01-02 15:48:47 +0100" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Sensitivity analysis 4. Wheat bran fibre with or without low fat diet versus control</NAME>
<DICH_OUTCOME CHI2="381.5459310524958" CI_END="1.1183281133866376" CI_START="0.967759789848312" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0403234977604379" ESTIMABLE="YES" EVENTS_1="1100" EVENTS_2="907" I2="97.90326685494144" I2_Q="99.46202076591858" ID="CMP-010.01" LOG_CI_END="0.04856924266224574" LOG_CI_START="-0.014232426668169746" LOG_EFFECT_SIZE="0.017168407997038018" METHOD="MH" MODIFIED="2016-11-16 07:22:06 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="2.220446049250313E-16" P_Q="1.4432899320127035E-15" P_Z="0.2838950712978767" Q="371.76156128310606" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="2884" TOTAL_2="2516" WEIGHT="300.0" Z="1.0716104111515128">
<NAME>Number of participants with at least one recurrent adenoma</NAME>
<GROUP_LABEL_1>WBR with or without low fat diet</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours WBR with or without low fat diet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.5972368673429098" CI_END="1.1923206686729533" CI_START="0.8823964955594858" DF="2" EFFECT_SIZE="1.0257190549171624" ESTIMABLE="YES" EVENTS_1="234" EVENTS_2="215" I2="0.0" ID="CMP-010.01.01" LOG_CI_END="0.0763930724396544" LOG_CI_START="-0.054336225366369534" LOG_EFFECT_SIZE="0.011028423536642443" MODIFIED="2016-11-14 10:49:52 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7418424498963578" P_Z="0.7408800764385733" STUDIES="3" TAU2="0.0" TOTAL_1="696" TOTAL_2="664" WEIGHT="100.00000000000001" Z="0.3306881211914077">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.1767248372535204" CI_START="0.8291503093216295" EFFECT_SIZE="0.987766046589576" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="153" LOG_CI_END="0.07067492024926698" LOG_CI_START="-0.08136673290965028" LOG_EFFECT_SIZE="-0.005345906330191674" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="848" O_E="0.0" SE="0.08931001968386919" STUDY_ID="STD-Alberts-2000" TOTAL_1="468" TOTAL_2="421" VAR="0.007976279615933102" WEIGHT="72.7874133160511"/>
<DICH_DATA CI_END="1.547397004716376" CI_START="0.7931246055154074" EFFECT_SIZE="1.1078260869565217" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="46" LOG_CI_END="0.18960175186214684" LOG_CI_START="-0.10065857657070698" LOG_EFFECT_SIZE="0.04447158764571994" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="849" O_E="0.0" SE="0.17050035373325667" STUDY_ID="STD-MacLennan-1995" TOTAL_1="150" TOTAL_2="156" VAR="0.02907037062316565" WEIGHT="20.377383891267122"/>
<DICH_DATA CI_END="2.1820805500459652" CI_START="0.6436301784695171" EFFECT_SIZE="1.1850961538461537" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" LOG_CI_END="0.33887077823893863" LOG_CI_START="-0.19136360093796412" LOG_EFFECT_SIZE="0.07375358865048723" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="850" O_E="0.0" SE="0.31146229903102024" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="78" TOTAL_2="87" VAR="0.09700876371768867" WEIGHT="6.835202792681789"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.922783541970986" CI_END="0.4688248050952445" CI_START="0.3624126892064333" DF="2" EFFECT_SIZE="0.4121990518927106" ESTIMABLE="YES" EVENTS_1="234" EVENTS_2="477" I2="77.585469931077" ID="CMP-010.01.02" LOG_CI_END="-0.32898941825490724" LOG_CI_START="-0.4407966047152674" LOG_EFFECT_SIZE="-0.3848930114850873" MODIFIED="2016-11-14 11:23:08 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.011546340943571431" P_Z="1.69092400853218E-41" STUDIES="3" TAU2="0.0" TOTAL_1="1094" TOTAL_2="926" WEIGHT="99.99999999999999" Z="13.494238864142913">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.42527369345683486" CI_START="0.3147367764162856" EFFECT_SIZE="0.3658541668113838" ESTIMABLE="YES" EVENTS_1="168" EVENTS_2="359" LOG_CI_END="-0.37133148100543123" LOG_CI_START="-0.5020525076063755" LOG_EFFECT_SIZE="-0.4366919943059034" MODIFIED="2016-11-14 11:23:08 +0100" MODIFIED_BY="[Empty name]" ORDER="848" O_E="0.0" SE="0.07678617810491234" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.0058961171479593195" WEIGHT="77.551402169219"/>
<DICH_DATA CI_END="0.7670370555392976" CI_START="0.4308788172240649" EFFECT_SIZE="0.5748913108212733" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="87" LOG_CI_END="-0.11518365478960048" LOG_CI_START="-0.36564485608297087" LOG_EFFECT_SIZE="-0.2404142554362857" MODIFIED="2016-11-14 11:23:08 +0100" MODIFIED_BY="[Empty name]" ORDER="849" O_E="0.0" SE="0.14712214944266744" STUDY_ID="STD-MacLennan-1995" TOTAL_1="193" TOTAL_2="197" VAR="0.021644926856630574" WEIGHT="16.571622098008103"/>
<DICH_DATA CI_END="0.9531118707941044" CI_START="0.33493499847983976" EFFECT_SIZE="0.5650048875855328" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="31" LOG_CI_END="-0.02085612137935692" LOG_CI_START="-0.47503946920390516" LOG_EFFECT_SIZE="-0.24794779529163105" MODIFIED="2016-11-14 11:23:08 +0100" MODIFIED_BY="[Empty name]" ORDER="850" O_E="0.0" SE="0.26678954675597055" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="99" TOTAL_2="102" VAR="0.0711766622582562" WEIGHT="5.876975732772881"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.860991974548613" CI_END="2.7894278811872857" CI_START="2.160324791822436" DF="2" EFFECT_SIZE="2.454805533383372" ESTIMABLE="YES" EVENTS_1="632" EVENTS_2="215" I2="0.0" ID="CMP-010.01.03" LOG_CI_END="0.44551513749498484" LOG_CI_START="0.3345190496195942" LOG_EFFECT_SIZE="0.39001709355728953" MODIFIED="2016-11-14 11:23:15 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.39435812299907713" P_Z="3.6637543052490485E-43" STUDIES="3" TAU2="0.0" TOTAL_1="1094" TOTAL_2="926" WEIGHT="100.00000000000001" Z="13.77380899379893">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="2.9736642240732656" CI_START="2.2126819333370773" EFFECT_SIZE="2.5651068407412843" ESTIMABLE="YES" EVENTS_1="502" EVENTS_2="153" LOG_CI_END="0.4732919279166378" LOG_CI_START="0.34491898983130925" LOG_EFFECT_SIZE="0.4091054588739735" MODIFIED="2016-11-14 11:23:15 +0100" MODIFIED_BY="[Empty name]" ORDER="848" O_E="0.0" SE="0.07540689928761403" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.005686200460172366" WEIGHT="73.69850316485173"/>
<DICH_DATA CI_END="2.736505126778818" CI_START="1.5229356725688283" EFFECT_SIZE="2.0414507772020727" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="46" LOG_CI_END="0.4371962661199143" LOG_CI_START="0.1826815595156864" LOG_EFFECT_SIZE="0.3099389128178004" MODIFIED="2016-11-14 11:23:15 +0100" MODIFIED_BY="[Empty name]" ORDER="849" O_E="0.0" SE="0.14950319852744004" STUDY_ID="STD-MacLennan-1995" TOTAL_1="193" TOTAL_2="197" VAR="0.02235120636993515" WEIGHT="19.537798698293734"/>
<DICH_DATA CI_END="4.0933272522488355" CI_START="1.4627857312406198" EFFECT_SIZE="2.446969696969697" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="16" LOG_CI_END="0.6120764668941013" LOG_CI_START="0.1651807153564047" LOG_EFFECT_SIZE="0.388628591125253" MODIFIED="2016-11-14 11:23:15 +0100" MODIFIED_BY="[Empty name]" ORDER="850" O_E="0.0" SE="0.26250877662289057" STUDY_ID="STD-McKeown_x002d_Eyssen-1994" TOTAL_1="99" TOTAL_2="102" VAR="0.06891085780404665" WEIGHT="6.763698136854552"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="591.403278396141" CI_END="1.1381249556212967" CI_START="0.9868761300197045" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.05980580847738" ESTIMABLE="YES" EVENTS_1="1046" EVENTS_2="790" I2="99.66182128624246" I2_Q="99.65987403542319" ID="CMP-010.02" LOG_CI_END="0.056189946204628326" LOG_CI_START="-0.005737355359685115" LOG_EFFECT_SIZE="0.025226295422471588" METHOD="MH" MODIFIED="2016-11-16 07:22:06 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="-8.881784197001252E-16" P_Q="-4.440892098500626E-16" P_Z="0.11031121108258647" Q="588.0174430341954" RANDOM="NO" SCALE="5.52" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1942" TOTAL_2="1553" WEIGHT="300.0" Z="1.5967958959123787">
<NAME>Number of participants with more than one adenoma</NAME>
<GROUP_LABEL_1>WBR with or without low fat diet</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours WBR with or without low fat diet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.286076824845673" CI_START="0.965615174426787" DF="0" EFFECT_SIZE="1.1143856143856143" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="154" I2="0.0" ID="CMP-010.02.01" LOG_CI_END="0.10926691229737752" LOG_CI_START="-0.015195918016301803" LOG_EFFECT_SIZE="0.047035497140537876" MODIFIED="2016-11-14 10:54:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.13850745272110676" STUDIES="1" TAU2="0.0" TOTAL_1="338" TOTAL_2="299" WEIGHT="100.00000000000001" Z="1.4813720716145224">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.286076824845673" CI_START="0.965615174426787" EFFECT_SIZE="1.1143856143856143" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="154" LOG_CI_END="0.10926691229737752" LOG_CI_START="-0.015195918016301803" LOG_EFFECT_SIZE="0.047035497140537876" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="853" O_E="0.0" SE="0.07311008262720164" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.005345084181756252" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.3582863326452277" CI_START="0.2763538293154757" DF="0" EFFECT_SIZE="0.3146645833548908" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="482" I2="0.0" ID="CMP-010.02.02" LOG_CI_END="-0.44576975831441" LOG_CI_START="-0.5585345132097312" LOG_EFFECT_SIZE="-0.5021521357620706" MODIFIED="2016-11-14 11:23:26 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="3.1093245248903214E-68" STUDIES="1" TAU2="0.0" TOTAL_1="802" TOTAL_2="627" WEIGHT="100.0" Z="17.455810581367423">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.3582863326452277" CI_START="0.2763538293154757" EFFECT_SIZE="0.3146645833548908" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="482" LOG_CI_END="-0.44576975831441" LOG_CI_START="-0.5585345132097312" LOG_EFFECT_SIZE="-0.5021521357620706" MODIFIED="2016-11-14 11:23:26 +0100" MODIFIED_BY="[Empty name]" ORDER="853" O_E="0.0" SE="0.06623857522005086" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.004387548847182336" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.846013721568709" CI_START="2.9012547285739063" DF="0" EFFECT_SIZE="3.3403990024937658" ESTIMABLE="YES" EVENTS_1="658" EVENTS_2="154" I2="0.0" ID="CMP-010.02.03" LOG_CI_END="0.5850108293540842" LOG_CI_START="0.4625858612940064" LOG_EFFECT_SIZE="0.5237983453240453" MODIFIED="2016-11-14 11:23:31 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="3.943471366173024E-63" STUDIES="1" TAU2="0.0" TOTAL_1="802" TOTAL_2="627" WEIGHT="99.99999999999999" Z="16.77151169838174">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="3.846013721568709" CI_START="2.9012547285739063" EFFECT_SIZE="3.3403990024937658" ESTIMABLE="YES" EVENTS_1="658" EVENTS_2="154" LOG_CI_END="0.5850108293540842" LOG_CI_START="0.4625858612940064" LOG_EFFECT_SIZE="0.5237983453240453" MODIFIED="2016-11-14 11:23:31 +0100" MODIFIED_BY="[Empty name]" ORDER="853" O_E="0.0" SE="0.07191303225185526" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.005171484207656375" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="601.2750649861955" CI_END="1.1238105788566806" CI_START="0.9423522290542833" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0290895996075256" ESTIMABLE="YES" EVENTS_1="861" EVENTS_2="681" I2="99.16843383483484" I2_Q="99.665475172599" ID="CMP-010.03" LOG_CI_END="0.05069311595736562" LOG_CI_START="-0.02578673782009909" LOG_EFFECT_SIZE="0.012453189068633252" METHOD="MH" MODIFIED="2017-01-02 09:57:41 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.1102230246251565E-16" P_Q="2.3314683517128287E-15" P_Z="0.5232910660125978" Q="597.862949527092" RANDOM="NO" SCALE="97.66019474908381" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="2478" TOTAL_2="2103" WEIGHT="300.0" Z="0.6382805630933618">
<NAME>Number of participants with at least one adenoma 1 cm or greater</NAME>
<GROUP_LABEL_1>WBR with or without low fat diet</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours WBR with or without low fat diet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.5409584838455888" CI_END="1.267341307290078" CI_START="0.8149349876950966" DF="1" EFFECT_SIZE="1.0162680614197848" ESTIMABLE="YES" EVENTS_1="118" EVENTS_2="104" I2="0.0" ID="CMP-010.03.01" LOG_CI_END="0.1028935903462048" LOG_CI_START="-0.0888770361820644" LOG_EFFECT_SIZE="0.007008277082070179" MODIFIED="2016-11-14 11:03:12 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.46203585706487105" P_Z="0.8860894519164514" STUDIES="2" TAU2="0.0" TOTAL_1="488" TOTAL_2="455" WEIGHT="100.0" Z="0.14325416695147705">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.3100205633704611" CI_START="0.8329541832579813" EFFECT_SIZE="1.0445990180032734" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="94" LOG_CI_END="0.11727811282235115" LOG_CI_START="-0.07937888635488374" LOG_EFFECT_SIZE="0.01894961323373371" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="851" O_E="0.0" SE="0.11551729478455362" STUDY_ID="STD-Alberts-2000" TOTAL_1="338" TOTAL_2="299" VAR="0.013344245394341458" WEIGHT="91.05147048080997"/>
<DICH_DATA CI_END="1.8627656059439075" CI_START="0.2845145939504528" EFFECT_SIZE="0.728" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.27015821053261235" LOG_CI_START="-0.545895451906538" LOG_EFFECT_SIZE="-0.13786862068696282" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="852" O_E="0.0" SE="0.4793539608475347" STUDY_ID="STD-MacLennan-1995" TOTAL_1="150" TOTAL_2="156" VAR="0.22978021978021979" WEIGHT="8.94852951919003"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9306157659604629" CI_END="0.23799798339089698" CI_START="0.1669389609184905" DF="1" EFFECT_SIZE="0.19932670681063414" ESTIMABLE="YES" EVENTS_1="118" EVENTS_2="473" I2="0.0" ID="CMP-010.03.02" LOG_CI_END="-0.623426722800278" LOG_CI_START="-0.7774422940141836" LOG_EFFECT_SIZE="-0.7004345084072309" MODIFIED="2016-11-14 11:25:13 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.33470312221932186" P_Z="4.3533625186017944E-71" STUDIES="2" TAU2="0.0" TOTAL_1="995" TOTAL_2="824" WEIGHT="99.99999999999999" Z="17.827111884687696">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.24646244528612085" CI_START="0.17157604303495166" EFFECT_SIZE="0.20563815579534575" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="422" LOG_CI_END="-0.6082492469650363" LOG_CI_START="-0.7655433522918906" LOG_EFFECT_SIZE="-0.6868962996284635" MODIFIED="2016-11-14 11:25:13 +0100" MODIFIED_BY="[Empty name]" ORDER="851" O_E="0.0" SE="0.092395336087373" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.008536898130698613" WEIGHT="90.3698741014638"/>
<DICH_DATA CI_END="0.3009696281156722" CI_START="0.06521550933652592" EFFECT_SIZE="0.14009956314131872" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="51" LOG_CI_END="-0.5214773283506339" LOG_CI_START="-1.1856491095090866" LOG_EFFECT_SIZE="-0.8535632189298603" MODIFIED="2016-11-14 11:25:13 +0100" MODIFIED_BY="[Empty name]" ORDER="852" O_E="0.0" SE="0.39013779195581527" STUDY_ID="STD-MacLennan-1995" TOTAL_1="193" TOTAL_2="197" VAR="0.152207496712159" WEIGHT="9.630125898536196"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.03549722610247413" CI_END="5.779527479097052" CI_START="4.002813317252846" DF="1" EFFECT_SIZE="4.809820117297366" ESTIMABLE="YES" EVENTS_1="625" EVENTS_2="104" I2="0.0" ID="CMP-010.03.03" LOG_CI_END="0.761892332951777" LOG_CI_START="0.6023653360013039" LOG_EFFECT_SIZE="0.6821288344765405" MODIFIED="2016-11-14 11:25:17 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8505576167266713" P_Z="4.674808092970281E-63" STUDIES="2" TAU2="0.0" TOTAL_1="995" TOTAL_2="824" WEIGHT="100.0" Z="16.761400564763004">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="5.790999753749952" CI_START="3.9492332133523353" EFFECT_SIZE="4.782259776091686" ESTIMABLE="YES" EVENTS_1="575" EVENTS_2="94" LOG_CI_END="0.7627535464659176" LOG_CI_START="0.596512780807052" LOG_EFFECT_SIZE="0.6796331636364847" MODIFIED="2016-11-14 11:25:17 +0100" MODIFIED_BY="[Empty name]" ORDER="851" O_E="0.0" SE="0.09765064865307932" STUDY_ID="STD-Alberts-2000" TOTAL_1="802" TOTAL_2="627" VAR="0.00953564918236714" WEIGHT="91.42403330421784"/>
<DICH_DATA CI_END="9.76922073838081" CI_START="2.666231900261633" EFFECT_SIZE="5.103626943005182" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="10" LOG_CI_END="0.989859922724039" LOG_CI_START="0.42589792025563705" LOG_EFFECT_SIZE="0.707878921489838" MODIFIED="2016-11-14 11:25:17 +0100" MODIFIED_BY="[Empty name]" ORDER="852" O_E="0.0" SE="0.3312740719068748" STUDY_ID="STD-MacLennan-1995" TOTAL_1="193" TOTAL_2="197" VAR="0.10974251071776124" WEIGHT="8.575966695782151"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" MODIFIED="2017-01-02 15:49:02 +0100" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Sensitivity analysis 5. Comprehensive dietary intervention versus control</NAME>
<DICH_OUTCOME CHI2="29.89762695452881" CI_END="1.0649926599249586" CI_START="0.9415851420328389" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0013896668926503" ESTIMABLE="YES" EVENTS_1="1219" EVENTS_2="1217" I2="93.31050587044318" I2_Q="93.31033877313331" ID="CMP-011.01" LOG_CI_END="0.027346614568115758" LOG_CI_START="-0.026140403163837218" LOG_EFFECT_SIZE="6.031057021392753E-4" METHOD="MH" MODIFIED="2016-11-16 07:22:46 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="3.219707687129869E-7" P_Q="3.2209101152869124E-7" P_Z="0.9647449116165316" Q="29.89688015841065" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3032" TOTAL_2="3031" WEIGHT="300.0" Z="0.044200088364902725">
<NAME>Number of participants with at least one recurrent adenoma (4 years)</NAME>
<GROUP_LABEL_1>Comprehensive dietary intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comprehensive dietary intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.122249885669013" CI_START="0.8988833971482498" DF="0" EFFECT_SIZE="1.0043763187567682" ESTIMABLE="YES" EVENTS_1="380" EVENTS_2="374" I2="0.0" ID="CMP-011.01.01" LOG_CI_END="0.05008956982925362" LOG_CI_START="-0.04629664114713556" LOG_EFFECT_SIZE="0.0018964643410590073" MODIFIED="2016-11-15 03:40:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9385223133634424" STUDIES="1" TAU2="0.0" TOTAL_1="958" TOTAL_2="947" WEIGHT="100.00000000000001" Z="0.07712725230688153">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.1222498856690128" CI_START="0.8988833971482498" EFFECT_SIZE="1.0043763187567682" ESTIMABLE="YES" EVENTS_1="380" EVENTS_2="374" LOG_CI_END="0.050089569829253534" LOG_CI_START="-0.04629664114713556" LOG_EFFECT_SIZE="0.0018964643410590073" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="854" O_E="0.0" SE="0.0566177374469702" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.0032055681936140512" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9037738083855527" CI_START="0.7333979332244085" DF="0" EFFECT_SIZE="0.8141411690685572" ESTIMABLE="YES" EVENTS_1="380" EVENTS_2="469" I2="0.0" ID="CMP-011.01.02" LOG_CI_END="-0.04394024879641752" LOG_CI_START="-0.13466031825119937" LOG_EFFECT_SIZE="-0.08930028352380842" MODIFIED="2016-11-15 03:47:01 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.1404756482154396E-4" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="100.0" Z="3.858580368550514">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.9037738083855527" CI_START="0.7333979332244085" EFFECT_SIZE="0.8141411690685572" ESTIMABLE="YES" EVENTS_1="380" EVENTS_2="469" LOG_CI_END="-0.04394024879641752" LOG_CI_START="-0.13466031825119937" LOG_EFFECT_SIZE="-0.08930028352380842" MODIFIED="2016-11-15 03:47:01 +0100" MODIFIED_BY="[Empty name]" ORDER="854" O_E="0.0" SE="0.05328941786932516" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.0028397620568515513" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3711747761701898" CI_START="1.1090912432249878" DF="0" EFFECT_SIZE="1.2331901464013326" ESTIMABLE="YES" EVENTS_1="459" EVENTS_2="374" I2="0.0" ID="CMP-011.01.03" LOG_CI_END="0.13709281546677074" LOG_CI_START="0.04496727635572089" LOG_EFFECT_SIZE="0.09103004591124582" MODIFIED="2016-11-15 03:46:54 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="1.0736495829047776E-4" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="99.99999999999999" Z="3.8733148965783286">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="1.3711747761701898" CI_START="1.1090912432249878" EFFECT_SIZE="1.2331901464013326" ESTIMABLE="YES" EVENTS_1="459" EVENTS_2="374" LOG_CI_END="0.13709281546677074" LOG_CI_START="0.04496727635572089" LOG_EFFECT_SIZE="0.09103004591124582" MODIFIED="2016-11-15 03:46:54 +0100" MODIFIED_BY="[Empty name]" ORDER="854" O_E="0.0" SE="0.05411499770260403" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.0029284329763528396" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="47.32665246505252" CI_END="1.065151223511077" CI_START="0.8537454954078059" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9536079168089446" ESTIMABLE="YES" EVENTS_1="511" EVENTS_2="536" I2="95.77405141536926" I2_Q="95.77400169761117" ID="CMP-011.02" LOG_CI_END="0.027411270567313416" LOG_CI_START="-0.06867157475954035" LOG_EFFECT_SIZE="-0.020630152096113435" METHOD="MH" MODIFIED="2016-11-16 07:22:46 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="5.2864379540551454E-11" P_Q="5.287781323914942E-11" P_Z="0.3999805016047" Q="47.326095679438836" RANDOM="NO" SCALE="5.35" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3032" TOTAL_2="3031" WEIGHT="300.0" Z="0.8416560722450841">
<NAME>Number of participants with at least one recurrent adenoma (8 years)</NAME>
<GROUP_LABEL_1>Comprehensive dietary intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comprehensive dietary intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.1946781289726222E-30" CI_END="1.1964478911624328" CI_START="0.7837281859525665" DF="0" EFFECT_SIZE="0.968343913765924" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="147" I2="100.0" ID="CMP-011.02.01" LOG_CI_END="0.0778937885546204" LOG_CI_START="-0.10583453401101521" LOG_EFFECT_SIZE="-0.013970372728197402" MODIFIED="2016-11-15 03:56:45 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.7656540847808058" STUDIES="1" TAU2="0.0" TOTAL_1="958" TOTAL_2="947" WEIGHT="100.0" Z="0.29806430511643806">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.1964478911624326" CI_START="0.7837281859525664" EFFECT_SIZE="0.9683439137659239" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="147" LOG_CI_END="0.07789378855462033" LOG_CI_START="-0.10583453401101528" LOG_EFFECT_SIZE="-0.013970372728197452" MODIFIED="2016-11-15 03:56:45 +0100" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.1079229261449188" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.011647357987681599" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.721223978545741" CI_START="0.49568071221499777" DF="0" EFFECT_SIZE="0.5979103740127673" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="242" I2="0.0" ID="CMP-011.02.02" LOG_CI_END="-0.14192984271366169" LOG_CI_START="-0.30479797990777224" LOG_EFFECT_SIZE="-0.22336391131071692" MODIFIED="2016-11-15 04:00:25 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="7.618127924339251E-8" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="100.0" Z="5.375946813872379">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.721223978545741" CI_START="0.4956807122149978" EFFECT_SIZE="0.5979103740127673" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="242" LOG_CI_END="-0.14192984271366169" LOG_CI_START="-0.3047979799077722" LOG_EFFECT_SIZE="-0.22336391131071692" MODIFIED="2016-11-15 04:00:25 +0100" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.09566954999810202" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.009152662796839343" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.842642225100923" CI_START="1.2609909297534099" DF="0" EFFECT_SIZE="1.5243212038913927" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="147" I2="0.0" ID="CMP-011.02.03" LOG_CI_END="0.2654410190237239" LOG_CI_START="0.10071196272517469" LOG_EFFECT_SIZE="0.1830764908744493" MODIFIED="2016-11-15 04:00:41 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="1.321421224776276E-5" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="100.0" Z="4.35652745900004">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="1.842642225100923" CI_START="1.2609909297534099" EFFECT_SIZE="1.5243212038913927" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="147" LOG_CI_END="0.2654410190237239" LOG_CI_START="0.10071196272517469" LOG_EFFECT_SIZE="0.1830764908744493" MODIFIED="2016-11-15 04:00:41 +0100" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.09676266309174744" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.009363012968607021" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="45.18382488498052" CI_END="1.1038067098155113" CI_START="0.8935497601933509" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9931295086017039" ESTIMABLE="YES" EVENTS_1="562" EVENTS_2="566" I2="95.57363723613221" I2_Q="95.57361757368345" ID="CMP-011.03" LOG_CI_END="0.0428930297247097" LOG_CI_START="-0.048881257399352875" LOG_EFFECT_SIZE="-0.002994113837321564" METHOD="MH" MODIFIED="2016-11-16 07:22:46 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.5433643252293905E-10" P_Q="1.5435086542225918E-10" P_Z="0.8982386378097298" Q="45.183624173754936" RANDOM="NO" SCALE="6.2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3032" TOTAL_2="3031" WEIGHT="300.0" Z="0.1278866983478783">
<NAME>Number of participants with more than one adenoma (4 years)</NAME>
<GROUP_LABEL_1>Comprehensive dietary intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comprehensive dietary intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2389480923413916" CI_START="0.8294081065158793" DF="0" EFFECT_SIZE="1.0137029107881335" ESTIMABLE="YES" EVENTS_1="161" EVENTS_2="157" I2="0.0" ID="CMP-011.03.01" LOG_CI_END="0.09305311131396743" LOG_CI_START="-0.08123172421927752" LOG_EFFECT_SIZE="0.00591069354734498" MODIFIED="2016-11-15 03:54:40 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8942405285901008" STUDIES="1" TAU2="0.0" TOTAL_1="958" TOTAL_2="947" WEIGHT="100.0" Z="0.13294038395256316">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.2389480923413916" CI_START="0.8294081065158793" EFFECT_SIZE="1.0137029107881335" ESTIMABLE="YES" EVENTS_1="161" EVENTS_2="157" LOG_CI_END="0.09305311131396743" LOG_CI_START="-0.08123172421927752" LOG_EFFECT_SIZE="0.00591069354734498" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="856" O_E="0.0" SE="0.10237577511607782" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.010480799330617739" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.7671034124209972" CI_START="0.5372478435528799" DF="0" EFFECT_SIZE="0.6419693560484303" ESTIMABLE="YES" EVENTS_1="161" EVENTS_2="252" I2="0.0" ID="CMP-011.03.02" LOG_CI_END="-0.11514608531251765" LOG_CI_START="-0.26982531903794177" LOG_EFFECT_SIZE="-0.19248570217522967" MODIFIED="2016-11-15 04:02:01 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.0715012113401994E-6" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="100.0" Z="4.878030938167799">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.7671034124209972" CI_START="0.5372478435528799" EFFECT_SIZE="0.6419693560484303" ESTIMABLE="YES" EVENTS_1="161" EVENTS_2="252" LOG_CI_END="-0.11514608531251765" LOG_CI_START="-0.26982531903794177" LOG_EFFECT_SIZE="-0.19248570217522967" MODIFIED="2016-11-15 04:02:01 +0100" MODIFIED_BY="[Empty name]" ORDER="856" O_E="0.0" SE="0.09085934756486969" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.008255421039913792" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.8424391672585994" CI_START="1.280583631384892" DF="0" EFFECT_SIZE="1.5360330202875763" ESTIMABLE="YES" EVENTS_1="240" EVENTS_2="157" I2="0.0" ID="CMP-011.03.03" LOG_CI_END="0.26539315744829145" LOG_CI_START="0.1074079463053825" LOG_EFFECT_SIZE="0.186400551876837" MODIFIED="2016-11-15 04:02:13 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="3.7465405591295434E-6" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="100.0" Z="4.624969207358476">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="1.8424391672585994" CI_START="1.280583631384892" EFFECT_SIZE="1.5360330202875763" ESTIMABLE="YES" EVENTS_1="240" EVENTS_2="157" LOG_CI_END="0.26539315744829145" LOG_CI_START="0.1074079463053825" LOG_EFFECT_SIZE="0.186400551876837" MODIFIED="2016-11-15 04:02:13 +0100" MODIFIED_BY="[Empty name]" ORDER="856" O_E="0.0" SE="0.09280129506475245" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.008612080365695246" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="71.29991895125607" CI_END="1.0354061013805191" CI_START="0.7549278096650214" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8841136014274378" ESTIMABLE="YES" EVENTS_1="265" EVENTS_2="302" I2="97.19494772305802" I2_Q="97.19327332323383" ID="CMP-011.04" LOG_CI_END="0.015110719838501012" LOG_CI_START="-0.12209457600405511" LOG_EFFECT_SIZE="-0.05349192808277707" METHOD="MH" MODIFIED="2016-11-16 07:22:46 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="2.220446049250313E-16" P_Q="6.661338147750939E-16" P_Z="0.12644955339243896" Q="71.25738379001476" RANDOM="NO" SCALE="5.7" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3032" TOTAL_2="3058" WEIGHT="300.0" Z="1.528253729012863">
<NAME>Number of participants with more than one adenoma (8 years)</NAME>
<GROUP_LABEL_1>Comprehensive dietary intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comprehensive dietary intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2722268372088266" CI_START="0.6560055905340323" DF="0" EFFECT_SIZE="0.913557834861275" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="69" I2="0.0" ID="CMP-011.04.01" LOG_CI_END="0.10456455263712602" LOG_CI_START="-0.18309245951498676" LOG_EFFECT_SIZE="-0.03926395343893035" MODIFIED="2016-11-15 04:05:37 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5926129178867614" STUDIES="1" TAU2="0.0" TOTAL_1="958" TOTAL_2="974" WEIGHT="100.0" Z="0.5350534239037904">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.2722268372088266" CI_START="0.6560055905340323" EFFECT_SIZE="0.913557834861275" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="69" LOG_CI_END="0.10456455263712602" LOG_CI_START="-0.18309245951498676" LOG_EFFECT_SIZE="-0.03926395343893035" MODIFIED="2016-11-15 04:05:37 +0100" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.16897115286332598" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="974" VAR="0.028551250499961475" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.5022524488059086" CI_START="0.2873105312417201" DF="0" EFFECT_SIZE="0.37987158077945293" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="164" I2="0.0" ID="CMP-011.04.02" LOG_CI_END="-0.2990779371077357" LOG_CI_START="-0.5416484548422229" LOG_EFFECT_SIZE="-0.4203631959749793" MODIFIED="2016-11-15 04:06:12 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.09787955788255E-11" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="100.0" Z="6.793049149022578">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.5022524488059086" CI_START="0.2873105312417201" EFFECT_SIZE="0.37987158077945293" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="164" LOG_CI_END="-0.2990779371077357" LOG_CI_START="-0.5416484548422229" LOG_EFFECT_SIZE="-0.4203631959749793" MODIFIED="2016-11-15 04:06:12 +0100" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.1424871228606659" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.020302580181110495" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.7027900542066954" CI_START="1.5599319630039197" DF="0" EFFECT_SIZE="2.053331097228628" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="69" I2="0.0" ID="CMP-011.04.03" LOG_CI_END="0.4318123121283638" LOG_CI_START="0.19310565685681483" LOG_EFFECT_SIZE="0.3124589844925893" MODIFIED="2016-11-15 04:06:49 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="2.88124395602055E-7" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="100.0" Z="5.131053891687839">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="2.702790054206696" CI_START="1.5599319630039195" EFFECT_SIZE="2.053331097228628" ESTIMABLE="YES" EVENTS_1="141" EVENTS_2="69" LOG_CI_END="0.43181231212836385" LOG_CI_START="0.19310565685681477" LOG_EFFECT_SIZE="0.3124589844925893" MODIFIED="2016-11-15 04:06:49 +0100" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.14021747092350836" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.019660939152184913" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="79.55241295376135" CI_END="1.0325910484958154" CI_START="0.7284962617744927" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8673169655731435" ESTIMABLE="YES" EVENTS_1="220" EVENTS_2="254" I2="97.48593420898186" I2_Q="97.48372671308303" ID="CMP-011.05" LOG_CI_END="0.013928355840273465" LOG_CI_START="-0.13757267243877533" LOG_EFFECT_SIZE="-0.06182215829925092" METHOD="MH" MODIFIED="2017-01-02 09:58:26 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.10969121292369728" Q="79.48262259106485" RANDOM="NO" SCALE="5.7" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3032" TOTAL_2="3031" WEIGHT="300.0" Z="1.5995825914776631">
<NAME>Number of participants with at least one adenoma 1 cm or greater</NAME>
<GROUP_LABEL_1>Comprehensive dietary intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours comprehensive dietary intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2847948230180468" CI_START="0.5981073488296107" DF="0" EFFECT_SIZE="0.8766100760231614" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="53" I2="0.0" ID="CMP-011.05.01" LOG_CI_END="0.10883377798190887" LOG_CI_START="-0.22322086146259404" LOG_EFFECT_SIZE="-0.05719354174034259" MODIFIED="2016-11-15 04:07:06 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4995654098572596" STUDIES="1" TAU2="0.0" TOTAL_1="958" TOTAL_2="947" WEIGHT="100.0" Z="0.6751737132592895">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="1.2847948230180468" CI_START="0.5981073488296107" EFFECT_SIZE="0.8766100760231614" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="53" LOG_CI_END="0.10883377798190887" LOG_CI_START="-0.22322086146259404" LOG_EFFECT_SIZE="-0.05719354174034259" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="855" O_E="0.0" SE="0.19505053890667548" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="958" TOTAL_2="947" VAR="0.03804471272778452" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.43799134093668896" CI_START="0.23247951215789378" DF="0" EFFECT_SIZE="0.31909875159634077" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="148" I2="0.0" ID="CMP-011.05.02" LOG_CI_END="-0.35853447538765265" LOG_CI_START="-0.6336153143818979" LOG_EFFECT_SIZE="-0.49607489488477524" MODIFIED="2016-11-15 04:08:23 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.5592583240951185E-12" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="100.0" Z="7.0691141641384405">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.43799134093668896" CI_START="0.23247951215789378" EFFECT_SIZE="0.31909875159634077" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="148" LOG_CI_END="-0.35853447538765265" LOG_CI_START="-0.6336153143818979" LOG_EFFECT_SIZE="-0.49607489488477524" MODIFIED="2016-11-15 04:08:23 +0100" MODIFIED_BY="[Empty name]" ORDER="855" O_E="0.0" SE="0.16158384649733348" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.026109339448873833" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.2542293236205846" CI_START="1.7535539098684316" DF="0" EFFECT_SIZE="2.3888211640981787" ESTIMABLE="YES" EVENTS_1="126" EVENTS_2="53" I2="0.0" ID="CMP-011.05.03" LOG_CI_END="0.5124481541551555" LOG_CI_START="0.24391912202732158" LOG_EFFECT_SIZE="0.37818363809123856" MODIFIED="2016-11-15 04:08:38 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="3.3776354304540497E-8" STUDIES="1" TAU2="0.0" TOTAL_1="1037" TOTAL_2="1042" WEIGHT="100.0" Z="5.52064187866506">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="3.2542293236205846" CI_START="1.7535539098684316" EFFECT_SIZE="2.3888211640981787" ESTIMABLE="YES" EVENTS_1="126" EVENTS_2="53" LOG_CI_END="0.5124481541551555" LOG_CI_START="0.24391912202732158" LOG_EFFECT_SIZE="0.37818363809123856" MODIFIED="2016-11-15 04:08:38 +0100" MODIFIED_BY="[Empty name]" ORDER="855" O_E="0.0" SE="0.1577352827120364" STUDY_ID="STD-Schatzkin-2000" TOTAL_1="1037" TOTAL_2="1042" VAR="0.024880419412246047" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" MODIFIED="2017-01-02 15:49:20 +0100" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Sensitivity analysis 6. Ispaghula husk versus control</NAME>
<DICH_OUTCOME CHI2="21.345835533893734" CI_END="1.5940942947704317" CI_START="1.0994527490285135" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3238698405039753" ESTIMABLE="YES" EVENTS_1="202" EVENTS_2="141" I2="90.63049091320728" I2_Q="90.5852819756777" ID="CMP-012.01" LOG_CI_END="0.20251400745359913" LOG_CI_START="0.041176569506600126" LOG_EFFECT_SIZE="0.12184528848009965" METHOD="MH" MODIFIED="2016-11-16 07:26:02 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="2.316410757174925E-5" P_Q="2.4382188576921315E-5" P_Z="0.0030723117398922923" Q="21.24333405241806" RANDOM="NO" SCALE="9.34528732598094" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="650" TOTAL_2="600" WEIGHT="300.0" Z="2.960408695535884">
<NAME>Number of participants with at least one recurrent adenoma</NAME>
<GROUP_LABEL_1>Ispaghula husk</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Ispaghula husk</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.0827706317107193" CI_START="1.0072079949930335" DF="0" EFFECT_SIZE="1.4483726150392817" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="36" I2="0.0" ID="CMP-012.01.01" LOG_CI_END="0.31864144523953913" LOG_CI_START="0.003119164446486643" LOG_EFFECT_SIZE="0.16088030484301288" MODIFIED="2016-11-15 04:09:07 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.04563916781644969" STUDIES="1" TAU2="0.0" TOTAL_1="198" TOTAL_2="178" WEIGHT="100.0" Z="1.9987152889589097">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="2.0827706317107193" CI_START="1.0072079949930335" EFFECT_SIZE="1.4483726150392817" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="36" LOG_CI_END="0.31864144523953913" LOG_CI_START="0.003119164446486643" LOG_EFFECT_SIZE="0.16088030484301288" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="857" O_E="0.0" SE="0.18533934959831835" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="198" TOTAL_2="178" VAR="0.03435067450952767" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0534930139294654" CI_START="0.5846206856576591" DF="0" EFFECT_SIZE="0.7847890214184943" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="69" I2="0.0" ID="CMP-012.01.02" LOG_CI_END="0.02263165999922755" LOG_CI_START="-0.23312582204728013" LOG_EFFECT_SIZE="-0.1052470810240263" MODIFIED="2016-11-15 04:14:20 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.10672398798283253" STUDIES="1" TAU2="0.0" TOTAL_1="226" TOTAL_2="211" WEIGHT="100.0" Z="1.6130944567834762">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="1.0534930139294654" CI_START="0.5846206856576591" EFFECT_SIZE="0.7847890214184943" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="69" LOG_CI_END="0.02263165999922755" LOG_CI_START="-0.23312582204728013" LOG_EFFECT_SIZE="-0.1052470810240263" MODIFIED="2016-11-15 04:14:20 +0100" MODIFIED_BY="[Empty name]" ORDER="857" O_E="0.0" SE="0.15023321097407288" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="226" TOTAL_2="211" VAR="0.022570017679580293" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.136135328592035" CI_START="1.5861532244894903" DF="0" EFFECT_SIZE="2.2303343166175025" ESTIMABLE="YES" EVENTS_1="86" EVENTS_2="36" I2="0.0" ID="CMP-012.01.03" LOG_CI_END="0.49639479482639626" LOG_CI_START="0.20034513842674828" LOG_EFFECT_SIZE="0.3483699666265722" MODIFIED="2016-11-15 04:14:23 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="3.974916484844472E-6" STUDIES="1" TAU2="0.0" TOTAL_1="226" TOTAL_2="211" WEIGHT="100.0" Z="4.612689615567575">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="3.136135328592035" CI_START="1.5861532244894903" EFFECT_SIZE="2.2303343166175025" ESTIMABLE="YES" EVENTS_1="86" EVENTS_2="36" LOG_CI_END="0.49639479482639626" LOG_CI_START="0.20034513842674828" LOG_EFFECT_SIZE="0.3483699666265722" MODIFIED="2016-11-15 04:14:23 +0100" MODIFIED_BY="[Empty name]" ORDER="857" O_E="0.0" SE="0.17390103363858714" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="226" TOTAL_2="211" VAR="0.03024156950056902" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="36.04033872435765" CI_END="1.5863779073218478" CI_START="0.7269444230920263" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0738754921516818" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="45" I2="94.4506625886723" I2_Q="94.37068083387393" ID="CMP-012.02" LOG_CI_END="0.20040665304102961" LOG_CI_START="-0.13849879088386596" LOG_EFFECT_SIZE="0.030953931078581826" METHOD="MH" MODIFIED="2017-01-02 09:59:20 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.4926079150434646E-8" P_Q="1.9281527263714793E-8" P_Z="0.7203233718459965" Q="35.52827510713597" RANDOM="NO" SCALE="226.15877507657314" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="650" TOTAL_2="600" WEIGHT="300.0" Z="0.35802664832613396">
<NAME>Number of participants with at least one adenoma 1 cm or greater</NAME>
<GROUP_LABEL_1>Ispaghula husk</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Ispaghula husk</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.869066657731736" CI_START="0.5508084236332144" DF="0" EFFECT_SIZE="1.797979797979798" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" I2="0.0" ID="CMP-012.02.01" LOG_CI_END="0.7685690420268934" LOG_CI_START="-0.25899942660420516" LOG_EFFECT_SIZE="0.2547848077113441" MODIFIED="2016-11-15 04:11:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.3310788635033789" STUDIES="1" TAU2="0.0" TOTAL_1="198" TOTAL_2="178" WEIGHT="100.0" Z="0.9719431106862294">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="5.869066657731736" CI_START="0.5508084236332144" EFFECT_SIZE="1.797979797979798" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.7685690420268934" LOG_CI_START="-0.25899942660420516" LOG_EFFECT_SIZE="0.2547848077113441" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="859" O_E="0.0" SE="0.6035988050198617" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="198" TOTAL_2="178" VAR="0.36433151742140507" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.42344081581478743" CI_START="0.09623473183115289" DF="0" EFFECT_SIZE="0.20186558239655586" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="37" I2="0.0" ID="CMP-012.02.02" LOG_CI_END="-0.37320728229017053" LOG_CI_START="-1.016668159559349" LOG_EFFECT_SIZE="-0.6949377209247597" MODIFIED="2016-11-15 04:11:51 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="2.30059619103347E-5" STUDIES="1" TAU2="0.0" TOTAL_1="226" TOTAL_2="211" WEIGHT="100.0" Z="4.233522045011884">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.4234408158147875" CI_START="0.09623473183115289" EFFECT_SIZE="0.20186558239655586" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="37" LOG_CI_END="-0.3732072822901705" LOG_CI_START="-1.016668159559349" LOG_EFFECT_SIZE="-0.6949377209247597" MODIFIED="2016-11-15 04:11:51 +0100" MODIFIED_BY="[Empty name]" ORDER="859" O_E="0.0" SE="0.37797210449062785" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="226" TOTAL_2="211" VAR="0.14286291177307409" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="23.204747882149277" CI_START="3.0426794196090228" DF="0" EFFECT_SIZE="8.402654867256636" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="4" I2="0.0" ID="CMP-012.02.03" LOG_CI_END="1.3655768542036084" LOG_CI_START="0.48325619697562494" LOG_EFFECT_SIZE="0.9244165255896166" MODIFIED="2016-11-15 04:12:05 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="4.009192103332796E-5" STUDIES="1" TAU2="0.0" TOTAL_1="226" TOTAL_2="211" WEIGHT="100.0" Z="4.106949286581512">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="23.204747882149277" CI_START="3.0426794196090228" EFFECT_SIZE="8.402654867256636" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="4" LOG_CI_END="1.3655768542036084" LOG_CI_START="0.48325619697562494" LOG_EFFECT_SIZE="0.9244165255896166" MODIFIED="2016-11-15 04:12:05 +0100" MODIFIED_BY="[Empty name]" ORDER="859" O_E="0.0" SE="0.5182795216134097" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="226" TOTAL_2="211" VAR="0.26861366252382485" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="32.822342525707406" CI_END="1.268933114783484" CI_START="0.5300370311593959" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8201106881998812" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="42" I2="93.9065897004958" I2_Q="93.90316200225232" ID="CMP-012.03" LOG_CI_END="0.10343873112071389" LOG_CI_START="-0.27569378725511706" LOG_EFFECT_SIZE="-0.08612752806720159" METHOD="MH" MODIFIED="2016-11-16 07:23:17 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="7.459720496871824E-8" P_Q="7.52886430976929E-8" P_Z="0.37320285964577404" Q="32.80388950368776" RANDOM="NO" SCALE="279.01636187492204" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="650" TOTAL_2="600" WEIGHT="300.0" Z="0.8904899733334979">
<NAME>Number of participants with at least one adverse effect</NAME>
<GROUP_LABEL_1>Ispaghula husk</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Ispaghula husk</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.397183225387034" CI_START="0.1837955793654092" DF="0" EFFECT_SIZE="0.898989898989899" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" I2="0.0" ID="CMP-012.03.01" LOG_CI_END="0.6431745625304723" LOG_CI_START="-0.7356649384357467" LOG_EFFECT_SIZE="-0.04624518795263712" MODIFIED="2016-11-15 04:12:21 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8954024979695436" STUDIES="1" TAU2="0.0" TOTAL_1="198" TOTAL_2="178" WEIGHT="100.0" Z="0.131471288401499">
<NAME>Completers only</NAME>
<DICH_DATA CI_END="4.397183225387034" CI_START="0.1837955793654092" EFFECT_SIZE="0.898989898989899" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6431745625304723" LOG_CI_START="-0.7356649384357467" LOG_EFFECT_SIZE="-0.04624518795263712" MODIFIED="2016-11-14 09:34:34 +0100" MODIFIED_BY="[Empty name]" ORDER="858" O_E="0.0" SE="0.8099371482331649" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="198" TOTAL_2="178" VAR="0.6559981840880716" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.24886803224054868" CI_START="0.024322960039151624" DF="0" EFFECT_SIZE="0.0778023598820059" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="36" I2="0.0" ID="CMP-012.03.02" LOG_CI_END="-0.6040308860879576" LOG_CI_START="-1.6139835737067083" LOG_EFFECT_SIZE="-1.109007229897333" MODIFIED="2016-11-15 04:13:15 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.674478049098829E-5" STUDIES="1" TAU2="0.0" TOTAL_1="226" TOTAL_2="211" WEIGHT="100.0" Z="4.304388226973712">
<NAME>Best case scenario</NAME>
<DICH_DATA CI_END="0.24886803224054868" CI_START="0.024322960039151624" EFFECT_SIZE="0.0778023598820059" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="36" LOG_CI_END="-0.6040308860879576" LOG_CI_START="-1.6139835737067083" LOG_EFFECT_SIZE="-1.109007229897333" MODIFIED="2016-11-15 04:13:15 +0100" MODIFIED_BY="[Empty name]" ORDER="858" O_E="0.0" SE="0.5932512080536863" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="226" TOTAL_2="211" VAR="0.35194699585715816" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="31.088145083391144" CI_START="2.9938780106333507" DF="0" EFFECT_SIZE="9.64749262536873" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="3" I2="0.0" ID="CMP-012.03.03" LOG_CI_END="1.4925948100431867" LOG_CI_START="0.4762341004866172" LOG_EFFECT_SIZE="0.9844144552649019" MODIFIED="2016-11-15 04:13:33 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="1.4662514744684396E-4" STUDIES="1" TAU2="0.0" TOTAL_1="226" TOTAL_2="211" WEIGHT="99.99999999999999" Z="3.796716775920262">
<NAME>Worst case scenario</NAME>
<DICH_DATA CI_END="31.08814508339113" CI_START="2.9938780106333516" EFFECT_SIZE="9.64749262536873" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="3" LOG_CI_END="1.4925948100431865" LOG_CI_START="0.4762341004866173" LOG_EFFECT_SIZE="0.9844144552649019" MODIFIED="2016-11-15 04:13:33 +0100" MODIFIED_BY="[Empty name]" ORDER="858" O_E="0.0" SE="0.5970153118601812" STUDY_ID="STD-Bonithon_x002d_Kopp-2000" TOTAL_1="226" TOTAL_2="211" VAR="0.35642728259550943" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2017-01-03 17:37:08 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2017-01-02 15:51:10 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAjEAAAKqCAYAAADLzg90AABdGElEQVR42u2dD2RX3//HfyRJkpH5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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2017-01-03 17:37:08 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION/>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAjAAAAEACAMAAACavbxtAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2017-01-03 17:37:08 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION/>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAWwAAAH5CAIAAAAqVpMeAAAdlUlEQVR42u3dv44UxxrG4ZGQEAEB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==
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2017-01-02 15:52:42 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2016-08-22 11:36:43 +0200" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-08-04 09:42:13 +0200" MODIFIED_BY="[Empty name]">Cochrane Library search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-08-22 11:36:43 +0200" MODIFIED_BY="[Empty name]">
<P>#1 MeSH descriptor: [Cereals] explode all trees</P>
<P>#2 MeSH descriptor: [Dietary Fiber] explode all trees</P>
<P>#3 MeSH descriptor: [Dietary Carbohydrates] explode all trees</P>
<P>#4 (wholemeal$ or whole meal$ wholegrain$ or whole grain$ or cereal$ or grain$ or starch or high-fiber or fibre or fiber or dietary intervention or dietary carbohydrate$ or roughage$ or wheat bran$)</P>
<P>#5 (#1 or #2 or #3 or #4)</P>
<P>#6 MeSH descriptor: [Colorectal Neoplasms] explode all trees</P>
<P>#7 MeSH descriptor: [Colonic Polyps] explode all trees</P>
<P>#8 ((colorect$ or colon$ or rect$ or anal$ or anus$ or intestin$ or bowel$) near/3 (carcinom$ or neoplas$ or adenocarcinom$ or cancer$ or tumor$ or tumour$ or sarcom$ or polyp$ or adenom$))</P>
<P>#9 (#6 or #7 or #8)</P>
<P>#10 (#5 and #9)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2016-11-24 11:19:27 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2014-08-04 09:04:13 +0200" MODIFIED_BY="[Empty name]">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-11-24 11:19:27 +0100" MODIFIED_BY="[Empty name]">
<P>1. exp Cereals/</P>
<P>2. exp Dietary Fiber/</P>
<P>3. exp Dietary Carbohydrates/</P>
<P>4. (wholemeal$ or whole meal$ wholegrain$ or whole grain$ or cereal$ or grain$ or starch or high-fiber or fibre or fiber or dietary intervention or dietary carbohydrate$ or roughage$ or wheat bran$).mp.</P>
<P>5. 1 or 2 or 3 or 4</P>
<P>6. exp Colorectal Neoplasms/</P>
<P>7. exp Colonic Polyps/</P>
<P>8. ((colorect$ or colon$ or rect$ or anal$ or anus$ or intestin$ or bowel$) adj3 (carcinom$ or neoplas$ or adenocarcinom$ or cancer$ or tumor$ or tumour$ or sarcom$ or polyp$ or adenom$)).mp.</P>
<P>9. 6 or 7 or 8</P>
<P>10. 5 and 9</P>
<P>11. randomized controlled trial.pt.</P>
<P>12. controlled clinical trial.pt.</P>
<P>13. randomized.ab.</P>
<P>14. placebo.ab.</P>
<P>15. clinical trial as topic.sh.</P>
<P>16. randomly.ab.</P>
<P>17. trial.ti.</P>
<P>18. 11 or 12 or 13 or 14 or 15 or 16 or 17</P>
<P>19. exp animals/ not humans.sh.</P>
<P>20. 18 not 19</P>
<P>21. 10 and 20</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2017-01-02 15:52:42 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2017-01-02 15:52:42 +0100" MODIFIED_BY="[Empty name]">Embase search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-08-22 11:36:55 +0200" MODIFIED_BY="[Empty name]">
<P>1. *cereal/</P>
<P>2. *dietary fiber/</P>
<P>3. *carbohydrate diet/</P>
<P>4. (wholemeal$ or whole meal$ wholegrain$ or whole grain$ or cereal$ or grain$ or starch or high-fiber or fibre or fiber or dietary intervention or dietary carbohydrate$ or roughage$ or wheat bran$).m_titl.</P>
<P>5. 1 or 2 or 3 or 4</P>
<P>6. exp large intestine tumor/</P>
<P>7. ((colorect$ or colon$ or rect$ or anal$ or anus$ or intestin$ or bowel$) and (carcinom$ or neoplas$ or adenocarcinom$ or cancer$ or tumor$ or tumour$ or sarcom$ or polyp$ or adenom$)).m_titl.</P>
<P>8. 6 or 7</P>
<P>9. 5 and 8</P>
<P>10. CROSSOVER PROCEDURE.sh.</P>
<P>11. DOUBLE-BLIND PROCEDURE.sh.</P>
<P>12. SINGLE-BLIND PROCEDURE.sh.</P>
<P>13. (crossover* or cross over*).ti,ab.</P>
<P>14. placebo*.ti,ab.</P>
<P>15. (doubl* adj blind*).ti,ab.</P>
<P>16. allocat*.ti,ab.</P>
<P>17. trial.ti.</P>
<P>18. RANDOMIZED CONTROLLED TRIAL.sh.</P>
<P>19. random*.ti,ab.</P>
<P>20. 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19</P>
<P>21. (exp animal/ or exp invertebrate/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans or man or men or wom?n).ti.)</P>
<P>22. 20 not 21</P>
<P>23. 9 and 22</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2016-08-22 10:41:55 +0200" MODIFIED_BY="[Empty name]">Criteria for judging risk of bias in the 'Risk of bias' assessment tool</TITLE>
<APPENDIX_BODY MODIFIED="2017-01-02 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<TABLE COLS="2" ROWS="28">
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>
<B>Random sequence generation</B>
</P>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for a judgement of &#8216;low risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>The investigators describe a random component in the sequence generation process such as:</P>
<UL>
<LI>referring to a random number table;</LI>
<LI>using a computer random number generator;</LI>
<LI>coin tossing;</LI>
<LI>shuffling cards or envelopes;</LI>
<LI>throwing dice;</LI>
<LI>drawing of lots;</LI>
<LI>minimisation*.</LI>
</UL>
<P>*Minimisation may be implemented without a random element, and this is considered to be equivalent to being random.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;high risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some systematic, non-random approach, for example:</P>
<UL>
<LI>sequence generated by odd or even date of birth;</LI>
<LI>sequence generated by some rule based on date (or day) of admission;</LI>
<LI>sequence generated by some rule based on hospital or clinic record number.</LI>
</UL>
<P>Other non-random approaches happen much less frequently than the systematic approaches mentioned above and tend to be obvious. They usually involve judgement or some method of non-random categorisation of participants, for example:</P>
<UL>
<LI>allocation by judgement of the clinician;</LI>
<LI>allocation by preference of the participant;</LI>
<LI>allocation based on the results of a laboratory test or a series of tests;</LI>
<LI>allocation by availability of the intervention.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;unclear risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Insufficient information about the sequence generation process to permit judgement of &#8216;low risk&#8217; or &#8216;high risk&#8217;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>
<B>Allocation concealment</B>
</P>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for a judgement of &#8216;low risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation:</P>
<UL>
<LI>central allocation (including telephone, web-based and pharmacy-controlled randomisation);</LI>
<LI>sequentially numbered drug containers of identical appearance;</LI>
<LI>sequentially numbered, opaque, sealed envelopes.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;high risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on:</P>
<UL>
<LI>using an open random allocation schedule (e.g. a list of random numbers);</LI>
<LI>assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non­opaque or not sequentially numbered);</LI>
<LI>alternation or rotation;</LI>
<LI>date of birth;</LI>
<LI>case record number;</LI>
<LI>any other explicitly unconcealed procedure.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;unclear risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Insufficient information to permit judgement of &#8216;low risk&#8217; or &#8216;high risk&#8217;. This is usually the case if the method of concealment is not described or not described in sufficient detail to allow a definite judgement &#8211; for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>
<B>Blinding of participants and personnel</B>
</P>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for a judgement of &#8216;low risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Any one of the following:</P>
<UL>
<LI>no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding;</LI>
<LI>blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;high risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Any one of the following:</P>
<UL>
<LI>no blinding or incomplete blinding, and the outcome is likely to be influenced by lack of blinding;</LI>
<LI>blinding of key study participants and personnel attempted, but likely that the blinding could have been broken, and the outcome is likely to be influenced by lack of blinding.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;unclear risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Any one of the following:</P>
<UL>
<LI>insufficient information to permit judgement of &#8216;low risk&#8217; or &#8216;high risk&#8217;;</LI>
<LI>the study did not address this outcome.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>
<B>Blinding of outcome assessment</B>
</P>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for a judgement of &#8216;low risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Any one of the following:</P>
<UL>
<LI>no blinding of outcome assessment, but the review authors judge that the outcome measurement is not likely to be influenced by lack of blinding;</LI>
<LI>blinding of outcome assessment ensured, and unlikely that the blinding could have been broken.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;high risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Any one of the following:</P>
<UL>
<LI>no blinding of outcome assessment, and the outcome measurement is likely to be influenced by lack of blinding;</LI>
<LI>blinding of outcome assessment, but likely that the blinding could have been broken, and the outcome measurement is likely to be influenced by lack of blinding.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;unclear risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Any one of the following:</P>
<UL>
<LI>insufficient information to permit judgement of &#8216;low risk&#8217; or &#8216;high risk&#8217;;</LI>
<LI>the study did not address this outcome.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>
<B>Incomplete outcome data</B>
</P>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for a judgement of &#8216;low risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Any one of the following:</P>
<UL>
<LI>no missing outcome data;</LI>
<LI>reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias);</LI>
<LI>missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups;</LI>
<LI>for dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate;</LI>
<LI>for continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size;</LI>
<LI>missing data have been imputed using appropriate methods.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;high risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Any one of the following:</P>
<UL>
<LI>reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups;</LI>
<LI>for dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate;</LI>
<LI>for continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size;</LI>
<LI>&#8216;as-treated&#8217; analysis done with substantial departure of the intervention received from that assigned at randomisation;</LI>
<LI>Potentially inappropriate application of simple imputation.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;unclear risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Any one of the following:</P>
<UL>
<LI>insufficient reporting of attrition/exclusions to permit judgement of &#8216;Low risk&#8217; or &#8216;High risk&#8217; (e.g. number randomized not stated, no reasons for missing data provided);</LI>
<LI>the study did not address this outcome.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>
<B>Selective reporting</B>
</P>
<P>Reporting bias due to selective outcome reporting.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for a judgement of &#8216;low risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Any of the following:</P>
<UL>
<LI>the study protocol is available and all of the study&#8217;s pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way;</LI>
<LI>the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be uncommon).</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;high risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Any one of the following:</P>
<UL>
<LI>not all of the study&#8217;s pre-specified primary outcomes have been reported;</LI>
<LI>one or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified;</LI>
<LI>one or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect);</LI>
<LI>one or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis;</LI>
<LI>the study report fails to include results for a key outcome that would be expected to have been reported for such a study.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;unclear risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>Insufficient information to permit judgement of &#8216;low risk&#8217; or &#8216;high risk&#8217;. It is likely that the majority of studies will fall into this category.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>
<B>Other bias</B>
</P>
<P>Bias due to problems not covered elsewhere in the table.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for a judgement of &#8216;low risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>The study appears to be free of other sources of bias.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;high risk&#8217; of bias</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>There is at least one important risk of bias. For example, the study:</P>
<UL>
<LI>had a potential source of bias related to the specific study design used; or</LI>
<LI>has been claimed to have been fraudulent; or</LI>
<LI>had some other problem.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Criteria for the judgement of &#8216;unclear risk&#8217; of bias</P>
</TD>
<TD VALIGN="TOP">
<P>There may be a risk of bias, but there is either:</P>
<UL>
<LI>insufficient information to assess whether an important risk of bias exists; or</LI>
<LI>insufficient rationale or evidence that an identified problem will introduce bias.</LI>
</UL>
<P/>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2013-05-28 15:33:36 +0200" MODIFIED_BY="[Empty name]">
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;5 studies (with 17 references) were included in the meta-analysis&lt;/p&gt;" WIDTH="176">
<FLOWCHARTBOX TEXT="&lt;p&gt;7 studies (with 21 references) were included&lt;/p&gt;" WIDTH="160">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;span&gt;45 of full-text articles assessed for eligibility&lt;/span&gt;&lt;/p&gt;" WIDTH="154">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;span&gt;804 of records screened&lt;/span&gt;&lt;/p&gt;" WIDTH="159">
<FLOWCHARTBOX TEXT="&lt;p&gt;804 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;1028 records identified through database searching&lt;/p&gt;" WIDTH="176"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;0 additional records identified through other sources&lt;/p&gt;" WIDTH="168"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;&lt;span&gt;757 of records excluded&lt;/span&gt;&lt;span modified=&quot;2017-01-02 09:00:00 +0000&quot; modified_by=&quot;[Empty name]&quot; class=&quot;deleted&quot;&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p&gt;1 record was identified as an ongoing study&lt;/p&gt;&lt;p&gt;1 record was awaiting for full text&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="206"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;&lt;span&gt;20 of full-text articles (with 24 references) were excluded, with reasons given in the report&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="204"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>